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Immune modulation by 
cow’s milk components: 
Implications for respiratory health
Olaf Perdijk
Im
m
une m
odulation by cow
’s m
ilk com
ponents: Im
plications for respiratory health
O
laf Perdijk
Immune modulation by  
cow’s milk components:
Implications for respiratory health
Olaf Perdijk
18039 Olaf Perdijk PM.indd   1 04-09-18   19:56
Thesis committee
Promotors
Prof. R.J.J. van Neerven
Special professor Mucosal Immunity
Wageningen University & Research
Prof. Dr H.F.J. Savelkoul
Prof. of Cell Biology and Immunology
Wageningen University & Research
Co-promotor
Dr S. Brugman 
Assistant Professor, Cell Biology and Immunology 
Wageningen University & Research
Other members 
Prof. Dr M.A.J.S. van Boekel, Wageningen University & Research
Prof. Dr E.C. de Jong, Academic Medical Center, University of Amsterdam
Prof. Dr E. Sverremark-Ekström, Stockholm University, Sweden
Dr P.A. Würtzen, ALK-Albelló, Hørsholm, Denmark
This research was conducted under the auspices of the Graduate School Wageningen 
Institute of Animal Sciences
18039 Olaf Perdijk PM.indd   2 04-09-18   19:56
Immune modulation by  
cow’s milk components:
Implications for respiratory health
Ó.IJ. Perdijk
Thesis 
submitted in fulfilment of the requirements for the degree of doctor 
at Wageningen University 
by the authority of the Rector Magnificus, 
Prof. Dr. A.P.J. Mol, 
in the presence of the 
Thesis Committee appointed by the Academic Board 
to be defended in public 
on Friday 12 October 2018 
at 4 p.m. in the Aula.
18039 Olaf Perdijk PM.indd   3 04-09-18   19:56
Olaf Perdijk 
Immune modulation by cow’s milk components: Implications for respiratory health, 
268 pages. 
 
PhD thesis, Wageningen University, Wageningen, the Netherlands (2018) 
With references, with summaries in Dutch and English 
DOI: https://doi.org/10.18174/457213
ISBN: 978-94-6343-491-1
18039 Olaf Perdijk PM.indd   4 04-09-18   19:56
voor Anouk
18039 Olaf Perdijk PM.indd   5 04-09-18   19:56
List of Abbreviations
1,25(OH)2D3: VitD3
Alkaline phosphatase:  ALP
Bovine lactoferrin: LF
C-C chemokine receptor: CCR
Chemokine (C-C motif ) ligand: CCL
Cluster of differentiation: CD
Dendritic cells: DC
Endotoxin unit: EU
Epidermal growth factor: EGF
Fc epsilon receptor I: FcεRI
Fructooligosaccharides: FOS
Fucosyllactose: FL
G protein coupled receptor: GPR
Galactooligosaccharides: GOS
Gastrointestinal: GI
Granulocyte-macrophage colony-stimulating factor: GM-CSF
Gut-associated lymphoid tissue: GALT
House dust mite: HDM
Human milk oligosaccharides: HMO
Immunoglobulin: Ig
Innate lymphoid cells: ILC
Interferon gamma: IFNg
Interleukin: IL
Lipopolysaccharide: LPS
Mesenteric lymph node: MLN
monocyte-derived DC: moDC
Neonatal Fc receptor: FcRn
Nuclear factor kappa-light-chain-enhancer of activated B cells: NF-kB
Ovalbumin: OVA
Pathogen-associated molecular pattern: PAMP
Peripheral blood mononuclear cells: PBMCs
Plasmacytoid DC: pDC
Polyinosinic-polycytidylic acid: Poly I:C
Programmed death-ligand 1: PD-L1
Regulatory T cells: Tregs
Resiquimod: R848
Respiratory syncytial virus: RSV
Retinoic acid: RA
Short chain fatty acids: SCFA
Sialyllactose: SL
T helper: Th
Thymic stromal lymphopoietin: TSLP
Tight junction: TJ
Toll-like receptor: TLR
Transforming growth factor: TGF
Tumor necrosis factor alpha: TNF
Very low birth weight: VLBW
18039 Olaf Perdijk PM.indd   6 04-09-18   19:56
Table of Contents
Chapter 1 General introduction 9
Chapter 2 Cow’s milk and immune function in the respiratory tract: 
potential mechanisms
21
Chapter 3 Bovine lactoferrin modulates dendritic cell differentiation and 
function
43
Chapter 4 Optimized triton X-114 assisted lipopolysaccharide (LPS) 
removal method reveals the immunomodulatory effect of food 
proteins
63
Chapter 5 Induction of human tolerogenic dendritic cells by 
3’-sialyllactose via TLR4 is explained by LPS contamination
85
Chapter 6 The oligosaccharides 6’-sialyllactose, 2’-fucosyllactose or 
galactooligosaccharides do not directly modulate human 
dendritic cell differentiation or maturation
105
Chapter 7 Sialyllactose and galactooligosaccharides promote epithelial 
barrier functioning and distinctly modulate microbiota 
composition and short chain fatty acid production
125
Chapter 8 3’SL increases Akkermansia prevalence in mice fed a low-fiber diet 155
Chapter 9 General discussion 175
Appendix I Mucosal immune development in early life: setting the stage 203
References 226
Summary 255
Acknowledgments 260
About the author
List of publications
Overview of completed training activities
263
265
267
18039 Olaf Perdijk PM.indd   7 04-09-18   19:56
18039 Olaf Perdijk PM.indd   8 04-09-18   19:56
Chapter 1
General Introduction
18039 Olaf Perdijk PM.indd   9 04-09-18   19:56
18039 Olaf Perdijk PM.indd   10 04-09-18   19:56
1General Introduction
11
Introduction
It has been almost 30 years since Strachan postulated the hygiene hypothesis stating 
that our Western lifestyle (i.e. a more hygienic environment) may be the underlying 
cause of the rise in allergy and asthma prevalence in the Western world1. To date, 
an estimated 30% of the world population is suffering from allergies and asthma 
that are causing dramatic health- and economic effects2,3. Additionally, we know that 
our mucosal immune system and microbiota, shaped in early life, influence disease 
prevalence later in life. Despite recommendations by the World Health Organization 
and scientific evidence showing health benefits (e.g. increased cognitive ability, 
reduced gastrointestinal and respiratory infections and reduced diabetes prevalence) 
of breastfeeding 4, the majority of children is not exclusively breastfed in the first six 
months of life. However, epidemiological studies report conflicting results on the 
association between breastfeeding and allergy prevalence, which may be explained 
by individual differences in breast milk composition5,6. Thus, we are far from 
understanding the interplay between early life nutrition, microbiota, and immunity 
and their relation in allergy and asthma prevalence. Hence, there is a pressing need to 
better understand the impact of early life nutrition on the health of neonate in order 
to design effective preventive strategies.
Allergies
Allergies are induced by a classical T helper (Th) 2-mediated immune response that is 
initiated in two phases: the sensitization and effector phase. In the sensitization phase, 
resident allergen-exposed dendritic cells (DC) mature and migrate in a C-C chemokine 
receptor type 7 (CCR7)-dependent manner to the draining lymph node and trigger 
the polarization of naïve T cells into allergen-specific Th2 cells. This allergen-driven 
programming of DC is enhanced by epithelial-derived chemokines and cytokines 
(e.g. thymic stromal lymphopoietin (TSLP) and alarmins like interleukin (IL)-33) 
that are produced upon allergen exposure. These soluble compounds also activate 
type 2 innate lymphoid cells (ILC2) that enhance the allergic cascade by producing 
IL-5 and IL-137,8. Allergen-specific Th2 cells play a central role in the induction 
of allergy by subsequent induction of IL-4 driven IgE class-switching in B cells. 
Allergen-specific IgE consequently binds to the high affinity Fc epsilon receptor I 
(FcεRI) on mast cells and basophils. Upon re-exposure, the allergen binds to IgE and 
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may induce cross-linking of these specific IgE antibodies, which results in the release 
of soluble mediators (e.g. histamine) that cause characteristic symptoms of IgE-
mediated allergy8. This Th2-mediated response is thought to have evolved to tackle 
helminth infections, but is now triggered by harmless antigens (e.g. birch pollen), 
causing the pathogenesis of allergy. In early life, this pathogenesis may be prevented 
by exposure to environmental factors (e.g. diet) that trigger the development of a 
local immunosuppressive microenvironment, which allows tolerogenic responses to 
be mounted against the particular allergen. An integrated overview of the mucosal 
immune system is required to understand this complex interplay between diet 
and local and systemic immunity. We will therefore give a brief introduction of 
the different players in the gastrointestinal (GI) immune system that play a role in 
maintaining immune homeostasis.
The larynx-associated and gastrointestinal mucosal 
immune system
The larynx-associated lymphoid tissue comprises of the palatine- and lingual tonsils9. 
The lymphoid structures in the oropharynx have organized lymphoid structures 
similar to those found in the intestine (i.e. Peyer’s Patches)9. Here, structurally intact 
(i.e. functional) proteins can interact with the immune system before being hydrolyzed 
in the intestine. These lymphoid structures are covered by epithelial cells similar to 
M-cells in the gut, which are specialized in antigen uptake. After swallowing, dietary 
antigens are exposed to enzymatic hydrolysis in the small intestine, where they come 
into contact with the GI immune system.
The GI tract has a staggering surface area of 400 m2 that contains 5-20% of all 
lymphocytes in the body10. The GI tract hosts an intimate symbiotic relationship 
between our microbiota and the mucosal immune system. The microbiota (3.8*1013) 
outnumber the total number of body cells (3*1013)11,12. The GI immune system is 
covered by a single layer of epithelial cells, covering a loose layer of connective tissue 
(called the lamina propria in the gut) that rapidly renews every 3-4 days. Antigens are 
taken up by epithelial cells, specialized sampling DC13 or via the neonatal Fcγ receptor 
(FcRn) if the antigen is coated with IgG. FcRn-mediated signaling induced by breast 
milk-derived allergen-specific IgG complexes was shown to be essential in the induction 
of tolerance towards allergens in animal models14–16.
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Epithelium and mucus – the first physical barrier
The epithelial cells of the intestine are covered by a thick layer of secreted mucus 
that is constantly shed by epithelial goblet cells. Mucus shields proteins expressed on 
epithelial cells from proteolysis, prevents epithelial cells from dehydration by its high 
hydrophobicity (i.e. >98% water) and it actively forms the first physical barrier17. 
Unlike the small intestine that consists of a single layer of mucus and where bacteria 
may come into contact at the villi tops, in the colon the mucus layer consist of two 
layers that act as a size exclusion filter, preventing direct contact between bacteria 
and epithelium17. Many commensal bacteria are capable of utilizing this outer mucus 
layer of the colon for their growth. Epithelial cells are covered in this thick layer of 
mucus. The epithelium is constantly renewed by stem cells that are located at the 
bottom of the intestinal crypts. In the small intestine, stem cells reside that undergo 
asymmetrical cell division, that results in one transitional effector cell and one stem 
cell18. These transitional effector cells differentiate into four different epithelial 
subsets: columnar cells, Paneth cells, goblet cells and endocrine cells that regulate 
barrier functioning, secrete anti-microbial peptides, produce mucus and hormones, 
respectively19. Columnar cells, also called enterocytes or colonocytes in the small and 
large intestine, respectively, form the first physical layer of the immune system. These 
columnar cells have a strong polarized morphology and functionality. Moreover, the 
apical side of the enterocytes has microvilli, contains specific transporters to import 
nutrients and expresses Toll-like receptor (TLR) that recognize TLR ligands. This 
apical TLR signaling was shown to contribute to barrier functioning and immune 
homeostasis via several mechanisms20. Enterocytes are linked to each other by 
tight junction proteins that regulate paracellular transport and only allow selective 
transport of small molecules (i.e. proteins of <0.5kDa) while preventing pathogens 
or pathogen-associated molecular patterns (PAMPs) to pass through the barrier21.
DC and macrophages
The key innate immune cell that is capable of orchestrating immune responses by 
activating cells of the adaptive immune system in the periphery are DC. Monocytes 
and DC differentiate from a common macrophage dendritic cell progenitor cell 
that gives rise to four distinct human cell types in the blood: two different types of 
classical DC (CD1c+ DC and CD141+ DC), plasmacytoid DC and monocytes22,23. 
18039 Olaf Perdijk PM.indd   13 04-09-18   19:56
Chapter 1
14
In the intestine, CX3CR1+ DC are capable of continuous sampling of antigens from 
the lumen, while DC subsets are more specialized to modulate mucosal T cell biology 
(e.g. CD103+ DC) upon activation13. CD103+ DC are derived from pre-DC and 
may receive their antigens from goblet cells24. Interestingly, these DC were shown 
to migrate to the mesenteric lymph node where they induce FoxP3+ regulatory 
T cell formation and instruct these cells to migrate back to the lamina propria to 
suppress local immune responses25–27. A local microenvironment comprising dietary 
components and microbial- or epithelial derived molecules potentially induces 
the differentiation of pre-DC into CD103+ DC25. Not only intestinal CD103+ 
DC migrate to the lymph node, but also CD103- DC are capable of doing so28. 
Additionally, a population of tissue-resident macrophages (e.g. Langerhans- and 
microglia cells) are derived from the yolk sack and are already seeded before birth29. 
In contrast to the skin and brains, the GI tract relies on a constant recruitment of 
monocytes to retain its tissue-resident macrophage population30. These macrophages 
produce IL-10 and TGFβ and are resistant to TLR stimulation30. Therefore, it was 
postulated that the GI tract is in a constant state of primed homeostasis in which the 
microbiota, diet or microbial derived product trigger a continuous tolerant state of 
macrophages and DC31.
Adaptive immunity
The induction of oral tolerance towards dietary antigens is still poorly understood. 
FoxP3+ regulatory T cells (Tregs) are abundantly present in the intestine but 
not in secondary lymphoid tissues, implying that they play an active role in the 
induction and maintenance of tolerance to food antigens. The concept of oral 
tolerance induction towards food proteins that can suppress subsequent systemic 
immune responses is already known for over 100 years32. However, only recently 
it was formally shown in mice that normal chow induced short-lived regulatory T 
cells in the periphery that are mainly detected in the small intestine and in lower 
numbers in the colon33. These regulatory T cells are instructed by CD103+ DC in 
the mesenteric lymph node to migrate back to the lamina propria where they produce 
high levels of immunosuppressive cytokines such as IL-10 and TGFβ32. Although 
the exact mechanism of this “bystander tolerance” is poorly understood, it is clear 
that oral tolerance can subsequently suppress the induction of systemic inflammatory 
responses32,34. As such, antigen-specific induced FoxP3- IL-10 producing Tregs (also 
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called type 1 Tregs or Tr1) are well-known to inhibit allergic responses (e.g. Tr1 are 
enhanced in successful immunotherapy)8. Similarly, IL-10 producing B cells (Bregs) 
were elevated after allergen-specific immunotherapy. Breg-derived plasma cells 
produce high levels of IgG4, which are known to block binding of allergen-specific 
IgE antibodies to FcεRI, and thereby prevent allergic sensitization35. Allergen-specific 
IgG4 antibodies are of similar affinity than IgE and are produced in at least a 1000-
fold excess compared to IgE. This competition is therefore very effective in blocking 
development of allergic symptoms. Interestingly, Bregs were shown to be induced by 
type 3 innate lymphoid cells (ILC3) in the palatine tonsils and were less prevalent in 
allergic individuals36. Hence, it is of interest to identify whether dietary compounds 
(e.g. intact proteins) are capable of restoring the allergy-dependent reduction in ILC3 
and Bregs in the pharynx.
Microbiota and microbial-derived metabolites
The microbiota colonizes the newborn’s gut upon birth and is further shaped 
by breast milk in early life – a process essential for the infant to adapt to its new 
environment37. Breastfeeding was shown to affect the microbiota composition in the 
nasopharynx38 and gut39. In the nasopharynx of six-week old breastfed infants, the 
lactate producing bacterium Dolosigranulum was more abundant compared to bottle-
fed infants of the same age. Its prevalence was inversely correlated with wheezing 
and mild respiratory symptoms38. In the gut, the predominant breast milk-derived 
components that influence microbiota composition are human milk oligosaccharides 
(HMO). HMO function as an important carbon source for specific microbes in 
the colon40. Breastfed infants show a higher abundance of Bifidobacteria and other 
bacteria considered as health-promoting bacteria (e.g. B. longum, L. johnsonii and L. 
casei)39. These bacteria produce metabolites such as short chained fatty acids (SCFA). 
In the last decade, in vitro- and animal models showed that SCFA can inhibit local 
and systemic inflammation and prevent diseases such as allergy and asthma12,41–46.
Breast milk and early life development
Viviparity has evolved multiple times in vertebrates, implying that it has a strong 
fitness advantage47. Viviparity gives the unique opportunity to nourish the newborn 
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during pregnancy and in early life, which gives the mother the chance to supply 
her infant with the best nutrition. Because of this intimate relationship between 
mother and child, the pre- and postnatal lifestyle of the mother impacts the health 
of the infant. Moreover, maternal diet and microbial-derived products aid in the 
development of the mucosal immune system of the unborn child48. After birth, the 
neonate receives a unique mixture of components (e.g. proteins, lactose, fat, lipids, 
oligosaccharides, vitamins) in the form of breast milk that further enhances the 
development of the neonate’s immune system. We have recently reviewed the effect 
of this dietary and microbial exposure on fetal and neonatal immune development 
and will therefore not further introduce it here49 (Appendix I). Thus, breast milk 
aids in the development of immune homeostasis and tolerance induction. This 
oral tolerance may suppress subsequent inflammation after exposure to airborne 
or dietary allergens32,34. Moreover, breast milk contains several immunoregulatory 
cytokines (e.g. TGFβ and IL-10)50, compounds that promote outgrowth of beneficial 
bacteria (e.g. human milk oligosaccharides promoting outgrowth of bifidobacteria), 
antimicrobial proteins that prevent outgrowth of pathogenic bacteria (e.g. lactoferrin 
(LF), lactoperoxidase) and factors promoting epithelial barrier functioning (e.g. EGF 
and TGF-β)34. 
Aims of this thesis
Several epidemiologic studies conducted at different sites in the world (New-Zealand, 
Europe and the U.S.A.) show that the consumption of raw cow’s milk in early life is 
inversely correlated with the development of allergies and asthma. Controlled studies 
with unprocessed cow’s milk in infants are impossible due to safety and ethical reasons 
and thus causality cannot formally be proven. Therefore, we used animal and in vitro 
models to identify functional allergy and immunomodulating milk components, 
which subsequently may allow human intervention studies. Therefore, the overall 
aim of this thesis was to investigate the effect of raw cow’s milk and its components 
on maintenance of mucosal immune homeostasis. Since the link between diet and 
respiratory health is still poorly understood, we summarized potential mechanisms by 
which cow’s milk may improve respiratory health in chapter 2.
One of the proteins in cow’s milk that may aid in immune homeostasis in early life 
is LF. Moreover, LF supplementation has been shown to prevent sepsis in low birth 
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weight infants and prevent viral infections. Although in vitro evidence also indicates 
that LF is an important immunomodulatory protein, its mechanism of action is poorly 
understood. In chapter 3 we investigated the effect of LF on human DC differentiation 
and functioning. It is challenging to investigate the immunomodulatory effect of LF 
since it binds the highly immunogenic gram-negative constituent LPS. We therefore 
tested multiple methods to verify that the protein structure was responsible for the 
immunogenic effect. One of these methods is described in chapter 4. In this chapter, 
we optimized an existing method to remove LPS from protein samples using Triton 
X-114. Importantly for the immunogenicity of the food protein of interest, we 
investigated whether the three-dimensional structure of the protein remained intact 
after applying the optimized Triton X-114 method.
Cow’s milk based infant nutrition is currently supplied with lactose-derived (i.e. 
GOS) or plant-derived oligosaccharides (e.g. FOS). Breast milk contains, in contrast 
to cow’s milk, a wider variety and larger quantity of HMO compared to cow’s milk. 
Hence, it is of interest to identify the functionality of these HMO to improve infant 
nutrition. One of the few oligosaccharides present in cow’s milk that can be isolated 
and represent a commercial interest is sialyllactose. Upon digestion, a fraction of the 
milk oligosaccharides may be taken up into the bloodstream and modulate immune 
cells. Therefore, our second aim was to assess the direct effects of milk oligosaccharides 
on the immune system. Hence, in chapter 5 we investigated the immunomodulatory 
effect of 3’SL. Many milk oligosaccharides were shown in literature to exert their 
immunogenicity via interacting with TLR4. As such, 3’SL was shown to exert 
immunomodulatory effects in a TLR4 dependent manner in mice. Hence, we 
investigated the effect of 3’SL on human TLR4 signaling and DC differentiation. 
Other mucosal factors present in cow’s and human milk are TGFβ and the inactive 
and active form (1,25(OH)2D3: abbreviated as VitD3) of vitamin D3. These factors 
are well-known to induce differentiation of monocytes into tolerogenic DC and 
might thereby modulate activity of the immune system. In chapter 6 we used these 
factors as benchmark to assess the effect of the milk trisaccharides 2’FL and 6’SL and 
the prebiotic galactooligosaccharides (GOS) on DC differentiation. Additionally, we 
used these TGFβ- and vitD3DC to investigate the effects of 6’SL, 2’FL and GOS on 
DC maturation.
The first important component of the immune system that comes into contact with 
milk oligosaccharides are the epithelial cells in the oral cavity. Subsequently, a large 
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fraction of milk oligosaccharides passes through the GI tract without being absorbed 
or digested and end up intact in the colon. It is thought that newborns have an 
immature epithelial layer and that factors in breast milk may aid in epithelial barrier 
functioning. Additionally, milk oligosaccharides function as an important carbon 
source that can be utilized by the microbiota, which produce metabolites such as 
anti-inflammatory SCFA. Although mechanistic evidence in animal models stresses 
the importance of nutrition on the host, the impact of prebiotic or HMO in early 
life is poorly understood. Therefore, in chapter 7 we study the effect of sialyllactose 
and GOS on epithelial barrier functioning, microbiota composition and SCFA 
production in vitro. Finally, we aimed to extrapolate these in vitro findings to an 
OVA-induced asthma model. In chapter 8 we used this model to determine whether 
sialyllactose or raw cow’s milk could alleviate OVA-induced asthma via modulating 
the microbiota (Figure 1). In chapter 9, the results of the previous chapters are 
discussed and integrated with respect to the further mechanistic understanding of the 
immunomodulatory capacity of raw bovine milk and its components. These insights 
might aid in rational design of future intervention strategies with raw bovine milk or 
relevant components derived thereof.
Figure 1. Overview of the investigated (raw cow’s milk-derived) components and their effects on different 
players of the mucosal immune system.
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Abstract
During the last decades, the world has witnessed a dramatic increase in allergy 
prevalence. Epidemiological evidence shows that growing up on a farm is a protective 
factor, which is partly explained by the consumption of raw cow’s milk. Indeed, 
recent studies show inverse associations between raw cow’s milk consumption in early 
life and the prevalence of asthma, hay, fever and rhinitis. A similar association of 
raw cow’s milk consumption with respiratory tract infections is recently found. In 
line with these findings, controlled studies in infants with milk components such 
as lactoferrin (LF), milk fat globule membrane, and colostrum IgG have shown 
to reduce respiratory infections. However, for ethical reasons, it is not possible to 
conduct controlled studies with raw cow’s milk in infants, so formal proof is lacking 
to date. Because viral respiratory tract infections and aeroallergen exposure in children 
may be causally linked to the development of asthma, it is of interest to investigate 
whether cow’s milk components can modulate human immune function in the 
respiratory tract and via which mechanisms. Inhaled allergens and viruses trigger local 
immune responses in the upper airways in both nasal and oral lymphoid tissue. The 
components present in raw cow’s milk are able to promote a local microenvironment 
in which mucosal immune responses are modified and the epithelial barrier is 
enforced. In addition, such responses may also be triggered in the gut after exposure 
to allergens and viruses in the nasal cavity that become available in the GI tract 
after swallowing. However, these immune cells that come into contact with cow’s 
milk components in the gut must recirculate into the blood and home to the (upper 
and lower) respiratory tract to regulate immune responses locally. Expression of the 
tissue homing-associated markers α4β7 and CCR9 or CCR10 on lymphocytes can 
be influenced by vitamin A and vitamin D3, respectively. Since both vitamins are 
present in milk, we speculate that raw milk may influence homing of lymphocytes to 
the upper respiratory tract. This review focuses on potential mechanisms via which 
cow’s milk or its components can influence immune function in the intestine and the 
upper respiratory tract. Unraveling these complex mechanisms may contribute to the 
development of novel dietary approaches in allergy and asthma prevention.
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2
Introduction
In the Western world, the prevalence of chronic inflammatory diseases, including 
allergies, has increased dramatically in the last few decades, while the number of 
serious infectious diseases has declined rapidly51. An inverse correlation, indicating a 
“protective effect” of infectious diseases against chronic inflammatory diseases (e.g. 
allergy and asthma), was postulated in 1989 by Strachan, who formulated the hygiene 
hypothesis1. The hygiene hypothesis suggests that the exposure to viruses and bacteria is 
essential to induce a T-helper (Th)1 response, which balances the immune system and 
protects against Th2-mediated diseases. With the discovery of additional T cell subsets 
such as Th17 cells and regulatory T cells (Tregs), this paradigm had to be revised. 
For example, it was demonstrated that suppressive dendritic cells (DCs) induced by 
helminths restored the disturbed Th1/Th2 balance by induction of Tregs52. The immune 
education of DCs was suggested to be an important step toward understanding the 
complex relation between infectious diseases and allergies53. Th2 responses are now 
known to be enhanced by the production of type 2 cytokines (e.g. TSLP, IL-25, IL-33) 
secreted by group 2 innate lymphoid cells and epithelial cells7,54. Thus, different cell 
types are responsible for Th2-mediated diseases such as allergies. Allergy is initiated as 
an aberrant immune response towards a harmless antigen (allergen). Via activation of 
Th2 cells, the allergen triggers the production of allergen-specific IgE by B cells that 
binds to high-affinity FcεR1 on effector cells like mast cells and basophils. Effector 
cells release soluble factors (e.g. histamine) upon secondary exposure to the allergen 
that cause immediate type I allergic symptoms. The term “atopic march” refers to the 
sequence of IgE responses and clinical symptoms initiated in early life55.
In the first year of life, the mucosal immune system is shaped by microbial colonization 
and dietary components, which contributes to health later in life49. Viral infections 
during this critical period also impact health later in life. For example, respiratory 
syncytial virus (RSV) infection in early life was shown to increase the risk of wheezing 
up to 11 years of age56 and allergic sensitization and development of asthma into 
adulthood57–59. The exact mechanism by which allergy and viral infection in the upper 
airways results in the development of asthma is not yet elucidated. However, Holt 
and Sly60 proposed a mechanism in which viral infection can trigger excessive type I 
interferon production that can result in upregulation of FcεR1 expression on airway 
resident DCs. FcεR1-mediated signaling in DCs has been suggested to contribute 
to allergic airway inflammation depending on the environmental stimuli61. In mice, 
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cross-linking of virus-specific IgE on these airway DCs results in the production of 
Th2 cytokines and the chemoattractant CCL28, recruiting effector Th2 cells to the 
airways62,63. However, recent evidence shows that not all asthma patients have this 
typical Th2 profile in early life64. Nevertheless, atopy and viral infections in early life 
are risk factors for asthma development. Therefore, preventive strategies for asthma, 
such as dietary interventions, should be targeted at early life to suppress allergen- or 
viral-induced airway inflammation.
In Europe, rapid evolutionary changes are found in the lactase persistence gene 
suggesting health benefits of cow’s milk consumption to humans (Box 1). The 
existing epidemiological evidence shows that consumption of cow’s milk in early life is 
associated with a lower prevalence of allergies, respiratory tract infections, and asthma. 
This suggests that milk components (e.g. proteins, sialylated oligosaccharides, and 
vitamins) may contribute to the protection against the development of allergies65 and 
respiratory viral infections66. Since raw cow’s milk may contain pathogenic bacteria, 
intervention studies in infants are impossible due to safety risks. Nevertheless, a 
recent mouse study showed a causal relation between raw milk consumption and 
the protection against house dust mite (HDM)-induced asthma, which was not seen 
in mice receiving heated milk67. The mechanisms underlying this protective effect 
of raw cow’s milk remains speculative. Therefore, in this review we discuss potential 
mechanisms by which dietary components, using cow’s milk as an example, can 
protect against airway inflammation.
Box 1.
The consumption of cow’s milk in Europe and the Middle East already dates back to the Neolithic 
cultural period. Milk fatty acids were traced by carbon isotope analysis on Middle Eastern pottery, 
showing that cow’s milk was already processed since 6500 BC68. This introduction of processed 
ruminant milk might explain why it was adopted so quickly, despite lactose intolerance. Lactase 
persistence (i.e., the capacity to digest lactose into adulthood) seems to have arisen around 5500 
BC in the European population due to a specific mutation in the gene encoding the lactase 
enzyme69. Its rapid expansion in the ancestral population suggests high selective pressure70. 
This makes it appealing to speculate that this mutation confers health benefits to the host by 
consuming cow’s milk.
Homology Between Cow’s Milk and Breast Milk
By comparing the immunomodulatory components in breast milk with those 
in cow’s milk, conserved mechanisms could be identified, which contribute to 
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immune homeostasis in early life. Overall bovine and human milk contain similar 
components. However, the concentration or presence of several specific components 
(e.g. β-lactoglobulin specific for cow’s milk) may differ. For a complete overview 
comparing breast milk and cow’s milk, we refer to a review by van Neerven et al. 
(2012) who compared the composition of breast milk to cow’s milk65. We briefly 
describe several immunomodulatory components in cow’s milk that are used in this 
review to illustrate potential mechanisms by which cow’s milk may affect respiratory 
health.
Systematic reviews conclude that TGFβ consumption in early life protects against 
allergies in humans and animal models71,72. Strikingly, the active forms of TGFβ1 and 
TGFβ2 are identical between cow and human73. Although articles report different 
concentrations of TGFβ in breast and cow’s milk, there is a consensus that TGFβ2 is 
several fold more abundant compared to TGFβ171,74. Remarkably, the concentrations 
of TGFβ1 and TGFβ2 are approximately fivefold more abundant in cow’s milk 
compared to breast milk65. The concentration of TGFβ1 in cow’s milk decline 
significantly after processing and are non-detectable in processed milk75.
Bovine lactoferrin (LF) has 77% homology to human lactoferrin on mRNA level and 
69% on protein level76. Nevertheless, LF is taken up by the human lactoferrin receptor 
and exerts similar bioactivities as human lactoferrin on human colon epithelial cells 
such as induction of proliferation, differentiation, and TGFβ expression77. Similarly, 
bovine IL-10 is 76.8% homologous and affects human cells50. Cow’s milk shows 
lower IgA and higher IgG levels compared to human milk65.
While the quantities of proteins in human milk are quite similar to cow’s milk, 
the oligosaccharide composition is completely different. In contrast to cow’s milk, 
human milk is unique among mammals in its high and diverse levels of complex 
oligosaccharides40. Cow’s milk contains only small amounts and a non-diverse profile 
of oligosaccharides, which is dominated by sialylated oligosaccharides. Therefore, 
this review will only address the effect of sialylated oligosaccharides present in cow’s 
milk. In colostrum, the concentrations of sialylated oligosaccharides range between 
0.23–1.5 and 1–3.3g/L in cows and humans, respectively78. The concentrations of 
sialylated oligosaccharides in mature bovine milk are approximately 10-fold lower 
compared to colostrum78. Most sialylated oligosaccharides in human- and cow’s milk 
are monomeric [e.g. 3'-sialyllactose (3'SL) and 6'-sialyllactose (6'SL)] and are present 
in very low concentrations in infant formulas79.
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Vitamin A and D, which are not specific for cow’s milk, are essential for the 
development of the mucosal immune system. Vitamin A can be obtained from 
different dietary sources and can be converted to its active metabolite retinoic acid 
(RA) by epithelial cells and DCs in the gut80. Breast milk contains, depending on 
the vitamin D status of the mother, low levels of vitamin D3, and additional vitamin 
D3 supplementation is recommended for infants81. Cow’s milk contains similar 
concentrations of vitamin A, vitamin D3, and 1,25(OH)2D3(active form of vitamin 
D3) compared to breast milk65,82.
Epidemiological Evidence for the Immune Modulatory 
Role of Cow’s Milk on Respiratory Health
It is now well established that children growing up on a farm less often develop 
allergies and asthma83. Of the different environmental factors investigated in these 
epidemiological studies, contact with farm animals, endotoxin levels in house dust, 
and the consumption of farm milk (i.e., cow’s milk with an unknown heating status) 
showed the strongest association with the protection of childhood asthma and 
allergy83,84. The consumption of farm milk was associated with higher Treg numbers 
in blood, which were negatively associated with asthma and serum IgE levels85. 
Moreover, increased demethylation of the FOXP3 gene and increased FoxP3+ T cell 
numbers were detected in PBMC cultures of children who were exposed to farm milk, 
suggesting that farm milk consumption induces an immunoregulatory phenotype.
Raw cow’s milk consumption in the first year of life showed an inverse correlation 
with the prevalence of atopy and doctors-diagnosed asthma in farmers and non-
farmers86. This study showed that raw cow’s milk consumption in the first year of 
life is inversely associated with atopic sensitization and asthma independently of the 
farming environment. Children who consumed raw cow’s milk produced higher 
IFNγ levels upon whole blood stimulation87. Since IFNγ production is associated 
with a Th1 profile, this finding—even though counterbalancing Th2 responses—
is in contrast to studies showing a regulatory phenotype induced by farm milk 
consumption in the first year of life85. Nevertheless, both studies show that either raw 
cow’s milk or farm milk is associated with lower total serum IgE levels and allergic 
diseases85,87. Other epidemiological studies have specifically addressed the question 
whether heating of farm milk influences its effect on allergic diseases.
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Loss et al. (2011), showed that the protective effect of cow’s milk on asthma and 
hay fever incidence was only noted in children who consumed raw milk and not 
in children who consumed high heat-treated shop milk (>85°C)88. Indeed, the 
thermosensitive whey proteins BSA, α-lactalbumin, and β-lactoglobulin were 
associated with the protective effects. Similar trends were found for LF and total IgG. 
No associations were found between microbiological communities or cell counts in 
the milk, showing that the protective effect was not primarily caused by bacteria in 
the raw cow’s milk88. A follow-up study investigated the association between raw, 
boiled, or commercially available cow’s milk consumption and the occurrence of 
common infections in infants (2–12 months of age). In comparison to ultra-heat-
treated milk, raw milk consumption in the first year of life was inversely associated 
with the occurrence of rhinitis, otitis, and respiratory tract infections at 12 months 
of age. In addition, soluble CRP levels were lower in the infants that received raw 
cow’s milk. Interestingly, respiratory tract infections and fever were also reduced 
in infants receiving boiled cow’s milk66. It was suggested that the milk fat globule 
membrane contributes to this negative association between boiled milk consumption 
and respiratory tract infections66. Indeed, non-heat-sensitive cow’s milk components 
may also contribute to the induction of a regulatory phenotype85. Nevertheless, these 
studies show that the thermosensitive fraction of the milk (i.e., proteins, most likely 
whey fraction) is an important driver of the protection against not only allergies and 
asthma but also viral infections, fever, and inflammatory conditions in the upper 
airways.
These epidemiological findings cannot be confirmed in controlled intervention studies 
in infants due to safety risks. However, controlled trails with infants fed experimental 
infant formulas rich in immune-related bovine milk components have shown effects 
on respiratory tract infections. Infants fed with a bovine milk fat globule membrane 
preparation rich in IgG and LF showed a reduced prevalence of acute otitis media 
and showed lower pneumococcal-specific IgG levels in serum89. Similarly, infants of 
4–6 months of age receiving infant formula supplemented with LF showed fewer 
respiratory illness90,91. A reduction in respiratory tract infections was also observed in 
an intervention study with children of 1–6 years of age receiving bovine colostrum 
that is extremely rich in IgG92. These findings indicate that bovine milk components 
may prevent respiratory tract infections in early life.
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Passage Through the Gastrointestinal Tract
After swallowing milk components, allergens, or pathogens, they pass through the GI 
tract and are exposed to different pH levels and proteases, varying from pancreatic, 
gastric, or peptidases on the enterocytic brush border. In adults, there is little evidence 
that intact dietary proteins can reach the circulation in homeostasis93. In early life, 
however, the digestion of proteins is lower compared to adults, which has several 
causes. First, the gastric acid production in infants only reaches the levels of adults 
after 6 months of age. Infants therefore have a higher pH in the stomach compared to 
adults. Lower gastric acid levels impair the activity of pepsins. Second, concentrations 
of other proteases (e.g. chymotrypsin and enterokinase) are significantly lower in the 
small intestine of neonates (10–60% of that of adults) compared to adults94. Thus, in 
infants, a significant fraction of milk proteins reaches the small intestine intact and 
may interact with intestinal immune cells (e.g. epithelial cells and sampling DC). 
For instance, 10% of the orally fed bovine IgG (bIgG) can be found in stool of 
infants, compared to <0.1% in adults95. In addition, the infants gut is in a “leaky 
state”96, which may promote sensitization to allergens and bacteria- or virus-induced 
inflammation. On the other hand, it is a window in which (milk-derived) components 
have an opportunity to induce tolerance.
Some milk proteins are less sensitive to the low pH and proteases and pass the GI 
tract intact or can even be activated by an acidic environment or protease activity. For 
instance, TGFβ, which is present in milk in its latent form first needs to be activated 
before exerting any effector function. The activation of this exogenous latent TGFβ 
can be triggered by multiple factors such as macrophages membrane-bound receptor 
TSP-1, αvβ-3/5/6 and αvβ8 integrins, ROS, low pH during passage of the stomach, 
and proteases97,98. Thus, TGFβ can be activated by binding integrins in the upper 
airways or by activation in the stomach and small intestine. Significant amounts 
of the abundant milk protein LF reach the small intestine intact and retain their 
functional activity in both adults and infants76.
In contrast to proteins, milk oligosaccharides escape enzymatic hydrolysis in the small 
intestine and low pH of the stomach and are fermented in the colon99. By escaping 
degradation in the small intestine, they function as a carbon source for the microbiota 
in the colon and can be converted into metabolites such as short-chain fatty acids 
(SCFAs). In breastfed infants, the genus Bifidobacterium is commonly present, which 
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comprises mainly comprises mainly of Bifidobacterium bifidum, Bifidobacterium 
longum subsp. infantis, and Bifidobacterium breve. Of the three, B. longum infantis 
has the right machinery to ferment sialylated oligosaccharides directly100,101 and is 
unique in its ability to import and degrade low-molecular-weight oligosaccharides102. 
Indeed, several B. longum strains were capable of converting 3'SL and 6'SL, which 
are abundantly present in bovine milk, into SCFA in vitro103. Nevertheless, it is 
unknown whether the concentrations of sialyllactose present in cow’s milk alters the 
microbiota in vivo. B. longum is abundantly present in breast-fed neonates and is 
thought to confer various health benefits (e.g. enhanced barrier functioning and anti-
inflammatory effects) to the host104. Although most of these sialylated oligosaccharides 
are fermented by these Bifidobacteria, a small fraction of oligosaccharides reaches 
the circulation intact105,106. Therefore, sialylated oligosaccharides might impact 
immunity directly. Interestingly, it has been shown that the microbial community in 
the upper respiratory tract can be differentially modulated by breast milk compared 
to formula-fed children38. Interestingly, breastfed infants showed a higher prevalence 
of Dolosigranulum that was negatively associated with respiratory tract infections38. 
Children with asthma show a lower nasal microbiota composition and higher 
abundance of Moraxella107. Moraxella was not associated with asthma in children who 
were exposed to a farming environment, which was in contrast to children who were 
not exposed to a farming environment. This indicates that the farming environment 
might protect the children from the detrimental effects of Moraxella. To date, it is 
unknown whether raw cow’s milk alters the nasopharyngeal microbiota composition 
and if this influences susceptibility toward upper respiratory tract infections or 
allergies.
Binding of Bovine IgG to Respiratory Pathogens
One mechanism by which food components could modulate immunity in the (upper) 
respiratory tract is by preventing contact between pathogens or allergens and the host 
immune system. In early life, maternal antibodies are essential for passive protection 
of the infant against viral infections. Interestingly, maternal RSV-specific antibodies 
in amniotic fluid were recently shown to protect mouse pups from RSV infection for 
at least 1 week after birth108. Human antibodies are found against conserved parts of 
the pre-fusion F protein of human RSV and metapneumovirus (PMV) that cross-
neutralize bovine RSV109. This cross-reactivity could also work vice versa if bovine 
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IgG could recognize conserved patterns on human RSV. Cross-reactive antibodies to 
other human pathogens have also been demonstrated in bovine milk and colostrum. 
Indeed, as reviewed by van Neerven, feeding colostrum of cows vaccinated against 
specific human pathogens protected children from subsequent infections110. 
Interestingly, bovine IgG was shown to bind human RSV and to induce phagocytosis 
via FcγRII receptors on macrophages, neutrophils, and monocytes111. The binding 
of bovine IgG to RSV also directly neutralizes RSV, as shown by protection of Hep2 
cells from infection with RSV in vitro111. Bovine IgG isolated from cow’s milk does 
not only bind to human viruses but was also found to bind to inhaled allergens (e.g. 
HDM)112. In addition, bovine IgG inhibits translocation of Pam3CSK4 over the 
epithelial barrier, thereby suppressing the production of pro-inflammatory cytokines 
in vitro113. Thus, bovine IgG can neutralize RSV infection in vitro and might also 
play a role in preventing sensitization by binding allergens and supporting barrier 
functioning by preventing binding of TLR ligands to the epithelium.
Next to bovine IgG, milk oligosaccharides have also been shown to prevent binding 
of viruses to host cells40. Viruses use lectin-like structures to adhere and infect host 
cells. It was hypothesized that breast-fed infants developed less otitis caused by 
viral infections (e.g. RSV and influenza) due to the decoy receptor activity of milk 
oligosaccharides40. However, as stated in the review by ten Bruggencate et al. (2014). 
it is to date uncertain which sialylated oligosaccharides can serve as a decoy receptor 
for human respiratory infecting viruses78. Thus, IgG and sialylated oligosaccharides 
present in cow’s milk might shield allergens or virus pathogens from inducing 
infection and inflammation (Figure 1).
The First Host Barrier: The Epithelium
When the allergen or virus is not neutralized, it will encounter the epithelial cell 
layer of mucosal tissues. This epithelial cell layer is the first line of defense in 
mucosal tissues. Epithelial cells are covered by a thick layer of mucus that keeps 
harmful compounds from entering the body. Epithelial cells act as the first physical 
barrier and the first responders of the innate immune system. The epithelial cells 
protect against inflammation and sensitization by preventing bacteria and virus 
entry and leakage of allergens into the mucosal tissue. The integrity of the epithelial 
barrier in the upper airways114 and intestine20 is regulated by tight junctions (TJs). 
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Homeostasis is maintained by hyporesponsiveness of epithelial cells toward bacterial 
constituents, because inflammation disrupts barrier functioning115. Therefore, the 
barrier functioning of the upper airways is under constant threat of environmental 
factors, including viral infections (e.g. RSV) and allergens116. Breaching of the barrier 
can results in tissue modifications in the upper airways as seen in patients suffering 
from allergic rhinitis or sinusitis117.
Figure 1. Potential mechanisms of cow’s milk-induced immune homeostasis in the upper respiratory 
tract. In the oropharynx, raw cow’s milk components can contribute to immune homeostasis via diff erent 
mechanisms. First, bovine IgG can bind and possibly even neutralize bacteria, viruses, or allergens. Immune 
complexes are transported over the epithelial barrier by neonatal Fc receptor (FcRn) or transported via M-like 
cells to reach the mucosal tissue in the Waldeyer’s ring. Th e immune complexes can bind to FcγRII on antigen-
presenting cells (APCs), leading to phagocytosis and clearance of the pathogens—as well as antigen presentation 
to (regulatory) T cells. Second, sialylated oligosaccharides may function as decoy receptors for viruses in the 
lumen of the oropharynx, preventing viral adhesion. Further, the expression of tight junction proteins can be 
enhanced by several milk components, thus strengthening the mucosal barrier against breaching by allergens 
and pathogens. Finally, several milk components contribute to immune regulation by inducing the diff erentiation 
into tolerogenic dendritic cells (tol. DC) and immunoregulatory T cells (Tregs). In this way, raw cow’s milk can 
promote a local microenvironment that contributes to immune homeostasis in the upper airways.
Tight Junctions
The integrity of the epithelial barrier is maintained by structural elements including 
adherens junctions, desmosomes, and TJs. TJs consists of a “ziplock-like” structure 
of multiple protein strands that are connected to the cytoskeleton, allowing selective 
transport across the barrier118. Cytosolic scavenger proteins (e.g. ZO-1) link the 
actin cytoskeleton to paracellular located proteins: the claudins and occludins. The 
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claudin family consists of transmembrane proteins, which via the interaction of 
claudin strands, are connected to each other by extracellular loops119. Claudins can 
be subdivided into pore-forming (e.g. claudin-2) and sealing claudins (e.g. claudin-4) 
that increase and decrease permeability, respectively119. Notably, pro-inflammatory 
cytokines (e.g. IL-6 and TNF) increase the expression of the pore-forming claudin-2 
and thereby reduce the epithelial barrier function120. The function and distribution 
of occludins is highly influenced by its phosphorylation status that is regulated by 
protein kinase C121. TJ proteins are key in maintaining epithelial barrier function and 
are shown to regulate proliferation on gene expression level122. For further reading 
about TJ proteins, we would like to refer to other excellent reviews specifically about 
occludins121, claudins119, or the function and morphology of TJs in general21,118.
Many allergens have protease activity that could breach barrier functioning123. For 
instance, the protease activity of one of the major HDM allergens, Der p 1, was shown 
to disrupt the cleavage site in the extracellular loops of claudins and occludins124. In 
contrast, RSV disrupts barrier functioning by remodeling the actin cytoskeleton and 
interfering with cytosolic scavenger proteins125. Disruption of barrier functioning in 
the upper airways results in increased exposure of allergens and viral particles to the 
underlying immune system (Figure 1), which could result in chronic inflammatory 
diseases such as asthma and allergies126. In early life, the epithelial barrier is more 
permeable compared to adults. Closure of the barrier occurs only after a few weeks 
in humans, while in mice, this is a more gradual process that develops during 
weaning96,127.
Effect of Milk Components on Barrier Functioning
Breast milk contains many growth factors that facilitate gut maturation. Neonates 
receiving infant formulas were shown to have a higher gut permeability compared 
to breast-fed neonates. This stresses the importance of identifying functional milk 
components that promote barrier functioning96. Currently, there is no in vivo 
evidence on effects of cow’s milk on epithelial barrier functioning. Nevertheless, at 
least two recent studies investigated the effect of cow’s milk on epithelial cells in 
vitro. To study barrier functioning of dietary components in vitro, most studies use 
colon carcinoma cell lines (Caco-2 or HT-29). It is to date impossible to study the 
effect of dietary components on barrier functioning in the upper airways since no 
human oropharyngeal epithelial cell lines are available that form TJs. Caco-2 cells 
express enzymes that are expressed in the fetal intestine and are biochemically and 
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morphologically similar to ileal enterocytes128. These in vitro models are thus one 
of the few limited models available to study the effect of dietary components on TJ 
regulation. The anti-inflammatory properties of milk components on the epithelium 
are reviewed by Chatterton et al. (2013)73. In this review, the role of dairy components 
on epithelial barrier function in terms of epithelial proliferation, differentiation, and 
TJ regulation is addressed.
The first study that looked at the effect of cow’s milk in vitro showed that cow’s 
milk induces the expression of the pore-forming TJ protein claudin-2 in Caco-2 
cells129. However, no differences were observed in permeability, which was proposed 
to be counteracted by the milk-induced increase of endogenous TGFβ expression. 
A second study stimulated HT-29 cells with raw milk versus pasteurized cow’s milk 
preparations. The authors showed with microarray analysis that raw milk induced 
the expression of genes related to immunity compared to the pasteurized cow’s milk 
or medium control130. This study showed that the thermosensitive milk fraction (i.e., 
proteins) induced the expression of immune-related pathways and thereby indirectly 
barrier functioning.
One of the proteins in cow’s milk that is important for epithelial barrier functioning 
is TGFβ. Apart from these exogenous sources of TGFβ, TGFβ is endogenously 
produced. In the gut, TGFβ is most prominently expressed in epithelial cells compared 
to its expression in the underlying lamina propria131. TGFβ1 is capable of promoting 
barrier functioning by regulating TJ expression and proliferation. TGFβ1 induces the 
expression of claudin-4 and protein kinase C expression in vitro, both strengthening 
the barrier132,133. On the other hand, TGFβ inhibits the proliferation of epithelial 
cells131,134. Interestingly, the production of endogenous TGFβ1 by epithelial cells is 
regulated through a positive feedback loop by other milk proteins like lactoferrin 
that triggers an intracellular cascade that results in the production of TGFβ1. Bovine 
and human lactoferrin were shown to have similar effects on barrier functioning. 
Moreover, in low concentrations, human lactoferrin induces differentiation of 
epithelial cells, whereas it stimulates proliferation in higher concentrations76.
In high concentrations, sialylated milk oligosaccharides affect the cell cycle and induce 
differentiation of intestinal epithelial cells135. In the colon, these oligosaccharides are 
fermented by the microbiota. These microbes produce SCFAs that also impact barrier 
functioning. As reviewed by Tan et al. (2017), SCFAs reduce paracellular permeability 
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and induces the expression of TJ genes and MUC2 expression, thus strengthening 
the epithelial barrier12 that may subsequently protect the host against infections136.
Another milk ingredient shown to have immunomodulatory effects is vitamin D. 
More specifically, the inactive and circulating form of vitamin D3 (25(OH)2D3) 
is converted to the active form (1,25(OH)2D3) by the enzyme 1α-hydroxylase, 
which is highly expressed in the kidney and lowly expressed in epithelial cells137. 
Epithelial cells transport the inactive form of vitamin D3 over the membrane, 
which can be subsequently systemically metabolized138. The conversion locally 
by epithelial cells of dietary inactive vitamin D3 into the active form can create a 
microenvironment containing active vitamin D3. Stimulation of Caco-2 cells with 
1,25(OH)2D3 was shown to result in the induction of E-cadherin, which indirectly 
promotes the transcription of ZO-1 and induces differentiation139. In support of 
this, blocking vitamin D receptor transcription resulted in a decreased transepithelial 
electrical resistance and expression of ZO-1 and E-cadherin and claudin 1, 2, and 
5 but not occludin140. Thus, it is evident that vitamin D3 contributes to epithelial 
barrier function by regulating TJ protein expression. Less is known about the effect 
of vitamin A on barrier functioning. RA was shown to enhance differentiation of 
epithelial cells, as indicated by the increase in alkaline phosphatase (ALP) expression. 
In contrast, RA also decreased the expression of claudin-2, resulting in a decrease in 
permeability of the Caco-2 model141. Thus, several components present in cow’s milk 
promote epithelial barrier functioning (Figure 1).
Do Milk Components Promote Immune Homeostasis?
The nasal mucus is cleared to the back of the throat every 10–15 minutes by the 
movement of cilia. Thus, it is likely that allergens and viruses are trapped in this thick 
layer of mucus and are subsequently swallowed. The oropharynx (throat) is the place 
where milk components, bacteria, viruses, and allergens may interact before they are 
digested. Lymphoid tissues in the upper airways are the lingual tonsils, tubal tonsils, 
palatine tonsils, and adenoids, together forming the Waldeyer’s ring9. Uptake of antigens 
by the tonsils occurs via M-like cells in specialized induction sites, which are composed 
of follicles containing both myeloid and lymphoid cells142. Similarly, in the GI tract, 
antigens can be taken up by columnar epithelial cells (transcellular), M cells, neonatal 
Fc receptor-mediated uptake143, or direct uptake by specific sampling subsets of DCs13.
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The mucosal immune system is capable of distinguishing between harmful and 
harmless compounds resulting in inflammation or tolerance, respectively. Food 
components are important non-self-antigens to which an immune response 
constantly needs to be suppressed. This type of tolerance induction is known as oral 
tolerance. Food does not only trigger local tolerance but also systemic tolerance, and 
thus food makes the systemic and mucosal immune systems relatively unresponsive 
to these food antigens. Breast milk contains many components that dampen 
immune responses. It is suggested that this regulatory milieu induced to breast milk 
components favors tolerance inductions towards other harmless antigens such as 
allergens34. This suppression of immune responses is antigen specific and long lasting.
The consumption of farm milk is associated with higher regulatory FoxP3+ T cell 
numbers, which were negatively associated with doctors-diagnosed asthma and 
IgE levels85. We here address several potential cow’s milk components that might 
promote these regulatory responses. Literature supports that raw cow’s milk contains 
a multitude of components, including proteins and vitamins, that promote the 
development of human “tolerogenic” or regulatory monocyte-derived DCs (moDCs) 
in vitro.
Cow’s milk and colostrum contain several immunoregulatory cytokines such as TGFβ 
and IL-10. Interestingly, a population of tolerogenic IL-10 producing DCs (IL-10 
DCs) with similar characteristics to in vitro monocyte-derived DCs, differentiated in 
the presence of IL-10, were identified in human blood144,145. Not only human IL-10 
but also bovine IL-10, which has 70% homology to human IL-10, was shown to 
induce a dose-dependent reduction of CD80/CD86 expression and IL-12 and TNF 
production 50. DCs with low CD86/CD80 expression in the presence of TGFβ or 
IL-10 are known to polarize naive T cells into FoxP3+ T cells146. IL-10 DCs also 
express PD-L1 which is critical for the induction of T cell anergy. Similarly, moDC 
differentiated in the presence of LF showed inhibited cytokine responses and surface 
marker expression upon stimulation with TLR ligands147.
TGFβ is an unique pleiotropic cytokine that is produced by leukocytes and epithelial 
cells148. The dual role of TGFβ was shown in a recent review, which showed that 
TGFβ-induced SMAD proteins are key in balancing immunity149. DCs from the 
lamina propria are essential for inducing FoxP3 expression in naive T cells, which 
requires an exogenous source of TGFβ150. Interestingly, pups of mice exposed to 
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airborne allergens developed oral tolerance towards the allergen that was dependent 
on milk-derived TGFβ151. In addition, TGFβ and IL-10 inhibit type I interferon 
production by pDCs152. Immunosuppressive cytokines such as IL-10 and TGFβ in 
milk are important in maintaining immune homeostasis and the suppression of type 
I interferon production. These immunosuppressive cytokines in cow’s milk could be 
essential for inducing a regulatory milieu, which subsequently may result in tolerance 
towards allergens.
Antigen-specific IgG in breast milk was shown to protect against OVA-induced 
asthma in a mouse model by inducing regulatory responses. Moreover, pups of 
mothers that were exposed to antigen aerosols during lactation resulted in a regulatory 
immune response that protected them from developing asthma14. The proposed 
mechanism involves binding of IgG to neonatal Fc receptor (FcRn), which resulted 
in the expansion of antigen-specific Tregs. Bovine IgG shows some affinity for human 
FcRn153 and is specific for human allergens112, and it is therefore possible that the 
uptake of bovine IgG–allergen complexes induces FoxP3+ T cells (Figure 1). These 
functional properties of milk proteins are lost upon heating. Another heat-sensitive 
fraction of bovine milk that has been suggested to induce immune regulation is 
exosomal microRNA154.
The role of milk oligosaccharides in the induction of oral tolerance remains inconclusive. 
6'SL was shown to alleviate OVA-induced food allergic symptoms by promoting IL-
10-producing T cells155. In contrast, pups fed milk that contained 3'SL had more severe 
induced colitis compared to pups fed milk devoid of 3'SL. Ex vivo cultures of mesenteric 
lymph node (MLN) DC showed direct TLR4 activation by 3'SL156. However, 3’SL did 
not induce TLR4-mediated activation of human immune cells ex vivo157. In addition, 
sialylated milk oligosaccharides were shown to alter the microbiota composition and 
growth in infants158. These changes in microbiota composition in turn impact the 
production of SCFAs that were shown to be essential, together with vitamin A, in oral 
tolerance induction159. In summary, the direct immunomodulatory effect of sialylated 
oligosaccharides remains inconclusive. Rather than having direct effect on the immune 
system, sialylated oligosaccharides may promote immune homeostasis indirectly by 
promoting the outgrowth of SCFA-producing bacteria.
In the gut, a subset of migratory DC expressing the integrin CD103 are known to 
convert vitamin A into RA. In mouse models, RA induces the differentiation of naive 
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T cells into Tregs in vivo25. These findings were confirmed in vitro in humans by 
differentiating moDC in the presence of RA. These RA DCs expressed CD103 and 
were capable of polarizing naive T cells into Tregs160 or FoxP3− IL-10-producing T 
cells27. Similarly, under steady-state conditions, lung macrophages produce RA and 
TGFβ toward harmless airborne antigens and induce antigen-specific Tregs161. Thus, 
dietary vitamin A triggers endogenous RA production that is essential to induce 
Tregs in the gut and the lung. However, it is unknown whether dietary vitamin A 
contributes in the upper airways to induce antigen-specific Tregs. The active form 
of vitamin D3, 1,25(OH)2D3 (VitD3), halts the differentiation of monocytes into 
moDC in vitro and does not affect pDCs162. These VitD3 DCs are less sensitive to 
TLR ligands and develop a semi-mature phenotype upon stimulation. These authors 
show that this semi-mature phenotype is instrumental for priming naive T cells to 
become Tregs and to induce T cell anergy163. In summary, cow’s milk contains a 
variety of components that are known to promote immune homeostasis and induce 
regulatory responses by human immune cells in vitro (Figure 1). Therefore, we 
hypothesize that these immune regulatory effects aid in tolerance induction toward 
allergens or suppress immune responses in the upper airways that could aid in the 
protection against asthma exacerbation.
Systemic Responses: the Gut–Lung Axis
Several recent studies have shown that immune responses triggered in the GI tract 
can influence immunity in the respiratory tract. Evidence for the existence of this 
so-called gut–lung axis is increasing, although the exact mechanisms involved are not 
yet completely understood163–166. The importance of TLR signaling by commensal 
microbiota in relation to airway immunity was demonstrated in multiple studies167–169. 
Mice treated with antibiotics before influenza infection showed a higher viral load in 
the lungs, reduced CD4+ T cells responses and reduced influenza specific antibody 
titers compared to control mice. Intrarectal administration of TLR agonists could 
restore immune responses to influenza infection in this model. To clear the influenza 
infection, commensal bacteria or TLR agonists were needed to induce inflammasome-
dependent cytokine release (IL-1β and IL-18). These cytokines allowed lung DCs to 
migrate to the mediastinal lymph node where they activate specific T cells167. Another 
study in mice showed that oral administration of a bacterial extract (OM-85) 
reduced the viral load in the respiratory tract after influenza infection. The bacterial 
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extract also boosted specific polyclonal antibodies against Klebsiella pneumoniae and 
Streptococcus pneumoniae, which protected the mice against these airway pathogens168. 
Furthermore, germ-free mice showed increased susceptibility to pulmonary infection 
with K. pneumoniae, which could be restored by i.p. injection of LPS169. These studies 
indicate that there is cross-talk between the commensal microbiota and immunity in 
the respiratory tract via TLR signaling (Figure 2).
Figure 2. Mechanisms involved in the gut-lung axis linked to milk components. TLR signaling by 
microbiota in the gut results in improved airway immunity although the exact mechanism in this gut–lung axis 
is unknown. Microbiota, specifi cally bifi dobacteria, may ferment sialylated oligosaccharides present in cow’s 
milk into SCFAs, which are taken up into the circulation. Cow’s milk contains vitamin A and the inactive- and 
the active form (1,25(OH)2D3) of vitamin D3. Vitamin A and vitamin D3 can be taken up by epithelial and 
dendritic cells (DCs) and converted by the enzymes RALDH and 1α-hydroxylase into retinoic acid (RA) and 
1,25(OH)2D3 (VitD3), respectively. However, the majority of vitamin D3 is taken up into the circulation and 
converted into its active form in the kidneys. In the lamina propria, RA may induce expression of gut homing 
markers CCR9 and α4β7 on T cells and CCR9 on B cells directly or prime DC to induce the expression of these 
markers in the mesenteric lymph node (MLN). VitD3 may induce the expression of homing marker CCR10 
on T and B cells directly or indirectly via VitD3-primed DC (VitD3 DC). In addition, VitD3 downregulates 
the expression of CCR9 on lymphocytes in a direct way. Lymphocytes expressing CCR9 have a homing capacity 
toward the small intestine, while lymphocytes expressing CCR10 have a homing potential toward the colon and 
respiratory tract, providing a potential mechanism of the gut–lung axis.
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Another link between airway immunity and the gut microbiota is the release of SCFAs. 
SCFAs are metabolites produced by bacteria in the gut from dietary non-digestible 
fibers. One type of non-digestible fibers is sialylated oligosaccharides present in cow’s 
milk. As mentioned earlier, milk oligosaccharides are fermented in the colon into 
SCFAs99. B. longum infantis has been shown to ferment sialylated oligosaccharides 
directly100,101. After release into the colon, SCFAs such as acetate and to a lesser extent 
propionate are taken up into the circulation in mice 44 and humans45. SCFAs bind 
to metabolite-sensing G protein-coupled receptors, and signaling influences gene 
expression via induction of histone deacetylases45. Both acetate and propionate bind 
via GPR41, which is expressed on various tissues and cells including enteroendocrine 
cells and PBMCs170. Several studies indicate that SCFAs play an important role in 
the gut–lung axis by regulating immune activation in the lung44,45 (Figure 2). A high-
fiber diet was prevented against allergic airway disease in mice44,45. This protective 
effect was shown to be mediated by acetate produced by the microbiota. Direct oral 
administration of acetate resulted in higher Treg numbers in the lung and protection 
against HDM-induced allergic airways disease 45. In another study, oral administered 
propionate did not affect Treg numbers in the lung, but resulted in hematopoiesis 
in the bone marrow of DCs that were found in the lungs. These DCs had a more 
immature phenotype (lower levels of MHCII and CD40) and therefore a reduced 
capacity of activating Th2 cells44. These studies demonstrate that microbial metabolites 
produced in the intestines can have an effect on immune function in the airways. In 
addition, other microbial components such as TLR ligands may be taken up in the 
circulation and impact immunity in the respiratory tract. TLR stimulation in the gut 
could activate DCs leading to the activation of lymphocytes in the mediastinal lymph 
node. Upon activation, these lymphocytes can migrate to the lung and potentially 
to the gut. Besides, microbiota can have an indirect effect via SCFA production, as 
SCFAs in the circulation can affect DCs and Tregs in the respiratory tract. Currently, 
direct effects of SCFAs on the induction of homing markers on DCs or lymphocytes 
are not known.
After activation, lymphocytes can migrate (i.e., home) to tissues depending on their 
homing marker (e.g. selectins, integrins, and chemokine receptors) expression. These 
receptors can bind to tissue-specific ligands (e.g. addressins and chemokines) expressed 
by the endothelium. In humans, mucosal vaccination was used as a model to show 
that the site of induction of a mucosal immune response resulted in IgA production 
in restricted mucosal tissues. Holmgren and Czerkinsky showed that specific IgA 
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antibodies are produced in the upper respiratory tract and gut in cholera toxin B 
(CTB) vaccinated individuals. In contrast, intranasal vaccination with CTB resulted 
in specific IgA production in both upper and lower respiratory tract and genital 
tract, but not in the gut. Furthermore, rectally vaccinated individuals only produced 
specific IgA locally in the rectum171. The fact that orally administered antigens result 
in effector cells being present both in the gut and the upper respiratory tract indicates 
that homing markers might overlap. Well-studied homing marker interactions in 
humans are among others, CCR9 binding to locally produced CCL25 in the small 
intestine172,173 and CCR10 binding to CCL28 produced in the airways and colon174. 
For B cells, there is no clear homing marker that differentiates between upper and 
lower respiratory tract homing as CCR10 expressed on B cells binds CCL28 produced 
locally in lower and upper respiratory tracts. In contrast, T cells express CCR10 to 
bind CCL28 produced in the lower respiratory tract and salivary glands63,175, while T 
cells express CCR3 to bind CCL28 in the nasal mucosal176. Another homing marker 
that could be important in migration between gut and lung is CCR6 as its ligand 
CCL20, which are expressed in both tissues177.
Thus, the homing potential of immune cells is affected by the site of induction and 
is dependent on local production of tissue-specific stromal factors. Recent evidence 
suggests that it can also be modified by dietary components. Of all dietary components, 
the effect on homing is best studied for RA and VitD3 (Figure 2). Dietary vitamin 
A as a source of RA is essential for efficient homing of T cells to the GALT178,179. In 
mice, RA production by mucosal CD103+ DCs179,180 or stromal cells in the MLN181 
is essential for efficient differentiation of naive T cells into FoxP3+ Tregs that express 
the gut homing markers α4β7 and CCR9 in the MLN. Interestingly, human RA-
primed CD103+ DCs were also shown to induce differentiation of naive T cells into 
IL-10-producing T cells expressing gut homing markers in vitro27. RA is also a factor 
that regulates B cell proliferation, differentiation, and class switching 182. Moreover, 
RA and TGFβ1 induce IgA class switching183. Similarly to the effects observed on T 
cells, RA derived from GALT-DCs alone was shown to induce gut homing markers 
on B cells184. Interestingly, vitamin D3 blocks the upregulation of RA-induced gut 
homing marker expression on T cells185,186 although this was not observed by Baeke et 
al. (2011)187. The majority of dietary vitamin D3 is taken up along the GI tract and 
converted into its active form 1,25(OH)2D3 in the kidney and becomes systemically 
available138. In addition, the inactive form of vitamin D3 is shown to be converted 
into its active metabolites by DCs and epithelial cells137,185. Dietary supplementation 
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of vitamin D3 to HIV-infected patients was shown to induce CCR10 expression on 
Tregs188. This finding is in line with in vitro studies showing VitD3 induces CCR10 
expression on human B and T cells185,187,189. Interestingly, RA also induces CCR10 
expression in human B cells and acts even synergistically with VitD3189. The balance 
of vitamin A and vitamin D3 may thereby regulate homing of lymphocytes to gut 
or respiratory tract, respectively (Figure 2). However, it should be noted that the 
concentrations of vitamin A and vitamin D3 are relatively low in cow’s and breast 
milk. In addition, the active metabolites of these vitamins can be endogenously 
produced (e.g. by stromal cells) in the secondary lymphoid tissues. In summary, we 
are only beginning to unravel the complex interplay between gut and lung. Hence, 
we can only speculate about the mechanisms by which cow’s milk through sialylated 
oligosaccharides and vitamin A and D could affect microbiota composition or 
homing of lymphocytes, respectively.
Concluding Remarks
The existing epidemiological evidence suggests that the consumption of raw cow’s 
milk contributes to protection against allergies and asthma and respiratory tract 
infections. In this review, we discussed potential mechanisms by which cow’s milk 
and its components may exert these immunological effects. Bovine IgG can bind to 
bacterial and viral pathogens, enhance phagocytosis, and may neutralize pathogens. 
Other milk components like TGFβ promote epithelial barrier functioning by 
upregulation of TJ genes and might favor the differentiation of Tregs that can reduce 
inflammation locally. Finally, recent evidence shows an interplay between gut and 
lung. We speculate about the effect of milk components on trafficking of lymphocytes 
from the intestine to the upper airways through modulation of homing receptors and 
microbiota. Further unraveling the impact of milk components on local responses 
in the respiratory tract, microbiota and immune trafficking are necessary to fully 
understand their effects on allergy, infection, and asthma.
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Abstract
Lactoferrin is an abundant glycoprotein in bovine milk that has immunomodulatory 
effects on human cells. Bovine lactoferrin (LF) binds lipopolysaccharides (LPS) 
with high affinity and is postulated to act via TLR4-dependent and -independent 
mechanisms. It has been shown that LF modulates differentiation of human monocytes 
into tolerogenic dendritic cells. However, in a previous study, we showed that LPS 
also mediates differentiation into tolerogenic dendritic cells (DC). Since LF binds 
LPS with high affinity, it remains to be investigated whether LF or LPS is mediating 
these effects. We, therefore, further investigated the LPS-independent effect of LF on 
differentiation of human monocytes into dendritic cells (DC). Human monocytes 
were isolated by magnetic cell sorting from freshly isolated PBMCs and cultured for 
six days in the presence of IL-4 and GM-CSF with or without LF or proteinase K 
treated LF to generate DC. These immature DC were stimulated for 48 h with LPS 
or Poly I:C + R848. Cell surface marker expression and cytokine production were 
measured by flow cytometry. DC differentiated in the presence of LF produced higher 
IL-6 and IL-8 levels during differentiation and showed a lower expression of CD1a 
and HLA-DR. These LFDCs showed to be hyporesponsive towards TLR ligands as 
shown by their semi-mature phenotype and reduced cytokine production. The effect 
of LF was abrogated by proteinase K treatment, showing that the functional effects 
of LF were not mediated by LPS contamination. Thus, LF alters DC differentiation 
and dampens responsiveness towards TLR ligands. This study indicates that LF can 
play a role in immune homeostasis in the human GI tract.
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Introduction
Bovine lactoferrin (LF) is an abundant glycoprotein in cow’s milk that is 69% identical 
to human lactoferrin at the protein level76. LF is an extensively researched protein 
that has been shown to exert antimicrobial and antiviral activity190. The involved anti-
pathogenic mechanisms, which are mostly investigated in vitro, range from depriving 
iron, antimicrobial activity by bioactive peptides and decoy receptor activity. These 
mechanisms may underlie the protective effect against sepsis by LF supplementation 
in very low birth weight (VLBW) infants191–195. LF was shown to protect against sepsis 
in VLBW infants in either breast fed or formula fed, showing the need for additional 
supplementation191. Subsequent analysis of this study showed that LF inhibits the 
progression of invasive fungal infections192, indicating immunomodulatory effects of 
LF. In line with these findings, LF was shown to induce the prevalence of regulatory 
T cells in VLBW infants194. Although these studies indicate an immunoregulatory 
role of LF in humans, little mechanistic evidence is available to date.
In infants, LF ends up in the intestine intact and is only partly hydrolyzed into 
bioactive peptides with antibacterial activity196. Moreover, intact human lactoferrin 
was found in stool and urine of VLBW infants and resisted trypsin and chemotrypsin 
treatment in vitro197. LF was shown to largely resists gastric hydrolysis in vivo in 
adults198. However, LF is completely degraded in the small intestine of adults199. Thus 
LF may, in contrast to adults, retain its bioactivity throughout the gastrointestinal 
tract and may even become systemically available in infants197,200,201. This could be 
explained by lower concentrations of proteases in the small intestine in infants compared 
to adults94. Additionally, breast milk contains protease inhibitors, which may limit 
degradation of milk proteins in the GI tract of infants202.
LF has specific domains that bind iron with high affinity, a high isoelectric point (pI 
around 9) and an overall nett positive charge with high cationic peptide regions, which 
is crucial for its bactericidal activity203. Due to these biochemical properties, LF may 
bind multiple receptors (e.g. intelectin-1 and DC-SIGN) with low affinity76,204,205. 
LF was shown to bind the human lactoferrin receptor (i.e., intelectin-1) on Caco-2 
cells and, dependent on the concentration, induce proliferation or differentiation of 
these epithelial cells77.
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Additionally, LF is known for its binding activity to lipopolysaccharides (LPS). 
Binding of LF to LPS may result in neutralization of LPS, which is hypothesized to 
play an important role in the immune regulatory role of LF206. In contrast, LF was 
shown to activate monocytes during DC differentiation, which resulted in diminished 
TLR activation147. Similarly, human LF was shown to induce the differentiation into 
anergic macrophages that were hyporesponsive towards TLR ligands207. However, 
LF binds LPS with a high binding affinity208. Since LPS induces differentiation of 
monocytes into tolerogenic DC as well157, it is of interest to investigate the true 
immunomodulatory potential of LPS-free LF. A previous study showed that LPS-
free LF induces the expression of pro-inflammatory cytokines on porcine derived 
macrophages in a TLR4-independent manner209. It is however unknown whether this 
TLR4-independent signaling of LF affects the functionality of human monocytes 
and dendritic cells. We therefore investigated whether LF, independently of bound 
LPS, is capable of inducing differentiation of human monocytes into tolerogenic 
dendritic cells.
Materials and Methods
Isolation of LF
The whey fraction from bovine colostrum was collected after spinning the milk at 
100.000 g for 45 min (Ultracentrifuge Avanti J301, Beckman Coulter, Brea, CA, 
USA). This casein and fat-free fraction was stored at −20 °C until further use. These 
whey proteins were thawed and diluted with washing buffer containing 0.01 M 
KH2PO4 and 0.1 M NaCl, pH 6.5. Samples were centrifuged at 23.500 g for 20 min 
and the supernatant was carefully collected through a filter paper to remove casein 
traces. Ion exchange chromatography (Akta Purifier, Pharmacia, Stockholm, Sweden) 
was used to isolate LF from the whey proteins. The Hiprep SP FF 16/10 column was 
preconditioned by rinsing the column with 100 mL washing buffer (3 mL/min; 12 
mS/cm) and elution buffer (3 mL/min; 85 mS/cm). Whey proteins were loaded on the 
preconditioned column with a flow rate of 3 mL/min (HiLoad P50 pump, Pharmacia). 
After the complete volume of whey protein has run over the column, it was connected 
to the AKTA. Unbound matrix proteins were washed from the column with washing 
buffer (3 mL/min). LF was eluted from the column using an increasing gradient of 
0.1–1 M NaCl. The preparation was desalted and concentrated on a 10 kDa Ultracel 
PLGC membrane using an Ultrafiltration Cell model 8200 (Amicon/Millipore).
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Isolation and Culturing of Monocyte-Derived DC
Peripheral blood mononuclear cells (PBMCs) were isolated by density centrifugation 
from buffy coats obtained from healthy anonymous donors (Sanquin blood bank, 
Nijmegen, The Netherlands) as described previously157. A written informed consent 
was provided before blood collection. In short, 1:1 diluted blood in phosphate buffered 
saline (PBS) (Mg2+ and Ca2+ free, Lonza, BE17-516F, Basel, Switzerland) was loaded 
on Ficoll-Paque (Amersham Bioscience, Uppsala, Sweden) and centrifuged for 20 
min at 500 g without brake. The PBMC layer was collected and washed three times 
with PBS. Cells were spun down and the pellet was resuspended with anti-human 
CD14 magnetic beads (BD Biosciences, 557769, Franklin Lakes, NJ, USA). CD14+ 
cells were isolated on a separation magnet (BD IMagnet, BD Biosciences) according 
to the manufacturer’s instructions. 100.000 monocytes per well were cultured in 96 
cells wells flat bottom plates in RPMI 1640 (GIBCO, MA, USA, 22409-015) and 
10% FCS (GIBCO, 10270-106), normocin (100 µg/mL, Invivogen, anti-nr-1, San 
Diego, CA, USA), penicillin and streptomycin (100 U/mL, GIBCO, 14150-122). 
Monocytes were differentiated into dendritic cells by culturing them for six days 
in the presence of 20 ng/mL IL-4 (Peprotech; 200-04, Rocky Hill, CT, USA) and 
GM-CSF (Peprotech; 300-03, Rocky Hill, CT, USA) with or without 10 µg/mL, 
250 µg/mL LF (FrieslandCampina) or 10 nM VitD3 (Sigma-Aldrich, D1530, St. 
Louis, MO, USA). After six days, immature DC were matured with 1 µg/mL LPS 
(Escherichia coli, Sigma, L2880, St. Louis, MO, USA) or 3 µg/mL R848 (Invivogen: 
tlrl-r848-5) and 20 µg/mL Poly I:C (Sigma, P1530) for 48h.
Isolation and Staining of moDC
After 6 days (immature-) or 8 days (mature-) moDC were incubated on ice (while 
shaking) for 30 min in ice cold FACS buffer (PBS (Lonza, BE17,516F) containing 
0.5% BSA fraction V (Roche, 10735086002, Basel, Switzerland), 2.0 mM 
EDTA (Merck, 108418, Kenalworth, NJ, USA) and 0.05 NaN3) to facilitate the 
detachment of DC from the surface. Surface marker expression was analyzed by using 
fluorochrome-conjugated antibodies directed against CD14 (FITC; BD Biosciences, 
555397), CD86 (V450; BD Biosciences, 560357), CD83 (FITC; BD Biosciences, 
556910), HLA-DR (APCef780; eBiosciences, 47-9956-42, MA, USA), CD80 (PE-
Cy5; BD Biosciences, 559370), PD-L1 (PE-Cy7; BD Biosciences, 558017), CD1a 
(PerCP/Cy5-5; BioLegend, 300130, San Diego, CA, USA). 10 µg/mL of human 
Fc Block (BD Bioscience, 554220) was added to the antibody mixture to block 
non-specific binding. Compensation beads (eBiosciences, 01-2222-41) stained with 
18039 Olaf Perdijk PM.indd   47 04-09-18   19:56
Chapter 3
48
single antibodies were run for every experiment. Cells were washed with 200 µL 
FACS buffer and stained by incubating the antibody mixture for 30 min in the dark 
at 4 °C. Before measuring DRAQ7 (Abcam; ab109202, Cambridge, UK) was added 
and incubated for 10 min in the dark to stain nonviable cells. Cells were resuspended 
in 100 µL FACS buffer and acquired on a BD FACS Canto II (BD Biosciences) and 
analyzed using the FlowJo software V10.
Quantification of Cytokine Levels in Supernatants
Levels of IL-8, IL-6, IL-10, TNF and IL-12p70 were measured in the supernatants of 
moDC cultures using cytometric bead array technique (BD Biosciences). Individual 
flex-sets for IL-8 (558277), IL-6 (558276), TNF (560112), IL-10 (558274) or IL-
12p70 (558283) were run according to the manufacturer’s instructions.
Proteinase K Treatment and SDS-Page
LF was treated with 100 µg/mL proteinase K for 1 h at 46 °C followed by 10 min on 
95 °C to inactivate the enzyme activity. 1 µg of LF and proteinase K treated LF were 
loaded on a SDS-page gel (Mini-PROTEAN TGX Precast SDS-page gel, Biorad, 
Berkeley, CA, USA) and run on 120 V for 1 h. The gel was stained with GelCode 
(Thermo Scientific, 24590, MA, USA) according to the manufacturer’s instructions.
LPS Detection
LF and Triton X-114 treated LF was tested for LPS contamination by a 
recombinant factor C LAL assay that was performed according to the manufacturers 
recommendations (EndoZyme recombinant factor C assay, Hyglos; 609050, Bernried 
am Starnberger See, Germany).
Triton X-114 Treatment
LPS was removed from LF by an optimized Triton X-114 method (Amresco, cat. 
# M114, OH, USA) 210. In short, 2% v/v Triton X-114 was added to the sample 
and the mixture was stirred for 30 min at 4 °C and thereafter transferred to a 41 °C 
water bath for 10 min. The micelles were spun down by centrifugation for 10 min 
at 20.000 g at 25 °C. The upper layer was collected and treated with 10 mg/mL 
Bio-beads SM-2 (cat. # 152-8920) under constant stirring at 4 °C to remove Triton 
X-114 traces.
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TLR4 Reporter Assay
HEK-293 cells expressing human TLR4, CD14 and MD-2 and harboring a pNIFTY 
construct (Invivogen, Toulouse, France) were grown on selective medium containing 
DMEM and Glutamax (Fisher Emergo, Landsmeer, The Netherlands) supplemented 
with 10% FCS, 100 µg/mL penicillin/streptomycin (Sigma, St. Louis, MO, USA), 
Zeozin (50 µg/mL), Normocin (100 µg/mL) and HygroGold (45 µg/mL) (Invitrogen, 
Carlsbad, CA, USA) in an atmosphere of 5% CO2 at 37 °C. HEK-293 cells were 
seeded at 3 × 105 cells/mL and cultured overnight before stimulation the next day. NF-
κB activation was measured after 24-h stimulation by adding Bright-GloTM (Promega, 
Fitchburg, MA, USA) substrate to cells. The plate was shaken and luminescence was 
measured using a spectramax M5 (Molecular Devices, Sunnyvale, CA, USA).
Statistics
Data was assessed for normality using a D’Agistino and Pearson omnibus test. A 
repeated measures ANOVA with Tukey’s multiple comparison test or Friedman test 
with Dunn’s multiple comparison post-hoc test was performed for normal and non-
normal distributed data, respectively. Data is represented as mean ± standard error of 
the mean (SEM). Graphpad Prism V. 5.0 was used for all statistical analyses.
Results
Monocytes were differentiated into monocyte-derived DC (moDC) in the presence 
or absence of LF. Upon differentiation into moDC, monocytes lost CD14 expression 
and gained CD1a expression. Although LFDC were negative for CD14, a lower 
percentage of cells gained CD1a expression (Figure 1A). LFDC showed a higher 
expression of CD86 and PD-L1 (Figures 1B-C) and a significantly lower expression 
of HLA-DR when differentiated in the presence of 250 µg/mL LF (Figure 1D). 
These phenotypical changes induced by LF during differentiation were accompanied 
by a dose-dependent increase in IL-8 production (Figure 1E) and increase in IL-6 
production when cultured in the presence of 250 µg/mL LF (Figure 1F). Interestingly, 
in contrast to the profound effects of LF during the differentiation of monocytes 
into moDC, LF did not induce phenotypic changes on moDC that were already 
differentiated (Figure S1). Moreover, moDC stimulated with LF or LF + Poly I:C and 
R848 for two days did not show phenotypic changes compared to moDC or moDC 
+ Poly I:C and R848, respectively.
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Figure 1. LF modulates DC differentiation. Monocytes were differentiated into moDC by culturing them 
for six days in the presence of IL-4 and GM-CSF with or without LF (10 or 250 µg/mL LF). (A) The percentage 
CD1a+CD14− DC and the median fluorescent intensity (MFI) of (B) CD86, (C) PD-L1 and (D) HLA-DR is 
shown. The production of (E) IL-8 and (F) IL-6 was measured in the supernatant by CBA. The mean ± SEM 
of four independent experiments with 12 different donors is shown. Significance is indicated by *** = p <0.001, 
** = p <0.01 and * = p <0.05.
Next, we investigated the responsiveness of LFDC by stimulating the cells with LPS. 
LFDC showed to be hyporesponsive towards LPS as observed by the reduced induction 
of the maturation marker CD83 (Figure 2A) and costimulatory molecules CD86 
(Figure 2B), PD-L1 (Figure 2C) and CD80 (Figure S2A) upon LPS stimulation. 
HLA-DR expression was lower on mature LFDC compared to mature moDC 
(Figure 2D). In line with their phenotype, LFDC also produced lower cytokine levels, 
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showing a lower production of IL-10 (Figure 2E), IL-6 (Figure S2B), TNF (Figure 
S2C) and abrogated levels of IL-12p70 (Figure 2F). Since DC were differentiated 
and subsequently stimulated in the presence of LF, we wanted to exclude the possibly 
that the hyporesponsiveness towards LPS was caused by neutralization of LPS by 
LF. We showed that the surface marker expression was unaffected by replacing ¾ of 
the medium and that the cells were also hyporesponsive towards R848 and Poly:IC 
stimulation, indicating that the effect was not mediated by LPS neutralization (Figure 
S3).
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Figure 2. LFDC are hyporesponsive for LPS stimulation. Immature DC that were cultured in the presence 
or absence of LF were stimulated with 1 µg/mL LPS for 48 h. The median fluorescent intensity (MFI) of 
(A) CD83, (B) CD86, (C) PD-L1 and (D) HLA-DR is shown. The production of (E) IL-10 and (F) IL-12p70 
was measured in the supernatant by CBA. The mean ± SEM of four independent experiments with 12 different 
donors is shown. Significance is indicated by *** = p <0.001, ** = p <0.01 and * = p <0.05.
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LF is reported to bind LPS and has been postulated to induce immunomodulation 
via TLR4-dependent mechanisms. However, previously we showed that low 
concentrations of LPS can also LPS induce these phenotypic changes. We therefore 
measured the concentration of LPS in LF by an endozyme LAL assay. LF used in this 
study showed concentrations of 2.6 EU LPS/mg LF (Figure S4A). We therefore applied 
an optimized Triton X-114 method210 to reduce LPS levels. This method reduced 
the endotoxin levels to 0.58 EU LPS/mg LF (Figure S4A). Despite this five-fold 
decrease in LPS levels, the immunomodulatory activity of LF remained the same 
(Figure S4). Nevertheless, we have previously shown that low concentrations of LPS 
induce endotoxin tolerance157. We therefore wanted to be absolutely certain that the 
functional effects of LF were not mediated by LPS. Therefore, we treated LF with 
proteinase K to degrade the protein and release any potentially bound endotoxins. 
We confirmed that LF was completely degraded after proteinase K treatment as 
observed on SDS-page gel (Figure S5A), Additionally, we showed by using a TLR4 
reporter assay that the NF-κB inducing capacity of LPS was unaltered by proteinase 
K treatment (Figure S5B), indicating that the LPS released from bound to LF 
remains functional. Interestingly, the dose-dependent increase of CD86 (Figure 3A) 
and PD-L1 (Figure S6B) and decreased CD1a (Figure 3B) expression induced by LF 
was reduced to moDC levels after proteinase K treatment. Similarly, the LF induced 
production of IL-6 (Figure 3C) and IL-8 (Figure S6A) during DC differentiation 
was abrogated after degradation of the protein. Thus, the LF-induced phenotype on 
immature DC was completely abolished by proteinase K treatment of the protein, 
showing that the effect is mediated by LF and not by LPS. In line with these findings, 
the responsiveness towards LPS of LFDC was completely restored to that of moDC 
upon proteinase K treatment as shown by the expression of CD86 (Figure 3D), CD83 
(Figure 3E), CD80 and PD-L1 (Figure S7A, B) and the production of cytokines such 
as IL-6 (Figure 3F), IL-12p70, TNF and IL-10 (Figure S7D–F).
Discussion
In this paper, we show that LF modulates human DC differentiation and function. 
Additionally, we show that its immunomodulatory capacity is not mediated by LPS. 
With this study, we confirm and expand on the study of Puddu et al. (2011), that 
showed that LF is capable of inducing differentiation into tolerogenic DC147. Since 
trace amounts of LPS can already induce a tolerogenic phenotype157, it is necessary to 
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Figure 3. Proteinase K treatment of LF restores responsiveness towards LPS. (A–C) monocytes were 
cultured in the presence of IL-4 and GM-CSF with or without LF or proteinase K treated LF. (D,E) These 
immature DC were subsequently stimulated with 1 µg/mL LPS for 48 h. The median fluorescent intensity 
(MFI) of (A,D) CD86 and (E) CD83 and (B) the percentage CD1a+CD14− DC is shown. (C,F) The 
production IL-6 was measured in the supernatant by CBA. The mean ± SEM of 3 different donors is shown. 
Significance is indicated by *** = p <0.001, ** = p <0.01 and * = p <0.05.
assess that LF and not LPS is responsible for the effect. Here, we show that LF alters 
the differentiation of monocytes into DC, resulting in a phenotypical distinct DC 
type which is hyporesponsive towards several TLR ligands.
It has been proposed that the GI tract is in a constant state of low-grade inflammation 
or “primed homeostasis” due to the constant exposure to commensal bacteria and 
microbial products in which monocytes are recruited toward the GI tract31,211. In line 
with this thought, a local micro-environment comprised of dietary and microbial 
factors may steer monocyte differentiation. We therefore investigated the effect of LF 
on monocyte differentiation into DC. It is well established that monocytes lose CD14 
expression and gain CD1a expression during differentiation into moDC. In the 
presence of LF, DC lose CD14 expression and gain less CD1a expression compared 
to conventional differentiated moDC. CD1a is an important functional marker for 
immature DC. Moreover, CD1a+ DC produce higher IL-12p70 levels and lower 
IL-10 levels upon stimulation and show a lower internalization capacity compared to 
CD1a-DC212,213. Potential explanations for the reduced CD1a expression on LFDC 
can be induction of PPARγ activity213, differentiation into more macrophage-like 
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cells due to IL-6-mediated autocrine M-CSF production214, or inhibition of GM-
CSF signaling215. Interestingly, an embryonic fibroblast cell line transfected with the 
human lactoferrin gene showed inhibited GM-CSF levels upon stimulation216. LF 
is, in contrast to moDC, internalized into the nucleus of human monocytes147. This 
finding makes it appealing to speculate about direct effect of internalized LF on the 
GM-CSF promotor in monocytes. Additionally, LF induces the production of IL-6 
and IL-8 within 24 h of differentiation (data not shown). Although IL-6 has been 
shown to be an important cytokine capable of modulating DC differentiation205 
and boosting autocrine G-CSF production214, Puddu et al. (2011) showed that the 
effects of LF are not mediated by IL-6. In line with these findings we show that IL-6 
production was not elevated if monocytes are differentiated in the presence of 10 µg/
mL LF and yet this concentration is sufficient to induce DC that are hyporesponsive 
towards TLR ligands.
LFDC produced much lower cytokine levels and upregulated costimulatory 
molecules markers to a lesser extent compared to moDC upon contact with TLR 
ligands. Moreover, they showed a semi-mature (CD83intCD86int) phenotype, which 
is postulated to induce polarization of naive T cells in regulatory T cells162. Thus, 
LF induces the differentiation of monocytes into more tolerogenic DC. In contrast 
to the effect of LF on monocytes, we show that LF does not induce phenotypical 
changes on human moDC nor modulate Poly I:C and R848-induced inflammation. 
These findings are in line with previous research, showing internalization of LF into 
the nucleus of human monocytes and not in moDC147. Their findings propose that 
the uptake of LF is mediated by a receptor expressed on human monocytes that is not 
expressed on moDC, which could explain the distinct effect of LF on both cell types. 
LF binds to intelectin-1 (i.e., intestinal lactoferrin receptor), which is expressed on 
epithelial cells77. To date, no evidence suggests expression of intelectin-1 on myeloid 
cells. LF also binds DC-SIGN which is expressed on monocytes and moDC205. 
However, the observed effects are also not likely mediated via DC-SIGN since 
its expression increases upon differentiation into DC217. Additionally, it has been 
suggested that LF binds with low affinity to several other receptors (e.g. RAGE and 
MNR). Interestingly, human LF was also shown to bind to soluble CD14218. Since 
CD14 expression is lost upon differentiation of monocyte into moDC, it is tempting 
to speculate that our phenotypic changes are induced via CD14. However, LF in 
concentration used in this study did not activate NF-κB on CD14-MD-2:TLR4 
expressing HEK cells (data not shown). Recently, CD14 was shown to be essential 
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for endocytosis of the TLR4 complex219, showing that its function is more than just 
facilitating LPS to bind TLR4. We therefore hypothesize that LF:LPS complexes can 
be internalized on monocytes in an unknown CD14-mediated manner.
This study shows, in line with the literature, that bovine LF, as well as human LF, 
induces differentiation of monocytes into hyporesponsive DC147 and macrophages207, 
respectively. However, due to the high binding affinity of LF to LPS, it is essential 
to investigate whether LPS or LF is responsible for this tolerogenic phenotype. 
Importantly, we showed that our sample did contain traces of LPS as measured by a 
LAL assay. In this assay, a recombinant factor C protein is used to detect LPS, which 
binds the lipid A part of the molecule220. LF was also shown to bind the lipid A part 
of the molecule208, which could shield LPS from binding TLR4 and apparently not 
factor C. According to the LPS contamination measured in our sample (i.e., 2.6 
EU/mg), the concentrations of LF used in our study of 0.25 mg/mL and 0.01 mg/
mL, thus, contain 0.65 EU and 0.026 EU, respectively. We have shown that LPS 
contamination of >0.5 EU induces the differentiation into tolerogenic DC157. The 
concentrations of LPS measured in LF in this study could, thus, theoretically explain 
the tolerogenic DC phenotype. Nevertheless, we demonstrated that the effects of LF 
are lost upon proteinase K treatment and that Triton X-114-treated LF shows the 
same immunomodulatory capacity compared to non-treated LF. We thereby exclude 
the possibility that effects of LF are mediated by endotoxin tolerance. This finding is 
in line with earlier research showing that the induced expression of pro-inflammatory 
genes in porcine macrophages is mediated in a TLR4-independent manner209.
This study adds on to the current understanding of the role of LF in immune 
regulation. Additionally, LF is well-known for its anti-pathogenic activity. Hence, LF 
supplementation to infants and immunocompromised individuals has been studied 
to investigate its efficacy against inflammatory conditions. Moreover, several clinical 
studies in children have been conducted with LF, all showing no adverse effects of LF 
supplementation221. LF supplementation to breast milk or infant formulas has been 
shown to reduce the incidence of sepsis VLWB infants191–195. These VLWB infants 
often suffer from excessive gut inflammation and have an impaired. Moreover, LF 
supplementation to children epithelial barrier functioning, which may result in 
necrotizing enterocolitis222. Additionally, several studies show that LF fortification to 
early life nutrition may alleviate symptoms of viral infections90,91,223,224 <5 years of age 
and to infants in the first year of life showed a reduction of the incidence of rotaviral 
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gastroenteritis223 and lower respiratory tract infections91. Similarly, LF supplementation 
to infant nutrition resulted in a lower incidence of symptoms of respiratory illness 
(e.g. running nose, coughing, wheezing) compared to infants receiving non-fortified 
formula90. LF supplementation has also been investigated for its additive effect in 
HIV therapy in children by measuring several immune parameters and viral titers. 
Interestingly, phagocytic activity, CD14/TLR2 expression and IL-12p70/IL-10 ratio 
in CD14+ was increased in children receiving LF supplementation224. Thus, apart 
from functioning as a direct anti-pathogenic protein, LF may inhibit infections by its 
immunomodulatory capacity. Since, LF is poorly digested in the GI tract of infants 
and a fraction of the protein is taken up intact and reaches the circulation197,200,201, it 
may impact the functionality of monocytes and DC in vivo. Larger cohorts should 
validate the protective effect of LF supplementation against viral infections and sepsis 
and investigate its immunomodulatory potential in vivo.
Conclusions
Taken together, our results show that LF inhibits DC differentiation which hampers 
their responsiveness towards TLR ligands. Additionally, we showed that these effects 
are diminished after degrading the protein, formally showing that the LF-induced 
differentiation of monocytes into hyporesponsive DC is not mediated by endotoxin 
tolerance. This study indicates that LF may promote immune homeostasis in the 
gastrointestinal tract.
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Figure S1. LF does not modulate immature DC activation. Monocytes were differentiated into moDC by 
culturing them for six days in the presence of IL-4 and GM-CSF. These immature DC were stimulated with 20 
µg/mL Poly I:C and 3 µg/mL R848 in the presence or absence of LF. The median fluorescent intensity (MFI) 
of (A) CD8, (B) CD86, (D) HLA-DR, (E) PD-L1, (F) CD80 and (C) the percentage of CD83+CD86+ DC is 
shown. The expression of three individual donors with mean and standard deviation is shown in a scatter plot.
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Figure S2. LFDC are hyporesponsive for LPS stimulation. Immature DC that were cultured in the presence 
or absence of LF were stimulated with 1 µg/mL LPS for 48 h. The median fluorescent intensity (MFI) of (A) 
CD80 is shown. The production of (B) IL-6 and (C) TNF was measured in the supernatant by CBA. The mean 
± SEM of four independent experiments with 12 different donors is shown. Significance is indicated by *** = p 
<0.001, ** = p <0.01 and * = p <0.05.
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Figure S3. Hyporesponsiveness of LFDC is not mediated by decoy activity. Immature DC that were 
cultured in the presence or absence of LF were stimulated with 1 µg/mL LPS (A) without or (B) with replacing 
¾ of the medium or (C) 20 µg/mL Poly I:C and 3 µg/mL R848 for 48 h. The median fluorescent intensity 
(MFI) of CD80 is shown. The mean ± SEM 3 different donors is shown.
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Figure S4. DC modulatory activity of LF is not reduced by Triton X-114 treatment. (A) An Endozyme 
LAL assay was used to detect LPS in LF before or after applying an optimized Triton X-114 method. Immature 
DC were cultured in the presence or absence of Triton X-114 treated or non-treated LF. (B) The percentage 
CD1a+ CD14− DC is shown on immature DC. These immature DC were stimulated with 1 µg/mL LPS for 
48 h. Median fluorescent intensity (MFI) of (C) CD83 and (D) CD86 is shown. The production of (E) IL-10 
and (F) IL-12p70 was measured in the supernatant by CBA. The mean ± SEM of 3 different donors is shown. 
Significance is indicated by *** = p <0.001, ** = p <0.01 and * = p <0.05.
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Figure S5. Proteinase K treatment does not affect NF-κB activation via TLR4 by LPS. (A) 1 µg/mL LF was 
loaded before and after proteinase K treatment on SDS-PAGE gel. (B) LPS, proteinase K treated LPS and 
heated LPS was tested for its NF-κB activation in a TLR4 reporter assay.
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Figure S6. Proteinase K treatment of LF abrogates its effect on DC differentiation. Monocytes were 
cultured in the presence of IL-4 and GM-CSF with or without LF or proteinase K treated LF. (A) The production 
of IL-8 was measured in the supernatant by CBA. The median fluorescent intensity (MFI) of (B) PD-L1 and 
(C) HLA-DR is shown. The mean ± SEM of 3 different donors is shown.
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Figure S7. Proteinase K treatment of LF restores responsiveness towards LPS. Monocytes were cultured in 
the presence of IL-4 and GM-CSF with or without LF or proteinase K treated LF for six days and subsequently 
stimulated with 1 µg/mL LPS for 48 h. The median fluorescent intensity (MFI) of (A) CD80, (B) PD-L1 and 
(C) HLA-DR is shown. The production of (D) TNF, (E) IL-10 and (F) IL-12p70 was measured in the 
supernatant by CBA. The mean ± SEM of 3 different donors is shown. Significance is indicated by *** = p 
<0.001, ** = p <0.01 and * = p <0.05.
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Abstract
Investigations into the immunological response of proteins is often masked by 
lipopolysaccharide (LPS) contamination. We report an optimized Triton X-114 
(TX-114) based LPS extraction method for β-lactoglobulin (BLG) and soy protein 
extract suitable for cell-based immunological assays. Optimization of an existing 
TX-114 based phase LPS extraction method resulted in >99% reduction of LPS 
levels. However, remaining TX-114 was found to interfere with LPS and protein 
concentration assays and decreased viability of THP-1 macrophages and HEK-Blue 
293 cells. Upon screening a range of TX-114 extraction procedures, TX-114-binding 
beads were found to most effectively lower TX-114 levels without affecting protein 
structural properties. LPS-purified proteins showed reduced capacity to activate 
TLR4 compared to non-treated proteins. LPS-purified BLG did not induce secretion 
of pro-inflammatory cytokines from THP-1 macrophages, as non-treated protein 
did, showing that LPS contamination masks the immunomodulatory effect of BLG. 
Both HEK293 cells expressing TLR4 and differentiated THP-1 macrophages were 
shown as a relevant model to screen the protein preparations for biological effects 
of LPS contamination. The reported TX-114 assisted LPS-removal from protein 
preparations followed by bead based removal of TX-114 allows evaluation of natively 
folded protein preparations for their immunological potential in cell-based studies.
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Introduction
Increasing food demand creates a need to search for more sustainable food systems. 
The number of studies focused on the functionality, processing, and industrial 
application of alternative proteins is rapidly increasing225. Nutritional and 
immunological aspects of these novel proteins are not well-known and introducing 
them to the human diet requires insight into these aspects225,226. In vitro cell culture 
models are a useful strategy to study the nutritional value and immunological 
potential of novel proteins226,227. LPS (lipopolysaccharide) is a major endotoxin found 
in food protein preparations and other food extracts such as polysaccharides210. LPS 
is a pathogen associated molecular pattern found in the outer membrane of most 
gram-negative bacteria and is capable of initiating a strong innate immune response 
upon bacterial infection in humans228–230. Soluble LPS particles form a complex 
with lipopolysaccharide-binding protein (LBP), which is transferred to CD14 and 
subsequently interacts with Toll-like receptor (TLR)4 and MD-2 to activate the NF-
κB pathway. This activation results in the secretion of pro-inflammatory cytokines, 
like IL-1β, IL-6 and TNF228,229. Investigation of the effect of food-derived proteins on 
the immune response is therefore masked by high levels of immunomodulatory LPS. 
Removal of LPS from protein preparations reveals the unbiased immunomodulatory 
effects that proteins may induce. A vast array of LPS extraction procedures have been 
published over the years and these methods often include several chromatographic 
steps, such as ion exchange, hydrophobic interaction chromatography, and gel 
filtration231–233. These methods are laborious, and do not fully eliminate biological 
activity of residing LPS234. Polymyxin B (PMB) is an antibiotic that has been used 
as alternative strategy to eliminate LPS activity and even though PMB was shown to 
prevent TLR4 signaling its presence does not prevent IL-1β secretion in monocyte 
cultures235. Other compounds which have been experimentally shown to eliminate 
the immunogenic potential of LPS include paeonol236 and gedunin235 although their 
mode of action potentially interferes with the immunogenic properties of proteins 
under investigation. Proanthocyanins isolated from different food sources237 and 
lactoferrin238 have also been identified as potent binding partners of LPS. However, 
the activity of LPS removal agents that act by interaction with LPS is influenced 
by the chemical properties of the protein, often require pH adjustment and do not 
guarantee complete dissociation and removal of protein-bound LPS231–233. A technique 
that triggers the dissociation of LPS from the protein irrespective of protein chemical 
properties is a two-phase detergent-based (e.g. Triton X-114, TX-114) extraction. 
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Recently, this method was described as an efficient way of endotoxin removal from 
protein preparations of animal origin239, recombinant proteins and antibodies240–242, 
plasmids243 and viral proteins244. TX-114 is an aqueous surfactant that assists LPS 
into forming micelles, which subsequently aggregate into a surfactant enriched phase 
at a temperature of 22˚C. After phase separation, the lipophilic LPS-rich fraction can 
be separated from the hydrophilic protein phase by means of centrifugation233,239. 
Although this method was shown to retain the biological activity and the structure 
of proteins245,246, TX-114 was also reported to be toxic at low concentrations to cells 
in culture239 urging elimination of this extraction agent from protein preparations to 
allow unbiased investigation of the immunogenic potential of proteins.
In this study we demonstrate that LPS and TX-114 can be effectively removed from 
protein preparations to levels that do not interfere with cell viability, LPS and protein 
concentration assays, and in vitro immunological read-outs and do not impact on 
protein structure. We further show that LPS- and TX-114 purified β-lactoglobulin 
does not induce secretion of pro-inflammatory cytokines from THP-1 macrophages.
Materials and Methods
Proteins
Bovine β-lactoglobulin (BLG) (Sigma, cat. # L0130) was dissolved in sterile 
phosphate buffered saline (PBS, Life Technologies, cat. # 18912-014) or MQ H2O. 
Soy protein extract (SPE) was obtained by extracting the proteins from soy flour 
(Sigma Aldrich, cat. # S9633) according to the procedure described by L’Hocine et 
al.(2006)247. Protein concentration was determined by absorbance at 280 nm using a 
NanoDrop ND1000 spectrophotometer.
Triton X-114-assisted LPS-extraction method
A previously published TX-114 based LPS extraction protocols240,248 was modified to 
optimize for LPS removal and removal of remaining TX-114. TX-114 (Amresco, cat. 
# M114) was added to the protein solution (BLG at 10 mg/ml and SPE at 14 mg/
ml in PBS) to a final TX-114 concentration of 2% v/v. The solution was incubated at 
4˚C for 30 min with constant stirring. Subsequently, the sample was transferred to a 
water bath set at 37˚C and incubated for 10 min followed by centrifugation at 20,000 
g for 20 min at 37˚C. The upper part containing the protein was separated from the 
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TX-114 layer by means of pipetting and the LPS concentration was determined. 
To investigate whether repeated TX-114-assisted extraction increased LPS removal 
efficiency, the extraction procedure was repeated one, two and three times. Bio-Beads 
SM-2 (Bio-Rad, cat. # 152-8920)249 with high affinity for Triton were added to the 
collected supernatant and incubated overnight at 4°C with constant stirring. The 
ratio of beads to protein solution was calculated based on the assumption that 1 g 
of beads adsorbs 0.07g of Triton. Using sedimentation, the Bio-Beads were removed 
from the samples. A similarly TX-114 treated protein free buffer control was included 
to determine TX-114 remaining concentrations using absorption at 280 nm.
TX-114 removal 
Several approaches were evaluated for their ability to eliminate TX-114 from protein 
preparations. First, 8 ml protein solution was subjected to dialysis for 24 h against 
distilled water using a Slide-A-Lyzer 10kDa cassette (Life Technologies, cat. # 66380). 
Second, a volume of 1 ml of 0.1% TX-114 in buffer and 1 ml of 1.0 mg/ml of BLG 
were applied to a HiTrap Desalting column (GE Healthcare Life Sciences, cat. # 29-
0486-84). Third, samples were centrifuged at 21,000 g and 25˚C for 10 and 20 min 
and at 37˚C for 10 and 20 min. Fourth, samples were centrifuged using 0.22 mm 
(cat. # 8160) and 0.45 mm (cat. # 8162) spin X filter columns (Costar) at 10,000 g 
at 37˚C for 4 min. Last, high-affinity Triton binding Bio-Beads SM-2 (Bio-Rad, cat. 
# 152-8920) were tested for their efficacy to remove Triton and used according to the 
manufacturer manual.
Measurement of LPS concentration
The LPS concentration was measured using the commercially available Endozyme 
Recombinant Factor C assay (Hyglos, cat. # 609050) according to the protocol of the 
manufacturer. The measurements were conducted in triplicate using a Tecan Infinite 
200Pro plate reader. The positive control (MQ) was spiked with a concentration of 
0.45 EU/l of LPS, and results for all tests were considered valid when the value of 
recovered LPS concentration was between 50 and 200% of this value. LPS units were 
converted from EU (Endotoxin Unit) to concentrations in pg/ml by assuming that 
1 EU corresponds to 100 pg of standard endotoxin EC-5250. It should be kept in 
mind that LPS concentration strongly depends on the source of the endotoxin, since 
endotoxin activity is highly variable, depending on the bacterial strain.
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SDS-PAGE
Non-reducing SDS-PAGE was used to evaluate the influence of the LPS removal 
procedure on protein content and quality. Samples were loaded onto a 12.5% 
polyacrylamide gel followed by staining using GelCode Blue Stain Reagent (Life 
Technologies, cat. # 24592).
Far-UV circular dichroism
Protein samples (BLG, SPE) at 0.1 mg/ml in PBS were placed in a quartz cuvette with 
an optical path of 0.1 cm. Far-UV circular dichroism (CD) spectra were recorded in a 
Jasco J-1500 spectropolarimeter at 25˚C. The wavelength range was set from 260 to 
190 nm with 0.5 nm resolution, 4.0 sec response time, and 1.0 nm band width. Data 
were collected as averages of eight scans at a scanning speed of 50 nm/min. Spectra 
were corrected by subtracting the buffer baseline. Measurements were performed as 
independent duplicates.
Intrinsic tryptophan fluorescence
Emission fluorescence spectra of protein samples (BLG, SPE) at 0.01 mg/ml in PBS 
were recorded at 25˚C using a Varian Cary Eclipse spectrophotometer. The excitation 
wavelength was set at 295 nm (5 nm bandwidth) and the emission intensity was 
recorded from 310 to 500 nm (5 nm band width) at a scan rate of 120 nm/min and 
a 0.5 nm data interval. Spectra were corrected for buffer and represent an average of 
two scans. Measurements were performed as independent duplicates.
Cell culture
HEK-Blue-hTLR4 and HEK-Blue-hTLR2 cells (InvivoGen hkb-htlr4 and hkb-
htlr2) were obtained by co-transfection of the human TLR4/TLR2, MD-2 and 
CD14 co-receptor genes and an inducible secreted embryonic ALP (SEAP) reporter 
gene into HEK293 cells. Stimulation of TLR4 or TLR2 with LPS activates NF-κB 
and AP-1 (activator protein 1), which induce the production of SEAP. SEAP activity 
was determined with the commercially available Quanti-Blue assay (InvivoGen, cat. 
# rep-qb1). The cells were grown in DMEM, 4.5 g/l glucose, 10% (v/v) fetal bovine 
serum, 50 U/ml penicillin, 50 mg/ml streptomycin, 100 mg/ml Normocin, 2 mM 
L-glutamine at 37°C in a humidified atmosphere at 5% CO2. For the cytotoxicity 
and activation of TLR4 and TLR2 receptors assays cells were plated at a density of 
1.25x103 cells per well in a 96-well plate and incubated for 24 h. Next day the medium 
was replaced by 150 µl of medium containing SPE or BLG. The human monocytic 
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leukemia cell line THP-1 (American Type Culture Collection, Rockville, Md.) was 
grown as described previously251. Macrophage differentiation was induced by treating 
THP-1 monocytes (106 cells/ml) for 48h with 100 ng/ml phorbol 12-myristate 
13-acetate (PMA, cat. # P1585) in 96-well cell culture plates containing 100 µl of 
cell suspension or 24-wells cell culture plates containing 500 µl of cell suspension in 
each well. It has been demonstrated that this differentiation method of THP-1 cells 
results in the expression of macrophage specific surface markers CD11b and CD36 
and also phagocytic activity252,253.
Cytotoxicity assay
The cytotoxic effect of TX-114 was determined using a cell viability test (CellTiter 
96 AQueous One Solution Cell Proliferation Assay, Promega, cat. # G3580). HEK-
Blue-hTLR4 and HEK-Blue-hTLR2 cells were incubated with 2, 1, 0.5, 0.25, and 
0.13 mg/ml of BLG or 2.8, 1.4, 0.7, 0.35, and 0.175 mg/ml of SPE. Phosphate 
buffered saline (PBS), PBS spiked with 0.005% of TX-114 (PBS/0.005% triton) 
and 0.1% of TX-114 were used as controls. After 24h incubation of both cell lines a 
volume of 20 µL of CellTiter 96 AQueous One Solution Reagent was added to each 
well followed by 1 h of incubation at 37°C. Absorbance was measured at 485 nm 
with FilterMax F5 Multi-Mode microplate readers and the percentage of viable cells 
was calculated in relation to cells cultured in pure medium. All experiments were 
performed in triplicate.
Activation of TLR4 and TLR2 receptors
HEK-Blue-hTLR4 and HEK-Blue-hTLR2 cells were incubated with 2, 1, 0.5, 0.25, 
and 0.13 mg/ml of BLG or 2.8, 1.4, 0.7, 0.35, and 0.175 mg/ml of SPE. The LPS 
standard curve, MQ water and MQ water spiked with 0.005% of Triton X-114 were 
used as controls. After 24h incubation in the presence of the stimuli the supernatant 
was collected and SEAP activity was measured using the Quanti-Blue assay according 
to the protocol of the manufacturer. The absorbance was measured at 620 nm after 
1 h of the incubation at 37°C. All samples were measured in triplicate. TLR4/TLR2 
receptor stimulation was expressed relative to the level of SEAP activity of cells 
cultured in pure medium.
Cytokine secretion by THP1 derived macrophages
Differentiated, adherent THP-1 macrophages were washed once with sterile PBS and 
once with complete RPMI 1640 medium. Cells were co-cultured for 24 h with 100 µl 
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of non-purified and LPS-purified BLG at protein concentrations of 100, 25 and 6.25 
µg/ml. After 24h of incubation the supernatant was collected and human cytokine 
concentrations (IL-6, IL-8, IL-1β and TNF) were determined using the cytometric 
bead array (CBA) kit (Human Inflammatory Cytokine Kit, BD Bioscience, cat. # 
551811) according to the manufacturer’s instructions. The samples were analyzed by 
flow cytometry (BD FACS Canto II, BD Bioscience). The results were normalized to 
cytokine levels of unstimulated macrophages cultured in the medium.
Gene expression analysis using Q-PCR
THP-1 macrophages were incubated with titrated amounts of LPS (10-15 to 10-5 g/
ml E. coli 0111:B4; Sigma) for 6 h. Cells were washed once with PBS and lysed 
using 200 µl TRIzol per well. RNA isolation, cDNA synthesis and RT-qPCR were 
performed as reported previously [30]. Investigated genes and used primers were 
IL-1β (FWD: GTGGCAATGAGGATGACTTGTTC; REV: TAGTGGTGGTCG-
GAGATTCGTA), IL-8 (FWD: CTGATTTCTGCAGCTCTGTG; REV: GGGT-
GGAAAGGTTTGGAGTATG), IL-10 (FWD: GTGATGCCCCAAGCTGAGA; 
REV: CACGGCCTTGCTCTTGTTTT), IL-12p40 (FWD: CTCTGGCAAAAC-
CCTGACC; REV: GCTTAGAACCTCGCCTCCTT), TNF (FWD: TTCTG-
CCTGCTGCACTTTG; REV: GGGTTCGAGAAGATGATCTG) and NF-κB 
(FWD: TGAGTCCTGCTCCTTCCA; REV: GCTTCGGTGTAGCCCATT). 
Relative fold-changes to non-stimulated THP-1 macrophages were calculated 
following normalization to GAPDH (FWD: TGCACCACCAACTGCTTAGC; 
REV: GGCATGGACTGTGGTCATGAG) and using the 2-ΔΔCt method.
Statistics
Results were expressed as mean ± SD of three to five independent measurements. 
Statistical analysis was carried out by GraphPad Prism 4 software. One-way ANOVA 
test with Tukey post-hoc (p<0.05, shown as one asterisk) was used to evaluate the 
significance if not specified differently in Figure legend.
18039 Olaf Perdijk PM.indd   70 04-09-18   19:56
Triton X-114: an optimized method for LPS removal from food protein
71
4
Results
Triton X-114 needs to be removed from protein preparations before in 
vitro applications
Even though TX-114 presents an effective LPS-extraction agent for LPS-contaminated 
protein preparations, residual detergent remaining in the treated protein solution has 
been reported to be toxic to cells in culture239 and hamper both determination of 
protein by absorbing at 280 nm and LPS concentration by interfering with most 
commercially available LPS detection assays. These observations motivated the need 
to lower the remaining TX-114 concentration after the purification procedure. TX-
114 concentrations were conveniently determined under conditions where no protein 
is present using the characteristic to absorb light at 280 nm in a linear concentration-
dependent manner (Figures 1A-B). This allowed estimation of the concentration of 
TX-114 in PBS spiked with 0.45 EU/l of LPS, after applying the TX-114 treatment. 
After one cycle of TX-114 purification the concentration of TX-114 remaining 
in LPS spiked PBS was estimated to be 0.12% (v/v) and this concentration was 
increasing with an increasing number of purification cycles (Figure 1C). A TX-114 
concentration of 0.12% (v/v) was found to interfere with the EndoZyme assay giving 
rise to false negative results (Figure 1D). At the same time, a concentration of TX-
114 in the medium equal to or higher than 0.006 % (v/v) significantly decreased 
the viability of THP-1 derived macrophages (Figure 1E). To evaluate the ability of a 
range of methods to effectively extract TX-114, PBS was spiked with 2% (v/v) TX-
114 and subjected to centrifugation, dialysis, Hi-Trap desalting and spin X column 
purification or treatment with Triton-binding Bio-Beads (Figure 2). The use of Bio-
Beads presented the most effective extraction of TX-114 by reducing TX-114 levels 
down to 0.005% (v/v). This concentration was significantly lower comparing to other 
conventional methods (Figure 2) and sufficiently low to permit reliable quantification 
of LPS with the EndoZyme assay (Figure 1D), UV-based determination of the 
protein concentration and was not cytotoxic to HEK 293 (Figure S1) or THP-1 
derived macrophages (Figure 1E).
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Figure 1. Optimization of TX-114 removal method from beta-lactoglobulin (BLG) and soy protein 
extract (SPE). (A) Triton concentrations can be quantified in protein-free solutions using spectroscopic 
absorbance at 280 nm. Absorbance spectrum of 0.005% (v/v) TX-114 solution in PBS was determined by a 
NanoDrop ND1000 spectrophotometer. (B) TX-114 in PBS dose-dependent absorption at 280 nm. Results 
are corrected for PBS background and represent an average of three independent measurements. (C) 
Concentration of TX-114 in PBS spiked with LPS (0.45 EU/l) after applying the TX-114 treatment described 
in Materials and Methods measured after one TX-114 cycle, three TX-114 cycles or after one TX-114 cycle 
followed with Bio-Beads treatment. (D) TX-114 reduces LPS detection with EndoZyme recombinant factor C 
assay in a dose-dependent manner. LPS concentration was measured in PBS spiked with 0.45 EU/l of LPS and 
decreasing concentration of TX-114. (E) Concentration of TX-114 in the medium equal or higher than 0.006 
% (v/v) decreases the viability of THP-1 derived macrophages. Viability of THP-1 macrophages cultured for 24 
h in the presence of TX-114 in the medium expressed as relative to cells grown in TX-114 free medium (n=1).
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Figure 2. Extraction of remaining TX-114 from protein extract with high-affinity Bio-Beads results in 
most effective lowering of detergent concentration to non-toxic levels. Comparison of different TX-114 
extraction methods. Starting from an initial TX-114 concentration of - 2% (v/v), the concentration of this 
detergent is effectively lowered by the application of dialysis, various centrifugation conditions, spin-X column 
and Bio-Bead assisted purification. Application of Bio-Beads results in most efficient TX-114 extraction down 
to 0.005% (v/v).
TX-114 assisted LPS extraction does not affect protein content and 
structure
TX-114-assisted LPS removal does not result in loss of proteins as protein 
concentrations of BLG and SPE, determined by OD280, were similar before and 
after application of the purification procedure (Figure 3A). Using SDS-PAGE, 
SPE showed a range of bands corresponding to β-conglycinin and glycinin similar 
to a previously reported migration profile 247. The TX-114-assisted LPS extraction 
procedure did not affect this band distribution and similar results were obtained for 
BLG (Figure 3B) suggesting that quaternary structural arrangements were not affected 
by the treatment. Further, the LPS removal procedure did not affect the secondary 
and tertiary structural organizations estimated from Far-UV CD and intrinsic 
tryptophan fluorescence (Figures 3C-F). The CD and tryptophan fluorescence 
spectra largely overlap when comparing non-treated with LPS- and TX-114 extracted 
BLG and SPE and the wavelength of maximum tryptophan fluorescence intensity, 
indicative of a folded protein structure, did not differ significantly for BLG. For SPE, 
intrinsic tryptophan and CD peak positions for both LPS-extracted and non-treated 
samples were not significantly different although a small degree of variation appeared 
in signal intensity for both read-outs.
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Figure 3. Protein yield and structure are retained upon application of the TX-114 assisted LPS extraction 
procedure. (A) BLG and SPE were dissolved in PBS at an initial concentration of  - 10 mg/ml and protein 
concentrations were determined again after application of the LPS extraction procedure. (B) Non-reducing 
SDS-PAGE of not purified BLG, SPE and LPS- and Triton-extracted (TX BLG, TX SPE), M - molecular 
weight marker. (C,D) Intrinsic tryptophan fluorescence and far-UV CD spectra (E,F) of BLG and SPE. BLG 
concentrations used for far-UV CD were determined spectroscopically using absorbance at 280 nm and 
resulting CD spectra were normalized for molar ellipticity. SPE CD spectra were distorted at wavelength values 
below 205 nm as a result of high (>800) voltage.
LPS extraction by TX-114 significantly reduces LPS contamination of 
β-lactoglobulin and soy protein
The initial concentration of LPS in BLG and SPE was estimated to be 1216 EU/
ml and 6 EU/ml, respectively. TX-114-assisted LPS extraction reduced the LPS 
concentration in BLG to 0.87 EU/ml and in SPE to 0.05 EU/ml demonstrating 
in purification efficiencies of 99.9% and 99.2%, respectively (Figure 4A). Repeated 
(one, two or three times) LPS-extraction did not lower LPS levels further (Figure 4B) 
but caused an increase of the residual TX-114 concentration in the protein sample 
(Figure 1E).
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Figure 4. TX-114 assisted LPS extraction reduce LPS levels in BLG and SPE extracts to the levels below 
1 EU/ml. (A) LPS concentration in protein preparations before (BLG, SPE) and after purification (pBLG, 
pSPE) with TX-114 method. (B) Repeated TX-114-assisted LPS extraction does not affect LPS extraction 
efficiency. BLG or PBS spiked with 0.45 EU/l of LPS were treated once, twice or three times with a 2% (v/v) 
TX-114 solution and subjected to incubation at 4˚C for 30 min followed by a 10 min incubation at 37˚C and 
centrifugation.
Stimulation of TLR4 and TLR2 receptors by β-lactoglobulin and soy 
protein
Figure 5 shows the levels of TLR4 and TLR2 receptor mediated signaling in HEK 
293 cells incubated with non-treated and TX-114 treated BLG and SPE. Incubation 
of HEK-Blue 293 cells with non-treated BLG resulted in high TLR4 activation (on 
average 10-fold higher than medium control) reaching the plateau for all tested 
concentrations (Figure 5A). The level of TLR4 stimulation was significantly lower 
(up to 88%), but followed a concentration-dependent pattern, upon incubation 
of cells with LPS-purified BLG. Incubation of non-treated SPE with HEK-Blue 
293 cells resulted in low activation of TLR4 (2-fold higher than medium control). 
This was observed only for the highest concentration of protein at 2.8 mg/ml, 
(corresponding with 1.2 EU/ml of LPS) and was reduced but not eliminated by 
treatment with TX-114 (Figure 5C). These data suggest that SPE itself, in the absence 
of LPS, may also induce TLR4 activation. A dose-dependent activation of TLR2, at 
lower level compared to TLR4, was observed upon incubation of HEK-Blue 293 
cells with non-treated BLG which was significantly reduced upon extraction of LPS 
from the protein (Figure 5C). An activation of TLR2 by LPS-purified BLG at the 
concentration of 2 mg/ml (0.17 EU/ml of LPS contamination) may be explained by 
an immunomodulatory effect of BLG itself as LPS at a concentration of 1 EU/ml did 
not induce TLR2 activation. However, contamination of the BLG preparation with 
other TLR2 ligands could not be excluded. Collectively, these data show that the 
described LPS extraction procedure sufficiently lowers LPS concentrations to reveal 
the immunomodulatory effects of proteins.
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Figure 5. Reduced TLR4 (A,B) and TLR2 (C) activation upon incubation of HEK-Blue 293 with LPS 
purified protein preparations. HEK-Blue 293 cells were incubated 24 h with non-treated BLG (BLG, black 
bars A, C), BLG purified with TX-114 method (TX BLG, white bars A, C), non-treated SPE (SPE, black bars 
B), SPE purified with TX-114 method (TX SPE, white bars B). The samples were tested in a range of dilutions 
and the corresponding concentration of protein (mg/ml) and LPS (EU/ml) in each dilution is presented on the 
x axis. The results are expressed as the relative to unstimulated cells (medium control =1). Statistically significant 
differences between corresponding dilutions of LPS-purified and non-treated preparations are shown (p<0.05). 
LPS standard curve, MQ water and MQ water spiked with 0.005% of TX-114 (MQ/TX-114) were used as 
controls.
THP-1 macrophages as a model to study immunomodulatory potential 
of BLG
To establish the potential of THP-1 derived macrophages to serve as a model to 
study the immunogenic potential of proteins we first analyzed the sensitivity 
threshold of THP-1 macrophages to E. Coli derived LPS by analyzing gene 
expression of inflammatory cytokines and measurement of released IL-8 levels in 
the medium (Figures 6A- B). LPS concentrations of 10 pg/ml and higher induced a 
pro-inflammatory gene response in THP-1 macrophages by significantly increasing 
TNF expression. Gene expression levels of IL-1β and IL-8 were increased albeit not 
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significantly (Figure 6A). These observations at the mRNA level directly translated into 
increased levels of IL-8 upon incubation of THP-1 cells with LPS at a concentration 
of ≤50 pg/ml (Figure 6B). Next, we incubated THP-1 macrophages with non-treated 
and LPS-purified BLG to investigate its immunomodulatory potential in the absence 
of interfering LPS. Non-treated BLG at a concentration of 25 µg/ml (304 pg/ml 
of LPS) significantly increased the level of IL-8 while higher concentration of BLG 
of 100 µg/ml increased significantly the secretion of IL-1β and IL-6 (Figures 6C-
E). Incubation of cells with LPS-purified BLG diminished the secretion of all three 
cytokines (IL-1β, IL-8 and IL-6) when compared to non-treated BLG, which was 
shown to be contaminated with LPS. These observations indicate that LPS can be 
eliminated from protein preparation in such a manner that the isolated natively 
folded protein-induced immunogenic effects on immune cells in culture can be 
reliably measured in the absence of LPS.
Discussion
Our work aimed at optimizing an LPS extraction procedure from proteins to enable 
functional investigation of the immunological properties of these proteins without 
the interfering effect of LPS or LPS extraction agents.
TX-114 based phase separation was shown to be an efficient, simple and cost-
effective strategy to significantly reduce or even eliminate endotoxin contamination 
from biological preparations232,239–241,243–246,248,254. Despite the scientific need for LPS 
removal to establish the immunological activity of natively folded proteins, only few 
studies reported on the experimental conditions that affect the efficiency of endotoxin 
removal from protein extracts using TX-114. Reported protocols vary in incubation 
conditions and TX-114-removal strategies after LPS-extraction234,239,240,253, which we 
have shown to critically influence the application of the purified protein in in vitro 
assays248. Lopes et al. (2010) showed that separation of LPS into a TX-114 micelle-
rich phase is more effective at higher TX-114 concentrations and that extraction 
efficiency is positively correlated with increasing incubation temperature (33-
41ºC)248. We therefore used a concentration of TX-114 of 2% (v/v) and incubated 
the TX-114-protein mixture at a temperature of 37ºC, resulting in an LPS extraction 
efficiency of 99.9% for BLG and 99.2% for SPE after a single TX-114 treatment. 
When using TX-114 at a concentration of 1% (v/v), some studies observed improved 
LPS-extraction efficiency after repeated treatment of the protein solution with 
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Figure 6. THP-1 derived macrophages as a model to study immunomodulatory potential of non-purified 
and LPS-purified BLG preparation. (A) LPS dose-dependence and differential gene expression of inflammatory 
cytokines and NF-κB in THP-1 macrophages. The data obtained for 3 repetitions is normalized to GAPDH 
and relative to unstimulated macrophages cultured in medium. Statistically significant differences relative to 
non-stimulated THP-1 macrophages were calculated with Student’s t-tests: * = p<0.05. (B) LPS dose-dependent 
secretion of IL-8 by THP-1 macrophages. THP-1 cells were incubated 24h with increasing concentration of 
LPS and IL-8 concentration in supernatant was determined with flow cytometry. The results and statistically 
significant differences are related to unstimulated cells medium control =1). (C-E) Dose dependent secretion of 
pro-inflammatory cytokines from THP-1 macrophages incubated 24h with non-purified BLG (BLG) and BLG 
purified with TX-114 method (TX BLG). The results are expressed as the relative to unstimulated cells (medium 
control =1). Statistically significant differences between corresponding dilutions of purified and non-purified 
BLG preparations are shown (p<0.05).
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TX-114239,240,246. We observed that the efficiency of LPS extraction did not increase 
further with additional cycles of 2% (v/v) TX-114 treatment. The observed 
differences may be explained by interactions between LPS and proteins resulting 
in the formation of protein–endotoxin complexes, as described before for different 
types of proteins206,255. Such endotoxin-protein complexes are able to activate Toll-
like receptor 4 and induce the secretion of pro-inflammatory cytokines as it has been 
shown previously for lactoferrin238. Protein associated LPS is difficult to remove 
during purification procedures233 although Reichelt and colleagues showed affinity 
chromatography with TX-114 as an effective method to remove tightly bound 
endotoxin from recombinant proteins241. Although to our knowledge the interaction 
between LPS and BLG and soy proteins have not been reported but can also not 
be excluded. Therefore, the application of optimized TX-114 (2%) for studied 
proteins provided sufficient detergent and micelle forming ability to dissociate also 
protein-bound LPS as no secretion of pro-inflammatory cytokines was observed after 
incubation of macrophages with purified BLG/soy protein sample. Nevertheless, 
the efficiency at which endotoxin is removed, especially when tightly associated, 
from a protein may depend on various factors including the type of interactions 
between the endotoxins and the protein. A number of proteins and peptides with 
different physicochemical characteristics244,255–258 were shown to interact with LPS via 
electrostatic interactions for basic proteins and hydrophobic interactions or formation 
of dynamically stable calcium bridges played a role for neutral and acidic proteins232. 
Moreover, it has been shown that the concentration of the protein itself effects 
significantly the amount of disaggregated endotoxin and the formation of protein-
LPS complexes. The protein concentration was also shown to has significant effect on 
protein-LPS binding and endotoxin removal by ultrafiltration membranes (300,000 
NMWCO)259. Because many variables influence the LPS extraction efficiency, it is 
challenging to develop one method that is generally suitable for LPS removal from 
different protein sources and it cannot be concluded that the method described here 
is indeed suitable to extract LPS from all these different proteins. However, the TX-
114 method applied in this study was demonstrated to efficiently extract LPS from 
two proteins with highly different physio-chemical profiles including BLG, a protein 
of animal origin belonging to the lipocalin family and SPE, a mixture of storage 
proteins, mostly globulins, isolated from soy.
The protein structure-function paradigm dictates that any change in protein structure, 
induced by the LPS extraction procedure may directly translate into an alternative 
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immunological profile260. Although the TX-114 treatment does not influence the 
biological activity and functionality of proteins240,242,246 a limited number of studies 
focus on the structural properties of the proteins after treatment with TX-114245. 
BLG and SPE studied here, did not show differences in secondary, tertiary and 
quaternary structure upon treatment as determined by SDS-PAGE, far-UV circular 
dichroism spectroscopy and intrinsic tryptophan fluorescence. Moreover, TX-114 
treatment did not result in loss of BLG and SPE based on protein concentration 
and SDS-PAGE. However, based on literature261, the significant decrease in protein 
concentration after TX-114 treatment of hydrophobic proteins can be expected 
making the procedure less suitable for highly hydrophobic proteins.
A major disadvantage of using TX-114 to extract LPS removal is that residual 
detergent persists in the protein phase after extraction resulting in toxicity of the 
preparations to living cells. We observed that 0.1% of TX-114 in the medium cause 
35% decrease in the viability of HEK 293 cells while a concentration of 0.006% 
and higher was already cytotoxic for THP-1 macrophages. TX-114 concentrations 
of 0.02% (v/v) were previously reported to influence cellular activity of PMA-
stimulated neutrophils239 demonstrating that, even though all cell types investigated 
responded to TX-114, different cell types may vary in their sensitivity towards this 
detergent. Virtual elimination of residual TX-114 after LPS extraction therefore 
seems crucial for applications using cell based read-outs. We further reported that 
TX-114 can interfere with common protein and LPS concentration determination 
assays. Previously published procedures often disregard this phenomenon giving rise 
to conclusions based on TX-114 induced bias in concentration assays234,244,246,248. 
Buetler and colleagues (2011)234 showed that glycolaldehyde-modified BLG 
preparations were unable to induce inflammatory signaling in receptor for RAGE-
expressing cells after TX-114 assisted extraction of LPS. The authors concluded 
that cell activation shown for non-treated preparations was connected to a LPS-
like lipophilic contamination. Interestingly, data presented by the same authors for 
glycolaldehyde-modified BLG preparations purified using affinity chromatography, 
which similarly resulted in efficient reduction of LPS contamination, demonstrated 
that incubation of cells with these preparations induced expression of TNF. Despite 
similar virtual elimination of LPS in both preparations, the TX-114-assisted LPS 
extracted glycolaldehyde-modified BLG did not induce inflammatory signaling while 
proteins treated by affinity chromatography did. This apparent inconsistency may 
be explained by the impact of TX-114 remaining after LPS-extraction in the TX-
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114 treated BLG. Although centrifugation was applied in this last study to remove 
TX-114 from BLG preparations we observed that centrifugation reduced TX-114 
levels to ±0.025% (v/v), a concentration that unambiguously affects cell viability. 
Similarly, Jensen and colleagues (2008)246 showed that TX-114 phase separation can 
be used to remove LPS from (His)6-tagged proteins and that biological activity of 
the treated recombinant protein was retained. These authors performed multiple 
cycles of TX-114 extraction followed by dialysis to remove residual TX-114 levels. 
However, the TX-114 concentration after dialysis was not determined, while we 
observed that dialysis does not sufficiently lower TX-114 concentrations to levels 
that do not interfere with in vitro and cell-assays. Above examples show the need 
to actively remove remaining TX-114 levels from treated protein solutions and to 
monitor levels of TX-114 after LPS-extraction. Based on our experiments comparing 
a range of TX-114 removal procedures, the application of Triton-binding Bio-Beads 
was found to reduce the TX-114 concentration to a non-cytotoxic concentration of 
0.005% (v/v) without influencing the protein structure and yield upon treatment as 
previously reported242,243,245. The optimized TX-114 based LPS-extraction procedure 
described in this manuscript allowed investigation of the immunologic potential of 
protein preparations without interference of LPS and TX-114. For this, we used 
HEK293 cells expressing the LPS receptor subunits (TLR4, CD14 and MD-2) and 
THP-1 macrophages that are naturally sensitive to endotoxins. Similar to Schwarz 
and colleagues (2014)262 we observed that incubation of HEK 293 cells with LPS 
showed activation of TLR4 and -2 at LPS concentrations higher than 1 pg/ml and 
100 pg/ml, respectively. LPS at a concentration of 10 pg/ml and higher increased 
the expression of pro-inflammatory cytokines from THP-1 macrophages. Consistent 
with these findings, LPS concentrations of 10 and 20 pg/ml were reported to induce 
secretion of IL-6 and TNF from murine bone marrow-derived dendritic cells263 and 
activation of monocytes isolated from human blood, especially CD1c+ dendritic 
cells262. Compatibility of the outcomes suggests that both HEK293 cells expressing 
the LPS receptor subunits and differentiated THP-1 macrophages may be used as a 
relevant model for the screening of protein preparations for biological effects of LPS 
contamination. The biological effects of LPS depend not only on its concentration 
but also on the source of endotoxin. It has been shown that the primary structure 
of the lipid A moiety, but also a specific conformation enhance its biological activity 
by enabling binding to the Toll-like receptors and accessory proteins, LPS binding 
protein (LBP), CD14 and the (TLR4)–MD-2 complex229,264,265. That suggests 
that comparable LPS amounts present in protein preparations may cause different 
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biological effects dependently of the source of contamination. Therefore, before an 
application in immunological in vitro studies each protein preparation should be 
tested individually in the functional screening assay for LPS activity like presented in 
this paper HEK 293 cell line transfected with TLR-4 receptor. Incubation of TLR4 
transfected HEK293 cells with LPS-extracted BLG resulted in stimulation of TLR4 
but significantly higher levels were achieved by non-treated BLG demonstrating 
that contaminating LPS interferes with reliable immunogenic profiling of protein 
preparations. Similarly, while non-treated BLG induced large-scale upregulation 
of IL-8, IL-1β and IL-6 in THP-1 macrophages, upon LPS-extraction of BLG this 
effect was eliminated. The BLG protein preparations, under these conditions and 
up to a concentration of 100 µg/ml, did not show immunomodulatory properties. 
This finding is in line with that of Brix and colleagues (2003)266 who showed 
that endotoxin is a major immunostimulatory component present in commercial 
β-lactoglobulin preparations.
Conclusion
Investigation of immunomodulatory properties of food proteins requires an 
unequivocal conclusion on the source of the observed immunological activity. We 
optimized an LPS extraction method consisting of a two-step procedure involving 
TX-114 assisted LPS extraction followed by treatment of the protein preparations 
using high-affinity triton-binding beads to reduce the detergent residuals to non-toxic 
levels. The procedure was further validated with functional assays using HEK293 
cells expressing LPS receptor subunits and differentiated THP-1 macrophages to 
demonstrate that the TX-114 based LPS extraction method allows measurement of 
the immunologic potential of proteins without the interfering effect of LPS or Triton.
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Figure S1. Triton X-114 at a concentration of 0.005% (v/v) does not influence the viability of HEK-Blue 
293 cells. HEK-Blue 293 cells were cultured for 24 h in the presence of non-treated BLG (BLG) and BLG 
purified with TX-114 (TX BLG) and the viability of cells was measured with CellTiter 96 AQueous One 
Solution Cell Proliferation Assay. Results are expressed as relative to unstimulated cells (medium control =1). 
PBS, PBS spiked with 0.005% (v/v) TX-114 and 0.1 % (v/v) TX-114 were used as controls.
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Abstract
The human milk oligosaccharide 3'-sialyllactose (3’SL) has previously been shown 
to activate murine dendritic cells (DC) in a TLR4-mediated manner in vivo. The 
aim of this study was to investigate whether 3’SL has similar immunomodulatory 
properties on human DC. Initial experiments indicated that the presence of 3’SL 
during DC differentiation resulted in phenotypically distinct DC. Moreover, 3’SL 
induced semi-mature (tolerogenic) DC, that produced IL-10 but abrogated IL-
12p70 and TNF levels upon stimulation with several TLR ligands. These effects of 
3’SL were completely abolished by blocking TLR4 signaling. To exclude possible 
LPS contamination in the commercially available 3’SL, a highly sensitive LAL assay 
was performed. Unexpectedly, LPS was detected in commercial 3’SL from different 
suppliers. After removal of LPS from the 3’SL, its ability to modify DC differentiation 
was studied. LPS removal from 3’SL completely abrogated the functional and 
phenotypical changes. In conclusion, in contrast to what has been reported in 
murine ex vivo cultures, LPS-free 3’SL does not activate NF-κB via TLR4 in humans. 
Removal of LPS from (oligo)saccharide preparations is therefore an absolute necessity 
to study their potential immunomodulatory function.
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Introduction
The mucosal immune system is largely shaped during the first months of life under 
the influence of microbial colonization and diet49. The resulting proper development 
of tolerance in early life will prevent the development of allergies, autoimmune 
diseases and chronic inflammation of the mucosa later in life127. Human milk is an 
unique exogenous source of oligosaccharides and proteins which promote growth 
and immune function40,49,158. Well-studied dietary factors such as vitamin A and D 
derivatives retinoic acid and 1,25(OH)2D3 (VitD3), respectively, can induce regulatory 
responses27,162. Human milk oligosaccharides (HMOs) are also postulated to regulate 
mucosal immune function, although its mechanism is poorly understood40.
HMOs escape enzymatic hydrolysis and are fermented in the colon, facilitating the 
outgrowth of (beneficial) bacteria. Low levels of HMOs can be absorbed in the small 
intestine and reach systemic circulation105,106. HMOs consist of the disaccharide 
lactose at the reducing end that can be elongated into either a trissacharide containing 
a neutral (fucose) or acidic (sialic acid) fraction or is further elongated into more 
complex oligosaccharides. The binding of the sialic acid N-acetylglucosamine to the 
backbone via either a α-2,3- or α-2,6 linkage results in 3’SL or 6’SL, respectively. 3’SL 
and 6’SL are abundant acidic oligosaccharides present in human and bovine milk78. 
Most infant nutrition does not contain such natural HMOs which are replaced by 
the lactose- or plant-derived oligosaccharides galactooligosaccharide (GOS) and 
fructooligosaccharide (FOS)267.
To date it has been appreciated that the architecture of HMOs is essential for their 
effect on the immune system267. Human milk components, including HMOs are 
postulated to modulate TLR signaling on immune cells and induce regulatory 
responses268,269. Moreover, lactose- or plant derived oligossacharide mixtures were 
shown to activate different cells of the innate immune system via TLR4270–272. The 
acidic (i.e. sialic acid containing-) HMO fraction – but not the neutral HMO fraction 
– was shown to induce IFNγ- and IL-10-producing T cells in human mononuclear 
cell cultures273,274. These studies indicate that the acidic HMO fraction is capable of 
modulating Th2 responses. Oral treatment with the natural milk trisaccharides 6’SL 
and 2’FL in an OVA induced food allergy model also induced regulatory immune 
responses and attenuated allergic symptoms155. In contrast, Kurakevich and colleagues 
(2013) demonstrated that mouse pups receiving milk devoid of the acidic 3’SL were 
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less prone to develop colitis and isolated MLN DC were shown to be activated 
directly by 3’SL in a TLR4-dependent manner as the cause of inflammation156. On 
the other hand, TLR4 activation was shown to be essential for the proper immune 
education275. Activation of the immune system by such HMOs via TLR4 therefore 
may be essential for immune development in early life. The aim of the current study 
was to investigate whether 3’SL exerts similar effects on human immune function.
Materials and Methods
Isolation and culturing of monocyte-derived DC
Peripheral blood mononuclear cells (PBMCs) were isolated by density centrifugation 
from buffy coats obtained from healthy anonymous donors (Sanquin blood bank, 
Nijmegen). First, the blood was diluted 1:1 in phosphate buffered saline (PBS) 
(Mg2+ and Ca2+ free, Lonza, BE17-516F). The diluted blood was loaded on Ficoll-
Paque (Amersham Bioscience, Uppsala, Sweden) and centrifuged for 5 minutes at 
200 g followed by 15 minutes at 500 g both without brake. The PBMC layer was 
collected and washed three times in 10 ml PBS. After the third wash, the cells were 
spun down and the pellet was resuspended with anti-human CD14 magnetic beads 
(BD Biosciences, 557769). CD14+ cells were isolated on a separation magnet (BD 
IMagnet, BD Biosciences) according to the manufacturer’s instructions. This positive 
selection resulted in a highly pure population (96.5 ± 2.1%; n =5) of monocytes. 
Monocytes were reconstituted in RPMI 1640 (Gibco, 22409-015) and 10% FCS 
(Gibco, 10270-106), normocin (100 µg/ml, Invivogen, anti-nr-1), penicillin and 
streptomycin (100U/ml, Gibco, 14150-122) and cultured in flat bottom 96 wells 
plates (100.000 cells/well). Monocytes were cultured for six days in the presence 
of 20 ng/ml IL-4 (Peptrotech; 200-04) and GM-CSF (Peprotech; 300-03) with or 
without 1 µg/ml – 1 mg/ml Triton X-114 treated- or commercially available 3’SL 
(Carbosynth; OS04397 or SantaCruz; SC-216626) or ultrapure LPS (0.0001-100 
EU/ml) from E. coli OIII:B4 (Invivogen; tlrl-3pelps). TLR4 signaling was blocked by 
adding an intracellular TLR4 inhibitor (Invivogen; CLI-095, 3µM) for 1 hour at 37 
degrees Celsius prior to adding stimuli. After six days, immature DC were matured 
with 1 µg/ml LPS (Escherichia coli, Sigma, L2880) or 3 µg/ml R848 (Invivogen: 
tlrl-r848-5) and 20 µg/ml Poly I:C (Sigma, P1530) for 48 hours.
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Isolation and staining of moDC
After 24 hours, 6 days (immature-) or 8 days (mature-) DC were incubated on ice 
(while shaking) for 30 minutes in ice cold FACS buffer (PBS (Lonza, BE17,516F) 
containing 0.5% BSA fraction V (Roche, 10735086002), 2.0 mM EDTA (Merck, 
108418) and 0.05 NaN3) to facilitate the detachment of DC from the surface. 
Surface marker expression was analyzed by using fluorochrome-conjugated 
antibodies directed against CD14 (FITC; BD Biosciences, 555397), CD86 
(V450; BD Biosciences, 560357), CD83 (FITC; BD Biosciences, 556910), HLA-
DR (APCef780; eBiosciences, 47-9956-42), CD80 (PE-Cy5; BD Biosciences, 
559370), PD-L1 (PE-Cy7; BD Biosciences, 558017), CD1a (PerCP/Cy5-5; 
Biolegend, 300130) or ICOSL (PE; BD Biosciences, 552502). Matching isotype 
controls mIgG2a FITC (BD Biosciences, 555573), mIgG1 V450 (BD Biosciences, 
560373), mIgG1 FITC (BD Biosciences, 555748), mIgG2b APC-ef780 (APCef780; 
eBiosciences 47-4732-80), mIgG1 PE-Cy5 (BD Biosciences, 555576), mIgG1 PE-
Cy7 (BD Biosciences, 557872) were included by adding the –to the specific Ab panel 
corresponding– isotype mixture to cells. Fluorescence minus one (FMO) controls 
were included in channels with spectral overlap. Compensation beads (eBiosciences, 
01-2222-41) stained with single antibodies were run for every experiment. Cells were 
washed with 200µl FACS buffer and stained by incubating the antibody mixture for 
30 minutes in the dark at 4°C. Before measuring 7-AAD (BD Biosciences; 555815), 
DRAQ7 (Abcam; ab109202) or fixable viability dye ef506 (eBiosciences, 65-0866-
14) was added to stain nonviable cells. The fixable viability dye requires two washing 
steps with PBS and 30 minutes of staining in the dark at 4°C. Thereafter cells were 
resuspended in 100µl FACS buffer and acquired on a BD FACS Canto II (BD 
Biosciences) and analyzed using the FlowJo software V10.
Quantification of cytokine levels in supernatants
Levels of IL-6, IL-10, TNF and IL-12p70 were measured in the supernatants of 
moDC cultures using cytometric bead array technique (BD biosciences). Individual 
flex-sets for IL-6 (558276), TNF (560112), IL-10 (558274) or IL-12p70 (558283) 
were run according to the manufacturer’s instructions.
TLR signaling capacity of milk oligosaccharides
HEK-293 cells expressing human TLR2, TLR2-1 or TLR4 and harboring a pNIFTY 
construct (Invivogen, Toulouse, France) were grown on medium containing DMEM 
and Glutamax (Fisher Emergo, Landsmeer, the Netherlands) supplemented with 
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10% FCS, 100 ug/ml penicillin/streptomycin (Sigma, St Louis, MO), Zeozin (50 
µg/ml) and Normocin (100 µg/ml) (Invitrogen, Carlsbad, USA) in an atmosphere of 
5% CO2 at 370C. TLR2, TLR2-1 and TLR4 expressing HEK cells were additionally 
supplemented with Blasticin (100 ug/ml), Puromcyin (100 ug/ml) or HygroGold 
(45 ug/ml) (Invitrogen, Carlsbad, USA), respectively. HEK-293 cells were seeded 
at 3*105 cells/ml and cultured overnight before stimulation the next day. NF-κB 
activation was measured after 24-hour stimulation by adding Bright-GloTM (Promega, 
Fitchburg, USA) substrate to cells. The plate was shaken and luminescence was 
measured using a spectramax M5 (Molecular Devices, Sunnyvale, USA).
LPS detection
3’SL was tested for LPS contamination by a recombinant factor C LAL assay that 
was performed according to the manufacturers recommendations (EndoZyme 
recombinant factor C assay, Hyglos; 609050).
LPS removal with Triton X-114
An optimized method of LPS removal by Triton X-114 (Amresco, cat. # M114) was 
used 210. In short, 2 % v/v Triton X-114 was added to the sample and stirred for 30 
minutes at 4˚C and transferred to a 37˚C water bath for 10 minutes. The micelles 
were spun down by centrifugation for 10 minutes at 20.000g at 25 ˚C. The upper 
layer was collected and treated with 10 mg/ml Bio-beads SM-2 (cat. # 152-8920) to 
remove triton traces.
Analysis of Sialyllactose and Sialic Acid by HPAEC-PAD
LPS-free 3’SL was loaded on a Dionex system to confirm that the Triton X-114 
method only removed LPS and not 3’SL. 3’SL was separated using a CarboPac PA1 
column (250x4 mm) and a CarboPac PA1 guard column (50x4 mm) with a flow 
rate of 1.0 ml/min. 3’SL was detected using an AU-electrode (2 Hz). The following 
eluents were respectively used; 200mM NaOH (carbonate free), 100mM NaOH 
(carbonate free) + 500mM NaAc and HPLC grade water. The percentage of eluent 
A, B and D fluctuated between 0-55 minutes. 3’SL was quantified using an external 
sialyllactose sodium salt standard (mixture of 3’SL and 6’SL Carbosynth; OS04397 
and OS04398).
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Statistics
Statistical differences between two groups were tested by paired student t-tests. A 
repeated measures ANOVA with a Dunnet’s or Tukey’s post-test was performed when 
multiple groups were compared to untreated cells (moDC) or between different 
groups, respectively. If the represented data was normalized to the moDC per donor, 
statistics was performed on the raw data, maintaining the variances of the groups276. 
Significant differences between conventional differentiated cells and a single treatment 
group or multiple groups were indicated by letters or asterisks, respectively; a/*** = 
P< 0.001, b/** = P< 0.01 and c/* = P< 0.05. All values are represented as mean +/- 
SEM. Graphpad Prism V. 5.0 was used for all statistical analyses.
Results
3’SL induces phenotypical and functional distinct DC
Monocytes require a differentiation time of 5-7 days in the presence of IL-4 and GM-
CSF to become functional immature DC (iDC)277. Monocytes were cultured for six 
days in the presence of IL-4 + GM-CSF with or without 3’SL to investigate the effect 
of 3’SL on DC differentiation (Figure 1A). 3’SL concentrations used were based 
on physiological concentrations of 3’SL present in breast milk (76 - 350µg/ml)78. 
Addition of 3’SL to the monocytes resulted in an early increase in membranous PD-
L1 compared to monocyte-derived DC (moDC) (Figure 1B), that was not further 
elevated during the differentiation period (Figure 1C). 3’SL also induced CD80 
expression on immature DC (iDC; day 6), although it was not elevated after 24 
hours compared to moDC (Figure 1C). iDC cultured in the presence of 3’SL showed 
upregulation of CD80 and PD-L1 in a dose-dependent fashion (Figure 1D). Since 
3’SL was responsible for upregulation of specific activation markers, we investigated 
whether cytokines were produced during the differentiation phase. 3’SL induced the 
production of IL-6 and TNF. This peaked already after 24 hours and did not increase 
during prolonged incubation (Figure 1E). 3’SL induced cytokine production by 
monocytes in a dose-dependent fashion during DC differentiation (Figure 1F). 
Next, we investigated whether 3’SL altered the differentiation of monocytes into 
DC by determining the percentage of CD14+ and CD1a+ cells. CD14+CD1a- 
monocytes differentiated into both CD14-CD1a+ and CD14-CD1a- iDC. After 
incubation with 3’SL a significantly higher percentage of cells were CD14+ and a 
lower percentage was CD1a+ compared to moDC (Figure S1). This indicates that 
3’SL halts DC differentiation, resulting in a monocyte-like DC phenotype.
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Figure 1. 3’SL induces phenotypical and functional distinct DC. (A) Monocytes were differentiated with 
IL-4 and GM-CSF into iDC for six days in presence or absence of 3’SL. Cells were harvested after 24 hours 
(during differentiation) or after six day of differentiation (end of differentiation period). (B) PD-L1 expression 
after 24 hours in the presence (solid line) or absence (dotted line) of 3’SL was measured on monocytes. 
Histogram shows one representative donor. (C) MFI of PD-L1, CD80 and CD86 of 3’SL exposed DC were 
compared to that of the moDC (n=3; 24 hours, n=9; six days). (D) MFI of PD-L1 and CD80 on iDC 
differentiated in the presence of 3’SL (1 – 1000 µg/ml) is shown (n=3-5). (E) A small fraction (1/10 of total 
volume) of supernatant was collected from the same culture on day 1 and day 6 and the cytokines IL-6 and TNF 
were quantified (n=3). (F) IL-10, TNF and IL-6 were measured in supernatants of iDC cultured in the presence 
of different doses of 3’SL (n=5).
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3’SL induces the differentiation of monocytes into regulatory DC
CD1a- and CD1a+ DC were shown to be functionally different in their capacity to 
secrete cytokines and chemokines and activate T cells213. We therefore investigated 
whether 3’SL exposure during DC differentiation also affected the functionality of 
these DC when activated with different TLR ligands (Figure 2A). Tolerogenic DC 
are defined by their semi-mature (CD86intCD83int) phenotype after encountering 
a TLR ligand, which shapes the balance between tolerance and immunity162. DC 
differentiated in the presence of 3’SL showed a dose-dependent decrease of cells with 
a mature phenotype (CD83+CD86+) upon stimulation with LPS (Figure 2B) or 
Poly I:C (20 µg/ml) and R848 (3 µg/ml) (Figure 6C). 3’SL-exposed DC showed 
lower expression levels of CD86, CD83 and ICOSL in contrast to HLA-DR and 
PD-L1 that were not significantly lower expressed compared to moDC (Figure 2C). 
Moreover, 3’SL-exposed DC produced similar levels of IL-10 and fully abrogated 
IL-12p70 and TNF levels compared to moDC (Figure 2D). Thus the notion that 
differentiation in the presence of 3’SL induces regulatory DC was further supported 
by the cytokine production upon encountering different TLR ligands.
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Figure 2. 3’SL induces differentiation into tolerogenic DC. (A) Monocytes were differentiated with IL-4 
and GM-CSF into iDC for six days in the presence or absence of 3’SL. These different iDC types were 
stimulated with different TLR ligands for 48 hours. (B) The percentage of CD83+CD86+ DC was determined 
on DC differentiated in presence of 3’SL (1–1000 µg/ml) and subsequently stimulated with LPS. FACS plots 
depict one representative donor and the bar graphs show the mean of five donors. (C) Similarly, the MFI of 
various surface markers on LPS matured DC was compared between 3’SL (375 µg/ml) exposed DC and moDC 
(n=3-5). (D) Cytokine levels were measured in the supernatant (n=3; Poly I:C + R848, n=7; LPS).
3’SL induces TLR4 signaling
In mice, 3’SL was shown to directly activate TLR4 which resulted in activation of 
MLN DC156. We therefore investigated whether 3’SL could also function as a TLR4 
ligand in humans. In line with the literature156, 3’SL also showed NF-κB activation 
via the human TLR4 (Figure 3) and not via TLR2 or TLR2-1 (Figure S2). Comparing 
NF-κB activation via TLR4 of ultrapure LPS that was used as a control to that of 
3’SL showed that 1 mg 3’SL induced a similar NF-κB activation as 3.64 EU of LPS 
(luminescence units = 2411.5 * ln[EU/ml LPS] + 5528.3; r2 = 0.978).
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Figure 3. 3’SL induces hTLR4 mediated NF-κB activation. Commercial 3’SL (1 mg/ml – 10 µg/ml) and 
ultrapure LPS (100 EU/ml – 0.0001 EU/ml) were tested for their NF-κB activation via TLR4 (n=3).
Early activation during DC differentiation by 3’SL is mediated through 
TLR4 signaling
As we demonstrated that 3’SL activates NF-κB transcription via TLR4 we further 
investigated whether the early phenotypical changes by 3’SL were TLR4 mediated. 
TLR4 signaling was inhibited by adding an intracellular signaling inhibitor (CLI-
095). CLI-095 (i.e. TAK-242) blocks the intracellular degradation of IRAK1278. 
Blocking TLR4 signaling was sufficient to completely abrogate upregulation of PD-
L1 (Figure 4A), IL-6 (Figure 4B) and TNF production (Figure 4C) by 3’SL compared 
to that of moDC. 3’SL thus induces its phenotypical and functional effects during 
DC differentiation primarily via TLR4.
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Figure 4. Early activation during DC differentiation by 3’SL is mediated through TLR4 signaling. 
Monocytes were cultured with IL-4 and GM-CSF with or without 3’SL (375 µg/ml). (A) PD-L1 expression and 
(B) IL-6 and (C) TNF production were measured after 24-hour differentiation. TLR4 signaling was blocked 
prior to adding stimuli by 1-hour pre-incubation with a TLR4 inhibitor (CLI-095; 3µM) (n=3).
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TLR4 signaling is explained by LPS contamination
Since LPS is a major bacterial contaminant that signals via TLR4, we wanted to 
exclude that low level contamination with LPS could explain why 3’SL affected DC 
differentiation. Unexpectedly, two batches from different suppliers of commercial 
3’SL showed to be positive in a recombinant factor C LAL assay, which resulted 
in TLR4 mediated NF-κB activation (Figure S3A-B). The 3’SL used for this study 
contained 10 ± 0.17 EU/mg 3’SL (Figure 5A) as measured by a recombinant 
factor C Endozyme assay. Therefore, 3’SL was treated with an optimized Triton 
X-114 method210 to remove any trace of LPS. HPLC analysis confirmed that the 
concentration of 3’SL was unaltered after applying Triton X-114 and Bio-beads 
SM-2 were added to remove LPS and Triton traces, respectively (Figure S3C). This 
methodology decreased the LPS contamination drastically to 0.11 ± 0.08 EU/mg. 
(Figure 5A). Next, we investigated whether 3’SL, 3’SL devoid of LPS, and ultrapure 
LPS were able to activate NF-kB via TLR4. Indeed, all TLR4 signaling activity in 
3’SL is abrogated by LPS removal by Triton X-114 treatment (Figure 5B).
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Figure 5. LPS in commercial 3’SL induces TLR4 mediated NF-κB activation. (A) 3’SL was tested for LPS 
contamination using a recombinant factor C LAL. LPS-free 3’SL was included with or without a 5 EU spiked 
control (n=2). (B) Commercial 3’SL (1 mg/ml) before and after Triton X-114 treatment and ultrapure LPS (10 
EU/ml) were tested for their NF-κB activation via TLR4 (n=3).
Low levels of LPS induce regulatory DC
Having established that not 3’SL but LPS was responsible for TLR4 signaling and 
subsequent NF-κB activation, we compared the effect of 3’SL to LPS-free 3’SL on DC 
differentiation. Ultrapure LPS was used as a control with concentrations based on LPS 
levels measured in the LAL assay (Figure 5A; 10EU LPS/mg 3’SL). The phenotypical 
changes (higher CD80 and PD-L1) of 3’SL-exposed DC and cytokine production 
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Figure 6. LPS induces tolerogenic DC. Monocytes were cultured with IL-4 and GM-CSF with or without 
LPS-free 3’SL, 3’SL (375 µg/ml) or ultrapure LPS. (A) CD80 and PD-L1 expression is shown on iDC. (B) 
the production of IL-6, TNF and IL-10 was measured in the supernatants (n=6). (C) Next, these iDC were 
stimulated with Poly I:C and R848. The percentage of CD86+CD83+ DC was assessed after 48 hours. (D) The 
cytokines TNF, IL-10, IL-6 and IL-12p70 were measured by CBA (n=3).
was restored to that of moDC when exposed to LPS-free 3’SL. LPS but not 3’SL 
was shown to induce higher expression of membranous CD80 and PD-L1 and 
cytokine production compared to moDC at a lower dose (Figures 6A-B). Our results 
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also indicate that DC were halted in their differentiation (remained CD14+CD1a-) 
solely due to the presence of LPS (Figure S1D). Thus phenotypical changes by 3’SL 
on iDC were shown to be fully driven by LPS. Next, we investigated the response 
to subsequent stimulations with different TLR ligands. Monocytes differentiated in 
the presence of 3’SL after LPS removal resulted in DC that showed a fully mature 
phenotype (CD86+CD83+) that were capable of producing IL-6, IL-12p70 and TNF 
in similar levels compared to moDC upon stimulation with Poly I:C + R848 (Figures 
6C-D) or LPS (Figure S4). In contrast, IL-10 production was not significantly altered 
by the presence of LPS during DC differentiation (Figure 6D).
Discussion
Here we show that the human milk oligosaccharide 3’SL can induce regulatory 
DC via TLR4. However, in contrast to what was previously shown in literature for 
mice, not the oligosaccharide itself but LPS contamination of commercially available 
3’SL was responsible for this effect. Moreover, removal of LPS from 3’SL resulted 
in an LPS free sample that did not induce NF-κB via hTLR4, and did not induce 
functional changes in DC.
HMOs are well known for their prebiotic effects by serving as an energy source 
for beneficial bacteria and preventing the adhesion of pathogenic bacteria279. In 
addition, HMOs can have direct effects on the immune system40,78,155,267–272. Since 
a fraction of the extremely high HMO concentrations in breast milk is taken up 
in the bloodstream, HMO may exert effects locally as well as systemically. Previous 
studies performed on human mononuclear cord blood cells showed that the acidic 
HMO fraction of breast milk – in contrast to the neutral HMO fraction – induced 
IFNγ+ and CD25+CD4+ T cells274. This effect was sufficient to restore the Th1/Th2 
cytokine balance in PBMCs of peanut allergic patients stimulated with the major 
allergen Ara h1273. In line with these human ex vivo models, oral supplementation of 
the acidic 6’SL but also the neutral trisaccharide 2’FL attenuated allergic symptoms 
and boosted IL-10+ T cells in the Peyer’s Patch in an OVA-induced feed allergic 
mouse model155. Despite these profound effects, no mechanistic evidence is currently 
available on how these HMOs exert their immunomodulation.
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One specific feature of acidic HMOs is their sialic acid group that is known to bind 
sialic-acid-binding immunoglobulin-like lectins (Siglecs) on immune cells. The 
Siglec family is subdivided in two groups: evolutionary conserved receptors (e.g. 
Siglec-1, 2 and 4) and rapid changing CD33-related receptors280. Interestingly, the 
repertoire of CD33-related receptors is very differences between mice and man. 
Moreover, human but not mouse monocytes express Siglec-5, -7 and -9281. Siglecs 
contain immunoreceptor tyrosin-based inhibitory (ITIM) motifs that are responsible 
for dampening immune responses280. Nevertheless, we show here that exposure of 
LPS-free 3’SL does not change the phenotype and functional activity of monocytes 
and DC.
Both HMO and other prebiotic oligosaccharides are shown in literature to be 
immunogenic via interacting with TLR4 on myeloid156,270,272 and epithelial cells271. 
TLR4 signaling is initiated by dimerization of MD-2 and TLR4, and results in 
activation of transcription factors that initiate the transcription of multiple genes 
including NF-κB, resulting in the production of pro-inflammatory cytokines282. Also 
other sources of natural polysaccharide structures are postulated to - depending on 
their structural confirmation - activate TLR4 signaling283,284. Lactose- or plant-derived 
oligosaccharides GOS, FOS and inulin were found to induce IL-10 production by 
human monocytes in a TLR4-dependent manner270,272 and subsequently to induce 
regulatory T cells272. Similarly, these oligosaccharides induced TLR4-mediated 
production of chemokines by human colonic epithelial cell lines271. 3’SL was found 
to be the milk oligosaccharide that is capable of directly activating TLR4 on murine 
MLN DC in ex vivo stimulations156. However, here we found that 3’SL was not 
capable of activating NF-ĸB via human TLR4 after the removal of LPS. This suggests 
that either the specificity of mouse TLR4 is different from human TLR4, or that LPS 
is a confounding factor in vitro for HMO research.
Myeloid cells are particularly sensitive to LPS contamination262. Insufficient 
removal results in activation of human monocytes and DC; masking the true 
immunomodulatory effect of the molecule of interest. The data shown here 
demonstrate that the presence of LPS traces present in commercially available 3’SL 
preparations during DC differentiation results in regulatory DC. Cytokine production 
induced by LPS traces already peaked after 24 hours and did not further increase after 
prolonged exposure of the cells. This in line with previous findings that showed the 
induction of a negative feedback loop involving IL-6- and IL-10-mediated SOCS3 
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activation that dampens TLR signaling285,286. STAT3 was also shown to bind the PD-
L1 promotor directly and to regulate its expression in TLR activated monocytes287, 
explaining the early upregulation of membranous PD-L1 by LPS traces. In literature, 
it was shown that LPS triggers upregulation of SOCS1 that subsequently inhibits 
GM-CSF signaling288. This explains why monocytes exposed to LPS were halted in 
their differentiation into DC. Similarly, the IRAK1 degradation inhibitor (i.e. TLR4 
inhibitor CLI-095) is known to interfere with GM-CSF signaling, resulting in lower 
cytokine and subsequent PD-L1 expression on TLR4 blocked- compared to IL-4 
and GM-CSF exposed monocytes289–291. In contrast to fully mature CD1a+ DC, 
CD1a- DC do not produce IL-12p70 upon stimulation212. Indeed, we show that 
iDC exposed to LPS during the differentiation period produced abrogated IL-12p70 
levels to multiple TLR ligands. Moreover, they showed a semi-mature phenotype, 
which is known to be involved in the polarization of naive T cells in regulatory T 
cells145,162. In literature, TLR4 signaling by oligosaccharides is also directly linked to 
the induction of regulatory responses270,272. Hence we stress the importance of the 
current findings, showing phenotypical changes and functional consequences of LPS 
contamination resulting in regulatory DC.
Specific glycan structures have previously been described to induce TLR4 signaling. 
Although this effect has also been described for the HMO 3’SL in mice, we show 
here that the effect of 3’SL on human monocytes and their differentiation into 
regulatory DC was driven by LPS contamination and not by 3’SL itself. Hence, it 
is an absolute necessity to remove LPS from glycan samples before studying their 
immunomodulatory capacity in vitro.
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Figure S2. 3’SL does not induce hTLR2 or hTLR2-1 mediated NF-κB activation. 3’SL (375 µg/ml) showed 
no NF-κB activation via (A) TLR2 or (B) TLR2-1 (n=3).
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Abstract
Breast milk plays an important role in immune development in early life and protects 
against diseases later in life. A wide range of the beneficial effects of breast milk are 
attributed to human milk oligosaccharides (HMOs) as well as components such as 
vitamin D3 (VitD3) or TGFβ. One mechanism by which HMOs might contribute 
to immune homeostasis and protection against disease is the induction of a local 
tolerogenic milieu. In this study we investigated the effect of the HMOs 6’-sialyllactose 
(6’SL) and 2’-fucosyllactose (2’FL) as well as prebiotic galactooligosaccharides (GOS) 
on DC differentiation and maturation. Isolated CD14+ monocytes were cultured for 
six days in the presence of GM-CSF and IL-4 with or without 6’SL, 2’FL, GOS, 
VitD3 or TGFβ. Additionally, immature VitD3DC, TGFβDC and moDC were 
used as different DC types to investigate the effect of 6’SL, 2’FL and GOS on DC 
maturation. Surface marker expression and cytokine production was measured by 
flow cytometry and cytometric bead array, respectively. Unlike TGFβ and vitD3, the 
oligosaccharides 6’SL, 2’FL and GOS did not influence DC differentiation. Next, 
we studied the effect of 6’SL, 2’FL and GOS on maturation of moDC, VitD3DC 
and TGFβDC that showed different profiles of HMO-binding receptors. 6’SL, 2’FL 
and GOS did not modulate LPS-induced maturation, even though their putative 
receptors were present on the different DCs types. Thus, whereas VitD3 and TGFβ 
halt DC differentiation, which results in phenotypically distinct tolerogenic DCs, 
6’SL, 2’FL and GOS do not alter DC differentiation or maturation of in vitro 
differentiated DC types.
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Introduction
Our mucosal surfaces are continuously exposed to foreign antigens that can be 
harmless or harmful. The mucosal immune system needs to distinguish between 
these antigens to mount regulatory or inflammatory responses. Proper development 
of the mucosal immune system in early life is therefore essential for health later in 
life. Breast milk plays an important role in immune development in early life49. It 
has become clear that breastfeeding is associated with lower child morbidity, higher 
cognitive abilities and reductions in overweight and diabetes4. Nevertheless, only a 
third of the infants are exclusively breastfed in the first 6 months of life worldwide4. 
Thus, the majority of the infants is currently depending on infant formula. Studying 
the functionality of breast milk components individually may identify components 
that aid in mucosal immune development and may improve infant formula.
Breast milk contains proteins, lactose, a wide variety of oligosaccharides, fatty acids 
and vitamins. These breast milk components contribute to the development of the 
mucosal immune system and maintain homeostasis in the neonate34. Moreover, 
breast milk components enhance epithelial gut maturation, reduce viral infections, 
influence the colonization of the GI tract and promote the development of tolerance34. 
A wide range of these beneficial effects are attributed to human milk oligosaccharides 
(HMOs)40. HMOs escape hydrolysis in the intestine and are metabolized by the 
microbiota in the colon - promoting the outgrowth of bacteria. Additionally, a small 
fraction of HMOs is taken up into the circulation105,106,279. HMOs can be subdivided 
into acidic and neutral HMOs. Acidic HMOs contain sialic acid, and neutral HMOs 
can be subdivided into fucosylated or non-fucosylated HMOs. All three groups of 
HMOs consist of a lactose backbone that can be further elongated into complex 
structures40. In contrast to the wide variety of oligosaccharides in breast milk, infant 
formulas nowadays often contain lactose- (e.g. galactooligosaccharides) or plant-
derived (e.g. fructooligosaccharides) oligosaccharides, that are best known for their 
prebiotic effect to mimic the functionality of HMOs in breast milk292. In addition 
to the prebiotic effects of HMOs and oligosaccharides used in infant formulas, milk 
oligosaccharides may have direct effects on the immune system155,156,269–274. However, 
breast milk contains over 140 different HMOs and the immunomodulatory potential 
of only a few has been investigated to date, and detailed mechanistic evidence is 
currently lacking.
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Dendritic cells (DC) are unique in their ability to induce antigen-specific T cell 
responses. Monocytes differentiate into monocyte-derived DC in the presence of 
inflammatory cytokines. Recent evidence suggests that our mucosal surface is in 
a state of “primed homeostasis”, in which monocytes are recruited to the lamina 
propria31. Breast milk components such as TGFβ and the active form of VitD3 
(i.e. 1α,25-dihydroxyvitamin D3) promote the differentiation of these recruited 
monocytes into tolerogenic DC160,162. Such tolerogenic monocyte-derived phagocytes 
are present in the GI tract and are essential to maintain oral tolerance in the lamina 
propria30,293. Additionally, components in breast milk may dampen inflammatory 
responses induced by immature DC upon activation by pathogens (i.e. maturation). 
As such, a complete pool of HMOs was shown to induce differentiation of bone 
marrow-derived cells into tolerogenic DC294. Immune regulation by such breast milk 
components may contribute to immune homeostasis.
To date no direct immunomodulatory effects of HMOs on human dendritic 
cell differentiation and maturation have been reported. We aimed to address this 
question by studying the effects of HMOs on DC differentiation and maturation. 
6’sialyllactose (6’SL) and 2’fucosyllactose (2’FL) were used as representatives of acidic 
and neutral fucosylated HMOs and galacto-oligosaccharides (GOS) as neutral non-
fucosylated oligosaccharides, which were compared to the known tolerogenic effects 
of TGFβ and VitD3 that were included as positive controls. First, the effect of 6’SL, 
2’FL and GOS was investigated on differentiation by culturing monocytes with 
IL-4 and GM-CSF in the presence or absence of these oligosaccharides. Second, 
differentiated moDC, vitD3DC and TGFβDC were assessed for their expression of 
HMO-recognizing receptors. These DC types were used to study the effect of 6’SL, 
2’FL and GOS on LPS-induced maturation.
Materials and Methods
Isolation and culturing of monocyte-derived DC types
Monocytes were isolated from PBMCs from healthy anonymous donors (Sanquin 
blood bank, Nijmegen) as described earlier157. Immature moDCs were generated by 
differentiating monocytes for 6 days in the presence of 20 ng/ml IL-4 (Peptrotech; 
200-04) and GM-CSF (Peprotech; 300-03) in the presence or absence of TGFβ (3 
ng/ml TGFβ1 + 10ng/ml TGFβ2, Peprotech; 100-21/100-35), 10nM VitD3 (Sigma-
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Aldrich, D1530), 0.5 mg/ml 2’FL (Inalco S.p.A.) or GOS (FrieslandCampina), or 
0.375 mg/ml 6’SL (Carbosynth, OS04398). These immature moDC, TGFβDC 
or VitD3DC were stimulated (i.e. maturated) with 1 µg/ml E. coli OIII:B4 LPS 
(Invivogen; tlrl-3pelps) with or without 0.5 mg/ml GOS, 2’FL, or 0.375 mg/ml 6’SL 
for 48 hours.
LPS detection
6’SL, 2’FL and GOS were tested for LPS contamination by a recombinant factor 
C LAL assay that was performed according to the manufacturers recommendations 
(EndoZyme recombinant factor C assay, Hyglos; 609050). Endotoxin levels of <0.05 
EU/mg were found in GOS and 2’FL preparations. 6’SL contained trace amounts of 
LPS; 0.12 EU/mg.
Isolation and staining of moDCs
DCs were put on ice for 30 minutes under constant shaking. The collected cells 
were stained with a mixture of conjugated monoclonal antibodies or matched isotype 
controls (S1 Table). Cell viability was analyzed by staining the cells with DRAQ7 
(Abcam; ab109202) or fixable viability dye ef506 (eBiosciences, 65-0866-14). Cells 
were acquired on a BD FACS Canto II (BD Biosciences) and analyzed using the 
FlowJo software V10.
Quantification of cytokine levels in supernatants
Levels of IL-8 IL-6, IL-10, TNF and IL-12p70 were measured in the supernatants 
using a cytometric bead array technique (BD Biosciences). Individual flex-sets 
for IL-8 (558277), IL-6 (558276), TNF (560112), IL-10 (558274) or IL-12p70 
(558283) were run according to the manufacturer’s instructions.
Statistics
The raw data was tested for normality with a Kolmogorov-Smirov test. Data with 
unequal distributions were transformed using the logarithm or square root of the raw 
data. A linear mixed model with a LSD test was used on the raw or transformed data 
to compare the various treatment groups to the control (moDC) as a reference group 
unless stated otherwise. Significant differences were indicated by: *** = P< 0.001, ** 
= P< 0.01 and * = P< 0.05. All values are represented as mean +/- SEM. IBM SPSS 
Statistics V23.0 was used for the statistical analysis.
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Results
To investigate the effect of the breast milk components on DC differentiation, 
monocytes were differentiated into immature monocyte-derived DC (iDC) by 
culturing the cells for six days with IL-4 and GM-CSF in the presence or absence of 
individual breast milk component. 6’SL, 2’FL or GOS did not alter the expression 
of any of the measured surface markers on immature DC (Figure 1). Monocytes 
differentiated in the presence of VitD3 remained CD14+ and did not gain CD1a 
expression on their surface, showing that VitD3 was capable of halting DC 
differentiation (Figure 1A). Similarly, significantly less DC that were differentiated 
in the presence of TGFβ showed CD1a expression compared to moDC (Figure 1A). 
In contrast, 6’SL, 2’FL or GOS did not alter CD14 and CD1a expression (Figures 
1B-C). Although fewer TGFβDC and VitD3DC showed to be CD1a+ compared to 
moDC, both DC types showed a different expression profile of activation markers. 
VitD3DC showed significantly lower HLA-DR (Figure 1D), CD80 (Figure 1E), 
CD86 expression (Figure 1F) and higher PD-L1 (Figure 1G) compared to moDCs. 
In contrast, TGFβDC expressed significantly lower levels of CD80 (Figure 1E) and 
PD-L1 (Figure 1G) on their surface compared to moDC.
To investigate whether breast milk components induced the production of cytokines 
during differentiation, we measured the cytokines in the supernatants that were 
produced during the differentiation period. Intriguingly, VitD3 induced the 
production of IL-6 (Figure 2A) and reduced the production of IL-8 (Figure 2B) 
during DC differentiation. TGFβ reduced the production of IL-8 and IL-6 (P=0.08) 
during DC differentiation compared to moDC. IL-10 and TNF production was 
below the detection limit of the assay (<10 pg/ml). 6’SL induced an approximate 
two-fold increase in IL-6 production compared to moDC (Figure 2A) and a trend 
(p=0.078) towards higher IL-8 levels (Figure 2B). However, since we measured trace 
amounts of 0.12EU/mg of LPS in this sample, we applied an optimized Triton 
X-114 method to remove LPS traces 210. Triton X-114 treated 6’SL showed a similar 
production of IL-6 and IL-8, showing that the two-fold increase in IL-6 was caused 
by LPS traces (Figure 2C).
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Figure 1. TGFβ and VitD3 induce phenotypic distinct DCs. CD14+ monocytes were cultured in the 
presence of IL-4 and GM-CSF for six days in the presence or absence of breast milk components. Surface 
marker expression was measured by flow cytometry. (A) A multi-color overlay of CD14 expression versus CD1a 
expression on moDC (black), TGFβDC (blue) or VitD3 (red) of one representative donor is shown. The 
percentage of (B) CD14+ and (C) CD1a+ DC and relative surface marker expression of (D) HLA-DR, (E) 
CD80, (F) CD86 or (G) PD-L1 on immature DC differentiated in the presence of TGFβ, VitD3, 6’SL, 2’FL 
or GOS is shown. Relative fold change was calculated by dividing the MFI (median fluorescence intensity) of 
DC differentiated in the presence of a breast milk component/MFI of moDC of each respective donor.
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Figure 2. TGFβ and VitD3 differentially modulate the production of IL-6 and IL-8 during differentiation. 
6’SL was treated with an optimized Triton X-114 method to remove LPS traces. Immature DC were cultured 
for six days in the presence or absence of VitD3, TGFβ, 6’SL, LPS-free 6’SL, 2’FL or GOS. (A,C) IL-6 and 
(B,C) IL-8 were measured in the supernatant by CBA.
After the differentiation period of six days, we assessed whether the DC types 
that were cultured in the presence of 6’SL, 2’FL, GOS, VitD3 or TGFβ were 
functionally different by stimulating these immature DC for 48 hours with LPS. 
moDC upregulated the expression of CD83, PD-L1, CD80 and CD86 upon LPS-
induced maturation (Figure 3A). Immature dendritic cells that were generated in the 
presence of 6’SL, 2’FL or GOS did not show any phenotypic changes (Figures 3B-
3E) or cytokine production (Figures 3F-3G) upon maturation compared to moDC. 
VitD3DC and TGFβDC showed to be hyporesponsive towards LPS as shown by a 
semi-mature phenotype (i.e. reduced expression of both CD83 and CD86) (Figures 
3B-3D) and lower expression of CD80 (Figure 3E), HLA-DR and PD-L1 (Figures 
S1A-B ). In addition, VitD3DC and TGFβDC produced lower amounts of IL-
12p70 after LPS stimulation compared to moDC (Figures 3F). However, the ratio 
of IL-10/TNF and quantitative IL-10 and TNF levels (Figures S1 C-D) was not 
significant different compared to conventional DCs (Figures 3G). Thus we showed 
6’SL, 2’FL and GOS, in contrast to vitD3 and TGFβ, did not induce differentiation 
of monocytes into tolerogenic DC.
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Figure 3. TGFβDC and VitD3DC induce tolerogenic DC. Immature DC were stimulated with LPS for 48 
hours. (A) The expression of CD83, PD-L1, CD80 and CD86 on immature DC (shaded histograms) or mature 
DC (open histograms) of one donor is shown. The relative surface marker expression of (B) CD83, (C) CD86 
and (E) CD80 are shown. Relative fold change was calculated by dividing the MFI (median fluorescence 
intensity) of DC differentiated in the presence of a breast milk component/MFI of moDC of each respective 
donor. (D) Percentage of CD86+CD83+ DCs. (F) IL-12p70 and IL-10 and TNF were measured in the 
supernatant by CBA. (G) The IL-10/TNF ratio is shown for the different mature DC that were differentiated 
in the presence of different breast milk components.
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Next, we investigated the expression of HMO-recognizing receptors on moDC, 
TGFβDC and VitD3DC to assess their potential responsiveness towards 6’SL, 
2’FL and GOS. Moreover, we investigated the expression of Siglec-5 and Siglec-7 
as potential receptors for 6’SL. DC-SIGN and CD206 were included as potential 
receptors of 2’FL and galactin-3 as putative receptor for GOS. We also measured the 
expression of TLR4 since we used LPS to mature DC. Monocytes expressed high 
levels of Siglec-5, Siglec-7, and TLR4, no expression of DC-SIGN and CD206 and 
low expression of Galactin-3 (Figure 4A). The expression of CD206 (Figure 4B) and 
DC-SIGN (Figure 4C) was high after differentiation of the monocytes into moDC. 
In contrast, the expression of Siglec-5 was markedly lower after differentiation. 
Interestingly, VitD3DC showed significantly lower expression of Siglec-5, Siglec-7, 
DC-SIGN and TLR4 compared to moDC (Figures 4D-F). TGFβDC of all three 
tested donors showed a lower expression of DC-SIGN (Figure 4C) and significant 
lower expression of Siglec-7 (Figure 4F) compared to moDC. This data thus showed 
that moDC, TGFβDC and vitD3DC express different levels of receptors that are 
known to recognize HMOs. 6’SL, 2’FL or GOS may therefore differentially modulate 
moDC, TGFβDC and VitD-3DC.
After having shown that moDC, TGFβDC or vitD3DC express different levels 
of TLR4 and HMO-recognizing receptors, we used these DC types to investigate 
the effect of 6’SL, 2’FL or GOS on LPS-induced maturation. While we observed 
differences in receptor expression, none of the oligosaccharides tested affected the 
phenotype of TGFβDC, VitD3DC or moDCs in the absence or presence of LPS 
compared to the respective DC type that was matured in the absence of HMOs 
(Figure 5). In line with these findings, 6’SL, 2’FL or GOS did not modulate the 
production of IL-6, IL-8, IL-10, IL-12p70 or TNF production by moDC, TGFβDC 
or VitD3DC in the presence or absence of LPS (Figure S2). VitD3DCs showed a 
higher expression of PD-L1 compared to TGFβDC or moDC (Figure 5A), which 
was also seen before on day 6 of culture (Figure 1G). As shown in Figure 3 and Figure 
S1 LPS stimulated VitD3DC and TGFβDC showed a lower expression of PD-L1, 
CD83 and CD80 compared to moDC (Figures 5C-D).
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Figure 4. moDC, TGFβDC and VitD3DC express different levels of HMO-recognizing receptors. The 
expression of several receptors that are shown in literature to recognize HMOs were measured on (A) monocytes 
and (B-G) moDC, TGFβDC and vitD3DC. The expression of Siglec-5, Siglec-7, TLR4, CD206, Galactin-3 
and DC-SIGN (open histograms) and their matching isotype control (shaded histograms) were measured on 
monocytes. The expression of (B) CD206, (C) DC-SIGN, (D) Siglec-5, (E) TLR4, (F) Galactin-3 and (G) 
Siglec-7 is shown by scatter plots (n=3-5) and histogram of one representative donor. Normal distribution was 
assumed due to the low sample size. Significance was tested by a repeated measures ANOVA with a Tukey’s 
multiple comparison post-hoc test.
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Figure 5. HMOs do not impact maturation of different in vitro generated DC. Immature moDC, 
TGFβDC and VitD3DC were stimulated with LPS with or without 6’SL, 2’FL or GOS for 48 hours. The effect 
of 6’SL, 2’FL and GOS was measured in the absence (A, C, F) or presence of LPS (B,D,F). The surface marker 
expression of (A,B) PD-L1 and (C,D) CD80 and (E,F) CD83 is shown as MFI (median fluorescence intensity) 
(two independent experiments, six donors).
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Discussion
In this study we investigated the effect of 6’SL, 2’FL and GOS and the well-studied 
factors TGFβ and VitD3 on DC differentiation. None of the oligosaccharides 
tested affected DC differentiation. VitD3 and TGFβ induced phenotypical distinct 
immature DCs. These immature DC produced different levels of cytokines during 
differentiation compared to moDC. As shown by others, DCs differentiated 
in the presence of VitD3 or TGFβ showed a tolerogenic phenotype; showing 
hyporesponsiveness towards LPS and abrogated IL-12p70 production160,295–297. We 
showed that these moDC, TGFβDC and VitD3DC differentially express HMO-
binding receptors and TLR4. However, 6’SL, 2’FL and GOS did not modulate LPS-
induced maturation on any of these DC types.
The GI tract is constantly exposed to commensal microorganisms and their 
metabolites. As a result, monocytes are constantly recruited to the GI tract31. 
These monocytes differentiate into macrophages or dendritic cells in the presence 
of cytokines. Environmental factors (e.g. diet) can alter the differentiation of 
these monocytes into functionally distinct cells160,162. Oligosaccharides are largely 
fermented in the colon and a small fraction becomes systemically available105,106. 
In bone marrow-derived DC cultures, a complete fraction of HMOs was shown 
to induce regulatory responses294. It is therefore of interest to study the direct 
immunomodulatory effect of individual HMOs on monocytes and DC. The data 
presented here show that in contrast to TGFβ and vitD3, 6’SL, 2’FL and GOS have 
no immunomodulatory effect on the differentiation of monocytes into DC. Next, we 
used these immature moDC, TGFβDC and vitD3DC to measure the surface marker 
expression of HMO-recognizing receptors and subsequently test their responsiveness 
towards 6’SL, 2’FL or GOS. Receptors that are postulated to bind HMOs are 
CD206 and DC-SIGN, which are shown to bind 2’FL298, while sialic-acid-binding 
immunoglobulin-like lectins (Siglecs) are known to bind sialic acid containing 
HMOs such as 6’SL. Siglecs contain intracellular tyrosin-based inhibitory (ITIM) 
motifs that dampen immune responses280. In line with literature, we showed that 
human monocytes express Siglec-5 and Siglec-7281. We showed that the expression of 
Siglec-5 and -7 was markedly downregulated on TGFβDC and vitD3DC compared 
to moDC. Nevertheless, we observed no difference in the immunomodulatory effect 
of 6’SL on both DC types, indicating that 6’SL does not induce DC functioning via 
Siglec-7. This could be explained by the low binding affinity of 6’SL to Siglec-7280. 
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Similarly, activation of CD206, DC-SIGN and galactin-3 may result in dampening 
of inflammation298–302. GOS may bind galactin-3 - a β-galactoside-binding lectin 
that is expressed on monocytes299. Although galactin-3 signaling has been shown 
to induce differentiation of monocytes into anti-inflammatory alternative activated 
macrophages300, we did not show any phenotypical changes if GOS was added during 
DC differentiation. Thus, we showed that although TGFβDC and vitD3DC express 
different levels of receptors that may recognize HMOs, 6’SL, 2’FL or GOS did not 
modulate DC maturation.
In contrast, others do show immunomodulation by HMOs in vitro155,156,274,294. For 
instance, the acidic HMO fraction of breast milk was - in contrast to the neutral 
HMO fraction - shown to induce the frequency IFNγ+ T cells and CD4+CD25+ 
regulatory T cells in a human mononuclear cord blood cell culture274. This 
immunoregulatory effect of the acid fraction was sufficient to restore the Th1/
Th2 cytokine balance in PBMCs of peanut allergic patients stimulated with the 
major allergen Ara h1273. In mouse pups, the acidic trisaccharide 3’SL was shown 
to promote colitis by inducing inflammation in a TLR4 mediated manner156. The 
prebiotic oligosaccharides scGOS/lcFOS mixture, FOS and inulin were also shown 
to exert immunomodulation on monocytes via TLR4270,272. Here we show that 6’SL, 
which is abundantly present in breast- and cow’s milk79, induces the production of 
IL-6 and IL-8 during DC differentiation and did not alter the phenotype. However, 
after applying an optimized Triton X-114 method210, we showed that this twofold 
increase was caused by trace amounts of LPS (0.12 EU/mg). We have previously 
shown that a 100-fold higher contamination of LPS in commercial 3’SL results in 
rapid IL-6 and IL-8 production and induces differentiation into tolerogenic DC157. 
Since LPS is an important contaminant that signals via TLR4, caution must be 
applied interpreting direct immunomodulation of HMOs via TLR4. Even though 
we could not demonstrate effects of 6’SL, 2’FL or GOS on monocytes and dendritic 
cells, it is possible that other HMOs or other prebiotic oligosaccharides can have 
immunomodulatory effects on monocytes and dendritic cells, since breast milk 
contains at least 140 different HMOs. Additionally, HMOs have been shown to 
have an important immunomodulatory role indirectly by altering the microbiota 
composition and enhancing the production of short chain fatty acids (SCFA). These 
SCFA produced by the microbiota are known to exert immunosuppressive effects on 
moDC303.
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VitD3 and TGFβ altered the differentiation into phenotypical distinct immature 
DCs. Both of these immature VitD3DC and TGFβDC types are hyporesponsive 
towards LPS. The notion that VitD3 and TGFβ induce phenotypical different DC 
types, which produce a very different cytokine profiles during differentiation, indicates 
that different pathways are responsible for the differentiation into regulatory DCs. 
This hypothesis is in line with literature showing distinct pathways involved in NF-
ĸB regulation by VitD3 and TGFβ on human monocyte-derived DC297. Although 
TGFβ and VitD3 may act via different mechanisms, we show in this study that both 
are capable of halting DC differentiation. One possible mechanism by which VitD3 
inhibits DC differentiation is by the inhibition of GM-CSF signaling via upregulation 
of SOCS1288,304, which could halt DC differentiation. The mechanism by which 
TGFβ influences DC development is not well established. Since the SMAD-induced 
pathways was shown to be active in moDC297, TGFβ may halt DC differentiation via 
this pathway. Interestingly, we show here that CD1a is expressed on fewer TGFβDCs 
compared to moDCs. CD1a+ DCs do in contrast to DCs produce IL-12p70 upon 
stimulation212, which we also observed for VitD3DCs and TGFβDCs. Additionally, 
we showed that VitD3 and not TGFβ triggers the production of IL-6 during DC 
differentiation. IL-6 in turn can induce STAT3 activation in vitro and in vivo and halts 
DC differentiation286,305. STAT3 binds the PD-L1 promotor directly and regulates its 
expression287. Indeed, we showed that vitD3 triggers IL-6 production and that PD-
L1 expression is higher on immature VitD3DCs compared to TGFDCs or moDC. 
Thus, VitD3DCs and TGFβDCs are less responsive to LPS (i.e. tolerogenic DC), as 
observed by their semi-mature phenotype and lower cytokine production, which is 
line with literature160,162,295,306.
Conclusions
The GI tract is constantly repopulated by monocyte derived DC and macrophages 
due to the exposure of microbes and their metabolites. Breast milk contains 
components such as VitD3 and TGFβ that can alter the differentiation of monocytes 
into tolerogenic DCs. Even though oligosaccharides are thought to play an important 
role in immune development in early life, the HMOs and GOS tested here do 
not alter DC differentiation or maturation of in vitro differentiated mucosal DC 
types. Further unravelling the impact of these and other breast milk components on 
immune homeostasis will improve our understanding of how breastfeeding promotes 
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immune homeostasis and development. This knowledge can be applied to develop 
new strategies to protect infants against infections and allergies.
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Supplementary files
Table S1. Conjugated antibodies used for flow cytometry
Target Fluorochrome Company Cat.nr. Ab Cat. nr. Isotype control
CD14 FITC BD Biosciences 555397 555573
CD83 FITC BD Biosciences 556910 555573
CD1a PerCP-Cy-5 Biolegend 300130 400149
CD86 V450 BD Biosciences 560357 560373
HLA-DR APCef780 eBiosciences 47-9956-42 47-4732-80
CD80 PE-Cy-5 BD Biosciences 559370 555576
PD-L1 PE-Cy7 BD Biosciences 558017 557872
Galactin-3 Alexa Fluor 488 Biolegend 125410 553929
Siglec-5 PE Biolegend 352003 555573
Siglec-7 APC Biolegend 339205 17-4714-81
DC-SIGN BV421 BD Biosciences 566278 562438
CD206 PE-Cy7 eBiosciences 25-2069-42 552868
TLR4 BV421 BD Biosciences 5167523 562438
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Figure S1. TGFβ and VitD3 induce tolerogenic DC. Immature DC differentiated in presence of 6’SL, 2’FL, 
GOS, TGFβ or VitD3 were stimulated with LPS for 48 hours. The relative surface marker expression of (A) 
HLA-DR and (B) PD-L1 are shown. Relative fold change was calculated by dividing the MFI (median 
fluorescence intensity) of DC differentiated in the presence of a breast milk component/MFI of moDC of each 
respective donor. (C) TNF and (D) IL-10 were measured in the supernatant by CBA.
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Figure S2. HMOs do not impact maturation of different in vitro generated DC. Immature moDC, 
TGFβDC and VitD3DC were stimulated with LPS with or without 6’SL, 2’FL or GOS for 48 hours. The effect 
of 6’SL, 2’FL and GOS on cytokine production was measured in the absence (A,C) or presence of LPS (B,D-G). 
(A,B) IL-8, (C,D) IL-6, (E) IL-10, (F) IL-12p70 and (G) TNF were measured by CBA.
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Abstract
Human milk oligosaccharides (HMO) and prebiotic oligosaccharides are proposed 
to confer several health benefits to the infant. They shape the microbiota, have anti-
inflammatory properties, and support epithelial barrier functioning. However, in 
order to select the best oligosaccharides for inclusion in infant formulas, there is a need 
to increase our understanding of the specific effects of HMO and prebiotics on the 
host immune system. Therefore, we investigated the effects of the HMO sialyllactose 
(SL), and galactooligosaccharides (GOS) on epithelial barrier functioning, microbiota 
composition, and SCFA production. Transcriptome analysis showed that SL and 
GOS both induced pathways that regulate cell cycle control in fully polarized Caco-2 
cells. This gene-expression profile translated to a phenotype of halted proliferation 
and included the induction of alkaline phosphatase (ALP) activity, a marker of 
epithelial cell differentiation. SL and GOS also promoted re-epithelialization in an 
in vitro epithelial wound repair assay. SL induced the outgrowth of members of the 
Bacteroides genus, including B. fragilis as well as Feacalibacterium prausnitzii, and 
led to elevated levels of propionate and butyrate production. Interestingly, these 
microbial species have both been associated with protection against colitis in animal 
models. GOS appeared to specifically support the outgrowth of the Bifidobacterium 
genus, which coincided with elevated levels of lactate and butyrate production. 
Our results show that SL and GOS can both modulate epithelial barrier function 
by inducing differentiation and epithelial wound repair, but differentially promote 
the growth of specific genera in the microbiota, which is associated with differential 
changes in SCFA profiles.
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Introduction
Microbial colonization directly after birth and breastfeeding are crucial events that 
determine health in neonatal and adult life48,49. Breast milk is a unique mixture 
of immunoregulatory proteins, antimicrobial peptides, micronutrients, milk fat 
globular membrane, miRNA containing extracellular vesicles, and human milk 
oligosaccharides (HMO)34,307. It has been widely recognized that breast milk confers 
health benefits to the infant by shaping the microbiota, preventing infections and 
promoting cognitive abilities4. Breast milk serves as the golden standard for infant 
nutrition and exclusive breastfeeding for the first six months in life is advocated by 
the WHO308. Nevertheless, more than half of the infants is not exclusively breast-
fed during the first six months of life worldwide4 and is thus dependent on infant 
nutrition. At present, infant formulas are commonly supplemented with prebiotic 
oligosaccharides like galactooligosaccharides (GOS), fructooligosaccharides (lcFOS), 
or polydextrose, or a mixture of these. Among these polymeric glycans, GOS is the 
most widely used prebiotic oligosaccharide in infant nutrition.
Contrary to other mammals, human breast milk contains a very high amount and a 
structurally diverse set of oligosaccharides that even exceeds the protein content of 
breast milk40,102,309. HMO consist of a lactose backbone that can be elongated into 
polymeric glycan structures that can contain fucose or sialic acid moieties. The simple 
trisaccharides 3’-sialyllactose (3’SL) and 6’-sialyllactose (6’SL) are among the most 
abundant sialylated HMO, with estimated concentrations in mature breast milk 
ranging between 170-500 µg/ml 6’SL and 76-300 µg/ml for 3’SL78. Compared to 
human milk, mature bovine milk contains low levels of 3’SL (30-119 µg/ml) and 
6’SL (17-88 µg/ml)78.
Exogenous sialic acids have been suggested to be essential for brain development in 
early life310. Additionally, sialylated oligosaccharides may, although mostly investigated 
in vitro and animal models, exert other health effect via neutralization of pathogens, 
fermentation into anti-inflammatory metabolites, direct immunomodulation, and 
improved epithelial barrier functioning78. HMO and prebiotics are metabolized 
by the microbiota in the colon and upon their colonic fermentation, sialylated 
oligosaccharides may function as an essential exogenous source of sialic acid. Animal 
models have shown that endogenous production of sialic acid in the liver is low 
during the first weeks of life311, suggesting that microbial production of sialic acid 
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in neonates could be relevant, and emphasizing the importance of proper colonic 
microbial colonization and fermentation.
It has been suggested that growth factors in human milk are important for epithelial 
barrier functioning. For instance, breast milk contains growth factors that promote 
the proliferation and differentiation of epithelial cells, thereby promoting gut 
maturation96,312. Improving gut maturation by means of nutrition in early life may be 
particularly relevant in the first weeks of life, for premature infants and infants suffering 
from intestinal infections or inflammatory bowel conditions127,222. Furthermore, 
nutrition may play a role in maintaining barrier function later in infancy during 
adverse episodes, e.g. when the epithelial layer is challenged by inflammation due to 
infection or physical damage.
The neonatal microbiota is shaped by colonization of bacteria from the mother during 
vaginal delivery and is further shaped by breastfeeding39. As reviewed by Mueller et al. 
(2015), introduction of infant formula instead of breastfeeding results in microbial 
changes. Breastfed children show a lower microbial diversity, decreased abundance of 
Clostridiales and Bacteroidetes members313, a lower prevalence of C. difficile and E. coli 
and increased prevalence of bifidobacteria39,314,315 and lactobacilli39,316. The capacity of 
bifidobacteria to digest HMO has been appreciated since the 1950s, which is the 
most likely explanation of the expansion of this bacterial group in breastfed infants.
The best described and most abundant group of metabolites are short-chain fatty 
acids (SCFA). SCFA such as acetate, propionate and butyrate are produced in the 
colon and reach high concentrations (20-100 mM) locally and much lower levels 
systemically (in the µM range)317. The increase in bifidobacteria was correlated with 
an increase in fecal lactate and acetate concentrations and lower pH318. SCFA are 
shown to exert direct anti-inflammatory effects on colonocytes and restore epithelial 
barrier functioning, which results in suppression of colitis in animal models319,320. 
Additionally, SCFA may exert systemic responses via inducing epigenetic changes 
and directly modulating gene transcription in immune cells. For instance acetate 
was shown to enhance regulatory T cell functioning by epigenetic modification of 
the FOXP3 gene45. This study by Thornburn et al. (2015) and comparable studies 
in other mouse models show that the diet can, via microbial-derived SCFA, alleviate 
respiratory diseases44–46. Although largely unexplored, fermentation of HMO or 
prebiotics in the colon may thereby serve as an important carbohydrate source that 
may impact the physiology and health of the infant321–323.
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To introduce part of the functionality of HMO into infant nutrition, prebiotic 
oligosaccharides like GOS have been added to infant formula to support the 
outgrowth of bifidobacteria. Prebiotics have no detrimental effect on growth of the 
infant and may reduce the pH and increase the softness of the stool, increase stool 
frequency and increase the fecal Bifidobacterium and Lactobacillus counts324–328. Fecal 
SCFA levels of neonates fed infant formula supplemented with a 9:1 GOS:FOS 
mixture are more similar to breast-fed neonates compared to infants that are bottle-
fed without prebiotic supplementation329. Sialyllactose (SL) is an easily accessible 
oligosaccharide present in bovine and human milk that could be of interest for early 
life nutrition. Identification of such HMO for use in infant nutrition may be of 
interest to improve health of infants. However, a better mechanistic understanding 
of individual HMO and currently used prebiotics is required. The aim of our study 
was therefore to investigate the effects of SL and GOS on epithelial barrier function 
(i.e. re-epithelialization, proliferation and differentiation of Caco-2 cells; supported 
by underlying mechanisms using transcriptomics), and their effects on microbiota 
composition and subsequent SCFA production.
Materials and Methods
Cell culturing
Ca9-22 (JCRB0625) gingival epithelial cells and Caco-2 cells (HTB-37) colon 
epithelial cell lines were purchased from the National Institute of Biomedical 
Innovation JCRB Cell Bank (Osaka, JP) and ATCC (Manassas, USA), respectively. 
Both cell lines were cultured in Dulbecco’s Modified Eagle Medium (DMEM) 
containing Glutamax (GIBCO, Invitrogen, Paisley, UK) and 10% fetal calf serum 
(FCS), 100 U/ml penicillin and 100 µg/ml streptomycin (Sigma-Aldrich, MO, 
USA). The cell lines were cultured at 37 °C in a humidified atmosphere containing 
5% CO2 and passaged every second day. Experiments were performed using cell-
passage numbers 9-20 and 12-41 for Ca9-22 and Caco-2, respectively.
Scratch Assay and automated image acquisition and segmentation
The scratch assay and analysis was performed as previously described330. In short, 
approximately 35.000 cells/well were seeded in 96-wells plates in DMEM + 10% 
FCS and grown overnight into a confluent monolayer. The next day, cells were starved 
for two hours by replacing the medium with DMEM without FCS. The cellular 
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cytoplasm was labelled with 2 µM CellTracker™ Red CMTPX (Molecular Probes, 
OR, USA) and the nuclei were stained with 2 µg/ml Hoechst 33342 (Molecular 
Probes, OR, USA). Longitudinal scratches (0.3 × 2 mm) were introduced in the 
monolayers using the HTSScratcher (Peira, Antwerp, BE). After washing away the 
cell debris, 100 µl of a mixture of 3’SL and 6’SL, as present in cow’s milk (25 µg/ml 
3’SL + 75 µg/ml 6’SL), human breast milk (125 µg/ml 3’SL + 375 µg/ml 6’SL) or 
human colostrum (750 µg/ml 3’SL + 2250 µg/ml 6’SL)78 or respectively matching 
concentrations of GOS of 100, 500 and 3000 µg/ml, 4 ng/ml TGFα (R&D Systems, 
MN, USA) or 10 µM of p38 inhibitor (SB203580; Cell Signaling Technology, 
MA, USA) + 10 µM MEK1/2 inhibitor (U0126, Cell Signaling Technology) in 
DMEM without FCS were added into the wells in a randomized manner. The BD 
Pathway 855 Bioimaging System (BD Biosciences, CA, USA) was programmed to 
acquire fluorescent and bright-field images every 20 minutes for five hours. Image 
segmentation was performed using CellProfiler 2.1.1 and visualized in FCS Express 4 
Plus (De Novo Software, CA, USA) software. The lag time (λ in minutes), repair rate 
(µm in cells minute
−1) and the maximum number of cells (A) within the scratch area 
of each well were calculated in R by fitting the modified Gompertz equation through 
the re-epithelialization measurements.
Caco-2 stimulation and RNA extraction for microarray and qPCR
One million cells were seeded and polarized for two weeks in each well of a 6-wells 
Transwell system or on flat bottom plates, for microarray and qPCR analysis, 
respectively. The polarized cell layer was incubated with 10 mg/ml sialyllactose 
isolated from bovine milk (FrieslandCampina) or GOS (FrieslandCampina) for 
transcriptome analysis and 10 mg/ml SL [mixture of 5 mg/ml 3’SL (OS04397, 
Carbosynth) + 5’SL 6’SL (OS04398, Carbosynth)] for verification by qPCR. Cells 
were grown in DMEM + 10% FCS and refreshed every second day. All treatments 
and controls were performed in triplicate. Medium was aspirated from the inserts 
and TRIzol or RLT buffer was added to lyse the cells for transcriptome and qPCR 
analyses, respectively. The samples for qPCR analysis were thawed and 1:1 diluted 
with 70% ethanol RNA and homogenized using a syringe. A RNeasy Mini Kit was 
used according to the manufacturer’s recommendations to isolate RNA for qPCRs 
(ref 74106, Qiagen). Cells were stored at -80ºC until further use. RNA was extracted 
by first adding 200 µl of chloroform to 1 ml of the thawed cell lysate. Next, samples 
were vortexed for 15 seconds, incubated for 2-3 minutes at room temperature and 
centrifuged for 15 minutes at 11.000 rpm at 4ºC. The upper aqueous phase was 
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transferred to a new tube and 500 µl isopropanol was mixed with the sample and 
incubated for 5-10 minutes at room temperature to precipitate the RNA. The 
samples were then centrifuged for 10 minutes at 11.000 rpm at 4ºC. Supernatants 
were discarded and the pellet was washed with 1 ml 75% ethanol and centrifuged 
for 10 minutes at 4ºC. The supernatant was discarded and the pellet was dried for 5 
minutes. 100 µl MQ was added and RNA was further purified using RNeasy Mini 
Kit, according to the manufacturer’s recommendations (ref 74106, Qiagen).
Gene expression profiling
RNA quality control using Nanodrop and Bioanalyzer, RNA labelling and 
array hybridizations were performed by Jenny Jansen and Mechteld Grootte 
Bromhaar, (Nutrition, Metabolism & Genomics (HNE), Division of Human 
Nutrition, Wageningen University;). RNA quantity and quality was assessed 
spectrophotometrically via a Nanodrop device (ND-1000, NanoDrop Technologies, 
Wilmington, DE, USA) and with 6000 Nano chips via a Bioanalyzer 2100 device 
(Agilent, Santa Clara, CA, USA), respectively. RNA was judged as being suitable for 
array hybridization only if samples showed intact bands corresponding to the 18S and 
28S ribosomal RNA subunits, displayed no chromosomal peaks or RNA degradation 
products, and had a RIN (RNA integrity number) above 8.0. The Ambion WT 
Expression kit (Life Technologies, cat. no. 4411974) in conjunction with the 
Affymetrix GeneChip WT Terminal Labelling kit (Affymetrix, Santa Clara, CA; cat. 
no. 900671) was used for the preparation of labelled cDNA from 100ng of total RNA 
without rRNA reduction. Labelled samples were hybridized on Affymetrix GeneChip 
Human Gene 1.1 ST arrays that contain 30.000 coding transcripts and over 11.000 
long intergenic non-coding transcripts, provided in plate format. Hybridisation, 
washing and scanning of the array plates was performed on an Affymetrix GeneTitan 
Instrument, according to the manufacturer’s recommendations. Detailed protocols 
can be found in the Affymetrix WT Terminal Labelling and Hybridisation User 
Manual (part no. 702808 revision 4), and are also available upon request. Quality 
control of the hybridizations to the Human Gene 1.1 ST array and primary data 
analysis were performed according to strict criteria to ensure that the array data were 
of the highest possible quality.
Statistical and functional analysis of microarray data
Packages from the Bioconductor project331 (www.bioconductor.org) were used for 
analyzing the scanned Affymetrix arrays. Arrays were normalized using quantile 
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normalization, and expression estimates were compiled using the pre-processing 
algorithm Robust Multiarray Analysis (RMA), applying the empirical Bayes approach 
available in the Bioconductor library affyPLM using default settings. Gene functional 
annotations, gene ontology (GO) enrichment and differential expression calculations 
were carried out using Bioconductor331 packages and third-party software modules 
(see below). The Bioconductor packages were integrated in the automated on‐line 
MADMAX pipeline332. Various advanced quality metrics, diagnostic plots, pseudo-
images and classification methods were applied to ascertain that only arrays that 
passed the most rigorous quality controls were used in the subsequent analyses333. 
Arrays were considered of sufficient quality when they showed not more than 10% of 
specks in fitPLM model images, were not deviating in RNA degradation and density 
plots, were not significantly deviating in NUSE and RLE plots, and were within 
each other’s range in boxplots. For a more extensive description of quality criteria, 
please contact the authors. Probe sets were redefined according to Dai et al. (2005)334 
utilizing current genome information. In this study, probes were reorganized based 
on the Entrez Gene database (remapped CDF v13 (November 2010), http://
brainarray.mbni.med.umich.edu). Differentially expressed probe sets were identified 
using linear models, applying moderated t‐statistics that implement empirical Bayes 
regularization of standard errors using Bioconductor’s limma package335. A Bayesian 
hierarchical model was used to define an intensity-based moderated T-statistic 
(IBMT), which takes into account the degree of independence of variances relative 
to the degree of identity and the relationship between variance and signal intensity336. 
When gene expression was low and just below significance, results of the limma 
analysis were compared to the IBMT test. P‐values were corrected for multiple 
testing using a false discovery rate (FDR) method337; the quality of the data was such 
that FDR p‐values (Q values) of < 0.01 to < 0.0001 yielded thousands of differentials, 
depending on the specific comparison. For pathway analysis comparisons, it is not 
recommended to use different numbers of input genes (several hundred compared to 
several thousand), which would occur if a fixed FDR p-value were used for all datasets 
submitted to pathway analysis. Therefore, FDR values between p < 10-7 and p < 10-8 
were chosen so that the number of genes included in Ingenuity Pathway Analysis 
(IPA) and Cytoscape were about 800 genes.
Data analysis
The open-source Bioconductor (www.bioconductor.org) packages were used for array 
quality control analyses and statistics. These packages are part of the MADMAX 
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pipeline where the microarray data were stored. For array annotations, we used the 
following software and database versions: R-version 2.11.1, Bioconductor version 
2.6; Custom CDF library: hugene11stv1hsentrezgcdf, and hugene11stv1hsentrezg.
db version 13.0.0.
Biological interpretation of transcriptome datasets
To identify pathways and processes among regulated genes activated or suppressed 
in response to saccharides (the “compounds”, Ingenuity Pathways Analysis (IPA) 
(Ingenuity Systems, Redwood City, CA, USA) was used (see below). The output was 
used to prioritize differentially regulated pathways that reflect Caco-2 responses to 
compounds, to identify cascades of upstream transcriptional regulators that could 
explain the observed gene expression changes, and to reconstruct protein-protein 
networks that could be used to overlay gene expression data and identify central 
regulatory proteins that were most likely to have driven differential gene expression 
following compound exposure.
We used three complementary methods for functional analysis of microarray 
expression data: ErmineJ (GO annotation enrichment or overrepresentation), 
Gene Set Enrichment Analysis (GSEA) and Ingenuity Pathway Analysis (IPA) 
(see below). Using these, we performed: (i) identification of statistically supported 
overrepresentation of functional gene ontology (GO) annotation (ErmineJ and 
GSEA), (ii) mapping of expression data onto pathways to determine their up‐ or 
downregulation in a statistical meaningful way (IPA), (iii) projection of transcript 
fold‐change values of co‐expressed genes onto interaction maps of the corresponding 
proteins (IPA), and (iv) the reconstruction of networks from the interactions of 
proteins expressed by all gene differentials per dataset to identify central regulators 
(IPA).
Two complementary methods were employed to relate changes in gene expression 
to functional changes. One method, ErmineJ, is based on overrepresentation 
of Gene Ontology (GO) terms338. As input all t‐test p‐values from the probe set 
comparisons across the respective conditions were used. Another approach, gene set 
enrichment analysis (GSEA) takes into account the broader context in which gene 
products function, namely in physically interacting networks, such as biochemical, 
metabolic or signal transduction routes339. This method aids the identification of up‐ 
or downregulated processes. Both applied methods have the advantage that they are 
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unbiased, because no gene selection step is used, and a score is computed based on all 
genes in a particular GO term or gene set.
Pathway analysis
All listed or reconstructed cellular pathways were derived from the expert‐annotated 
pathways that are provided by the Ingenuity Knowledge Base (www.ingenuity.com) 
that includes protein‐protein and protein‐DNA interaction information that is present 
in on‐line databases including NCBI, Ensembl, BIND, KEGG and MIPS and cross‐
checked in the Human Protein Resource Database (www.hprd.org). As a consequence, 
the data interpretation used curated information. Biological cellular functions and 
transcriptional networks altered after compound exposure were identified using 
Ingenuity Pathways Analysis (IPA; Ingenuity Systems, Redwood City, CA). IPA 
annotations follow the GO annotation principle, based on a proprietary knowledge 
base of over 1,000,000 protein‐protein interactions. For IPA analysis, gene expression 
ratios x between 0 and 1 were transformed to negative fold-changes using the formula 
fc =-1/(ratio x). We also performed an IPA upstream regulator analysis to identify 
the cascade of upstream transcriptional regulators that can explain the observed gene 
expression changes in a user’s dataset, which can provide insights into the biological 
activities occurring in the tissues or cells being studied. The IPA output includes 
metabolic and signaling pathways with statistical assessment of the significance of their 
representation being based on Fisher’s Exact Test. This test calculates the probability 
that genes participate in a given pathway relative to their occurrence in all other pathway 
annotations. Input gene lists included the differentially regulated genes (FDR p-values 
(Q values) < 10-7 or < 10-8 where appropriate; we aimed to include similar amounts, 
780-800 genes for IPA analysis of the different HMOs, since the statistical output of 
the Fisher’s Exact Test that IPA uses is sensitive to highly diverse numbers of input 
genes. IPA computes networks and ranks these according to a statistical likelihood 
approach. All networks with a score of at least 10 focus genes were considered to be 
biologically relevant and representative to show part of the underlying biology of the 
responses of Caco-2 cells to saccharide compounds. Every interaction between gene 
products in the network was supported by published information that was directly 
retrieved from within the Ingenuity software suite.
cDNA synthesis
Caco-2 cells were stimulated with 10 mg/ml sialyllactose (5 mg/ml 3’SL + 5 mg/
ml 6’SL) for verification of the transcriptome analysis by quantitative PCR (qPCR 
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analysis). 1 µg of RNA was treated with 1U DNase (Qiagen, Germany) for 15 minutes 
at room temperature. DNase activity was inhibited with 25 mM EDTA (Invitrogen) 
followed by incubation for 10 minutes at 65ºC. Next, 300 ng of random primers 
and 0.5 mM dNTPs were added and incubated for 10 minutes at 65ºC followed 
by 5 minutes at 4ºC for annealing. Thereafter a mixture of 200 U of Superscript 
III (Invitrogen), 0.1M DTT (Invitrogen) and 40 of RNAse OUT inhibitor in first 
strand buffer was incubated for 10 minutes at 21ºC. The reaction was performed for 
50 minutes at 50ºC using a Biometra T3 Thermocycler (Westburg, The Netherlands). 
The reverse transcriptase reaction was inactivated by incubation at 70 °C for 15 min. 
cDNA was stored at -20°C.
Fecal sample preparation and batch cultures
A pooled preparation of infant and adult fecal samples was prepared to test the prebiotic 
effect of SL and GOS in a batch culture system. All participants had no known 
gastrointestinal disorders and did not consume prebiotic products three months prior 
to sampling. Infant feces were collected from 13 infants from 1-6 months of age who 
did not receive solid food, antibiotics, prebiotics or probiotics in the last month. 6 
grams per infants was pooled in 300 ml dilution medium containing lactose (1% w/v) 
as a carbon source as a replacement for the carbohydrates (e.g. starch, pectin) used 
in adult fecal cultures340. Adult fecal slurry was prepared from fecal samples collected 
from 16 adult volunteers. Individual fecal samples were diluted to a 10% w/v mixture 
using 0.1M, pH7, reduced PBS and pooled. This fecal slurry was homogenized for 
120 seconds at normal speed (Seward Stomacher 80 Biomaster), aliquoted and frozen 
until further use. Culture medium was reduced overnight in an anaerobic cabinet 
(10% H2, 10% CO2, 80%N2) and 10% w/v fecal slurry was added the next day. 
Cultures were kept at 37ºC for 24 hours. Autoclaved anaerobic chemostat nutrient 
medium, according to the preparation described in341 was used. The chemostat vessels 
were equipped with magnetic stirrers and pH meters that were set to maintain pH 
between pH6.8 and pH7 by adding 0.5M NaOH or 0.5HCl. 10g/L of GOS or SL 
were added to the vessels just before adding 10% w/v of the fecal slurry.
Detection of SCFA by HPLC 
SCFA levels were measured in fecal samples from the batch cultures using a method 
developed by Guerrant et al.342.
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qPCR
A mixture containing 7µl SYBR Green Mix, 1 µg cDNA template and 2.1 µM 
of forward and reverse primers per sample was run on the Rotor Gene Real-timer 
Cycler (Corbett Research, the Netherlands). Primers amplifying genes that were 
highly modulated by SL in the microarray (Table I) were designed by the authors 
and synthesized by BaseClear. In total, 35 reaction cycles consisting of 95°C for 15 
s, 60°C for 30 s and 72°C for 45 s were run followed by a final hold of 60°C for 
1 min. Data was analyzed using RotorGene Q series software (Qiagen). Relative 
gene-expression was calculated using the Pfaffl method343. To assess the abundance 
of bacterial genera from the different batch cultures by qPCR, fecal slurry was 
thawed and DNA was isolated using DNA Stool Mini Kit (Qiagen) according to the 
manufacturer’s recommendations. The differential bacterial counts were quantified 
using quantitative PCR. The bacterial count was calculated based on a dilution series 
of DNA that was isolated from bacterial strains with predetermined CFU. Primers 
and probes were based on 16S rDNA gene sequences retrieved by http://greengenes.
lbl.gov. Primer Express software was used to design the primers.
Table I. list of qPCR primers for verification of commercial SL
Gene primer sequence
IFIT1 FW GTGTCCAGAAATAGACTGTGA
RV CCATCCAGGCGATAGGCA
CDK1 FW TCAACTCTTCAGGATTTTCAG
RV GGATGATTCAGTGCCATTT
EDNRB FW CTTGGCTCTGGGAGACC
RV CACGGAGGCTTTCTGTAT
MARCH3 FW CTGTCGCACTCTTCACTATTTA
RV CAGACTTTGGAATGAGGAGAATC
TNFRSF9 FW GTAAACAAGGTCAAGAACTGA
RV CCATTCACAAGCACAGAC
GAPDH FW TGC ACC ACC AAC TGC TTA GC
RV GGC ATG GAC TGT GGT CAT GAG
Intestinal microbiota chip
Microbiota samples from infant and adult incubations were analyzed by microarray 
analysis according to Ladirat et al. (2013)344. Adult samples were analyzed with the 
I-chip which was based on adult microbiota composition, whereas the II-chip was 
used for analyzing the infant samples. The II-chip was based on infant microbiota 
composition and therefore partly includes different micro-organisms as compared to 
the I-chip, but all experimental protocols for working with both chips are identical344.
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Caco-2 cell counts and alkaline phosphatase measurements
Caco-2 cells were seeded at a density of 200.000 cells/well in flat bottom 24-wells 
plates. GOS or SL were added to the wells for four days. Physiological relevant 
mixtures of SL as present in cow’s milk (25 µg/ml 3’SL + 75 µg/ml 6’SL), human 
milk (125 µg/ml 3’SL + 375 µg/ml 6’SL) or human colostrum (750 µg/ml 3’SL + 
2250 µg/ml 6’SL) were included78 as well as higher concentrations (5 and 10 mg/
ml) of equal amounts of 3’SL and 6’SL to match the concentrations of GOS we 
used. The supernatant was collected and quantified for secreted ALP by QUANTI-
Blue (Invivogen, rep-qb2) as a marker of differentiation. QUANTI-Blue powder was 
reconstituted according to the manufacturer’s instructions. 60µl supernatant was 
added to 190µl QUANTI-Blue and incubated for 3 hours at 37ºC. The optical density 
(OD) at 625µm was measured using a FilerMAX F5 (Molecular Devices, Nederman, 
Germany). To count the cells, trypsin was added to the cells. The cells were spun 
down at 1,800 rpm for 5 minutes and washed twice with PBS. 150 µl Trypsin-EDTA 
(0.25%) (ThermoFisher, 25200) was added to detach the cell monolayer. Trypsin was 
inactivated by resuspending the cells in 150 µl PBS + 4% FCS + 0.02% EDTA. Dead 
cells were stained with DRAQ7 (Abcam; ab109202) and 50 µl of 0.975E6 beads/
ml (Fluoresbrite YG Carboxylate microspheres 10µm, 18142) were added to count 
cells (Figure S2; gating strategy). Cells were acquired on a BD FACS Canto II (BD 
Biosciences) and analyzed using the FlowJo software V10.
Results
Intestinal epithelium
Since the majority of oligosaccharides are considered to be digested in the large 
intestine, undigested prebiotics may directly affect epithelial cells in the proximal 
regions of the intestinal tract. To investigate the effect of GOS and SL on barrier 
functioning, a fully polarized monolayer of Caco-2 cells that has the biochemical 
characteristics of a small intestinal epithelial cell line128 was exposed for six hours 
to 10 mg/ml SL or GOS. We performed a microarray to investigate what pathways 
were modulated by GOS or SL. IPA identified cellular pathways in Caco-2 cells 
that had been differentially modulated by the oligosaccharides compared to the 
medium control. In total, 28 pathways were significantly modulated by SL, of which 
3 were predicted to be repressed and one to be induced (Table S1). Of the 25 other 
significantly modulated pathways, the gene expression profiles did not enable IPA to 
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predict whether a modulated pathway was induced or repressed. Cell cycle: G2/M 
damage checkpoint regulation, ATM signaling and role of CHK proteins in cell cycle 
checkpoint control were all predicted to be downregulated (Figure 1A). The mitotic 
role of polo-like kinases and ERK5 were predicted to be upregulated by SL (Figure 
1A). Next, we investigated the effect of GOS on epithelial barrier transcriptomes. 
GOS induced the modulation of 63 pathways of which 8 were predicted to be 
activated and 13 to be repressed according to IPA (Table S1). Interestingly, 4 out 
of the top 5 most significantly modulated pathways by SL compared to medium 
control were also significantly modulated in the same direction by GOS (Figure 1B). 
Additionally, GOS was predicted to induce estrogen-mediated S phase entry and 
to modulate ATM signaling and role of CHK proteins, pathways that participate 
in DNA replication checkpoints, among others. Additionally, GOS repressed cell 
cycle: G2/M DNA damage checkpoint regulation and strongly induction of mitotic 
roles of polo-like kinases modulation Taken together, IPA analysis showed that both 
oligosaccharides modulate pathways involved in cell cycle progression and mitosis 
(supplementary text). Since the SL (FC) used for the transcriptome studies on Caco-
2 was isolated from bovine milk and may contain salts, we verified the transcriptome 
data with qPCR using commercially available, synthesized SL (Carbosynth) (Figure 
S1). To investigate whether these transcriptional effects were also translated to a cell 
cycle progression and (or) cell proliferation phenotype, we cultured Caco-2 cells for 
four days in the presence of SL or GOS in complete medium. The number of cells 
and the fraction of live cells was assessed using flow cytometry (Figure S2A). We 
cultured the Caco-2 cells for four days in the presence of SL or GOS the cell number 
was more than doubled and the monolayer was still non-confluent, suggesting little 
contact-inhibition (Figure S2B). Caco-2 cells grown for four days in the presence 
of high concentrations (10 mg/ml or 20 mg/ml) of SL or GOS showed a lower cell 
count (Figure 1C), which could partially be explained by cell death (Figure S2C). 
Nevertheless, GOS showed more cell death in higher concentrations (> 3 mg/ml) as 
compared to SL (Figure S2C). This decrease in cell counts was accompanied by an 
increase in ALP activity at high concentrations of GOS and SL (Figure 1D), which 
suggests that SL and GOS modulate the balance between cell proliferation and cell 
differentiation and may thus influence intestinal homeostasis.
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Figure 1. SL and GOS modulate cell proliferation and induce differentiation. A fully polarized epithelial 
layer of Caco-2 cells cultured in DMEM + 10% FCS was exposed to 10 mg/ml SL or GOS for 6 hours. After 
6 hours the cells were lysed and RNA was isolated for microarray analysis and subsequent IPA analysis. The top 
five most significantly, excluding ERK5 (p=0.07), regulated pathways by (A) SL and (B) GOS (IPA analysis 
results). Next, phenotypic changes were assessed by culturing Caco-2 cells for 4 days in the presence of different 
concentrations of GOS and SL (0.1- 20 mg/ml), followed by (C) cell counting by flow cytometry and (D) ALP 
activity determination in culture supernatants.
We thus showed that GOS and SL alter cell cycle progression and, at higher 
concentrations, halt proliferation and induce differentiation of Caco-2 cells. We 
therefore investigated the effect of SL and GOS on re-epithelialization, an important 
phase in wound-healing where control of epithelial cell proliferation and differentiation 
is tightly controlled by intrinsic pathways. We used a scratch assay that tracks the 
presence (in terms of numbers and location) of epithelial cells in the scratch area 
over time. Caco-2 cells are tightly connected to neighboring cells, which makes this 
cell line unsuitable for scratch assays. We therefore used Ca9-22 cells (immortalized 
gingival-) epithelial cells330. We tested a mixture of SL as present in cow’s milk (0.1 
mg/ml), human breast milk (0.5 mg/ml) and human colostrum (3 mg/ml) and the 
same concentrations of GOS. Strikingly, GOS and SL induced a significant increase 
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in the maximum number of cells present in the scratch area five hours after applying 
the oligosaccharides when compared to medium control (Figure 2A). The repair rate, 
as a non-linear measurement of cellular influx over time, also showed an increase 
at the lowest dose used although not significantly different when compared to the 
medium control (Figure 2B). The positive control TGFα, stimulated a significant 
increase in the repair rate (Figure 2B) whereas the maximum number of cells present 
in the scratch area was not significantly higher (Figure 2A). The negative control 
consisting of p38 mitogen-activated protein kinase- and MEK1/2 phosphorylation 
inhibitors resulted in a significantly lower maximum number of cells present in the 
scratch area and repair rate (Figures 2A-B). Thus, SL and GOS in concentrations 
present in cow’s milk and breast milk both stimulated re-epithelialization of Ca9-22 
in terms of a more complete closure of the scratch area within 5 hours after applying 
the oligosaccharide mixture (Figure 2C).
Microbiota
The microbiota plays an important role in gut homeostasis and barrier functioning. 
We therefore investigated the effects of SL and GOS on microbiota composition. 
Pooled adult or infant fecal cultures were spiked with 10 mg/ml SL or GOS. Fecal 
slurry was collected after 3, 6, 9 and 24 hours for microbiota analysis. Microbiota 
analysis was first performed on genus level by performing qPCRs using generic or 
specific 16S rRNA primers to detect the numbers of total bacteria, Bifidobacterium, 
Bacteroides, Lactobacillus and Escherichia coli. The starting amount of bacteria in the 
fecal slurry of the pooled adult samples (Figure 3A) was higher compared to those 
of infants (Figure 3D). Nevertheless, the total bacterial numbers in infant and adult 
cultures increased in the first 6 hours of the culture, independent of the inoculum 
(Figures 3A,D). Notably, infants showed relatively to the low bacteria numbers a high 
amount of bifidobacteria compared to adults. In infant batch cultures, SL and GOS 
both induced an increase in bifidobacteria (Figure 3F) while lactobacilli numbers 
were not markedly increased compared to control (Figure S3A,D). Also in infant 
batch cultures, the number of Bacteroides bacteria had increased after spiking by 
GOS (Figure 3E). After spiking of fecal batch cultures of adults by SL, the numbers 
of Bacteroides bacteria had increased; this increase had not been induced by GOS 
(Figure 3B). However, again in the adult fecal batch cultures, GOS substantially 
promoted the outgrowth of bifidobacteria (Figure 3C). No differences were observed 
in the numbers of Clostridium and Escherichia (Figure S3).
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Figure 2. SL and GOS promote re-epithelialization, one aspect of wound healing. Longitudinal scratches 
were applied to a confluent layer of labelled Ca9-22 epithelial cells. The medium with cell debris was replaced 
by fresh medium containing mixtures of 3’SL and 6’SL as present in cow’s milk (0.1 mg/ml), human milk (0.5 
mg/ml) and human colostrum (3 mg/ml) or matching concentrations of GOS or inhibitors or TGFα that were 
used as negative and positive controls, respectively. (A) The total number of cells at the end of the measurement 
(t = 280 minutes) and (B) the increase in cell numbers over time (i.e. repair rate) was calculated using a non-
linear model using the Gompertz equation. (C) An image of one representative well per stimulus is shown.
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Next, fecal slurries from time point 0 and 24 hours were analyzed at species level 
using an intestinal microflora chip (I/II-chip; TNO). Of the 400 species quantified 
on the chip, changes in bifidobacteria, Bacteroides and several other species 
were markedly changed by the prebiotic supplements. Overall, the chip analysis 
confirmed the 16S rRNA qPCR data, showing that Bacteroides and bifidobacteria 
were markedly increased in adult batch cultures in the presence of SL and GOS, 
respectively (Figure 3G), and that this distinct pattern was less pronounced in infant 
fecal batch cultures (Figure 3F). In adult batch cultures, SL induced a specific increase 
of Faecalibacterium prausnitzii, Ruminococcus obeum, Collinsella aerofaciens, 
Eubacterium halii and Ruminococcus productus (syn. Blautia producta, comp. 
nov.) (Figure 3G). GOS increased the abundance of several Bifidobacterium species, 
including B. bifidum, B. infantis and B. longum in adult cultures (Figure 3G). In 
infant cultures, SL induced the specific outgrowth of members from the B. prevotella 
group and B. thetaiotaomicron (Figure 3H). In line with the qPCR data, this increase 
in abundance of Bacteroides species (e.g. B. fragilis, B. thetaiomicron, B. ovatus) 
induced by SL was also seen in if infant batch cultures were supplemented with 
GOS (Figure 3H). The specific outgrowth of Bifidobacterium species GOS was less 
pronounced in batch cultures from infants compared to adults (Figure 3H). Thus, we 
showed that SL and GOS distinctly modulate microbiota composition as shown by 
the outgrowth of Bacteroides and bifidobacteria species, respectively. Several of the 
abovementioned taxa belong to the class of Clostridia (i.e. Rumincococcus species), 
well-known producers of SCFAs, suggesting that supplementation of SL and (or) 
GOS in fecal batch cultures might alter SCFA production.
Short chain fatty acids
Next, we assessed whether the microbial changes induced by SL or GOS altered 
SCFA production in the fecal batch cultures. SL and GOS both boosted the total 
production of SCFA including the production of acetate in adult- (Figure 4B) 
and infant batch cultures (Figure 4H). Strikingly, in contrast to the control batch 
culture that showed no butyrate production, butyrate was produced after 9 hours 
of the batch culture, only if GOS or SL were present (Figures 4C, I). In adult batch 
cultures, GOS (Figure 4D) and SL (Figure 4E) induced the production of lactate 
and propionate, respectively. The concentration of lactate declined after 6-9 hour 
of batch culturing, indicating that secondary producers may have used lactate as a 
carbon source (Figure 4D ,J). This decline in lactate coincided with the increase of 
butyrate if growth medium was supplemented with GOS or SL (Figures 4C,I). These 
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secondary producers include Eubacterium halii and Faecalibacterium prausnitzii and 
Clostridium butyricum as quantified in adult (Figure 3G) and infant (Figure 3H) 
batch cultures, respectively. Butyrate was also produced in batch cultures inoculated 
with SL in absence of lactate production (Figures 4C and D). In infant fecal cultures, 
lactate (Figure 4G) and propionate (Figure 4K) were produced in the presence of SL 
or GOS. The concentration of formate, acetate and total SCFA was higher in SL and 
GOS-containing cultures compared to batch cultures in baseline medium (Figures 
4A,B,F,G,H,L). Thus in line with the associated changes in microbiota composition, 
SL and GOS induce a distinct SCFA profile that is dominated by propionate and 
lactate, respectively.
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Figure 3. SL and GOS differentially modulate microbiota composition. Batch cultures of adult and infant 
pooled fecal samples cultured in growth medium were supplemented with or without SL or GOS in duplo. 
Fecal samples were collected at the start of the batch culture and after 3, 6, 9 and 24 hours. Microbiota 
composition on genus level (A–F) and on species level (G,H) was determined by qPCR and chip analysis, 
respectively. Bacterial numbers were shown as mean ±SEM of two independent batch. Raw fluorescence data 
are shown for both individual runs for chip analysis.
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Figure 4. SL and GOS differentially stimulate SCFA production. Batch cultures of (A-F) adults and (G-L) 
infants pooled fecal samples were inoculated with SL or GOS. Fecal samples were collected at the start (0 hours) 
and after a culture time of 3, 6, 9 and 24 hours. SCFA levels were measured in the fecal samples by HPLC. 
SCFA levels of two independent batch cultures were represented as mean ±SEM.
Discussion
Dietary fibers are widely considered to contribute to infant and adult intestinal 
health, via largely unexplored biological mechanisms that are thought to result 
from microbial fermentation of fibers into short-chain fatty acids (SCFAs). In this 
paper we show that SL and GOS both directly positively contribute to regulation 
of epithelial cell proliferation and differentiation in vitro. Transcriptome analysis of 
18039 Olaf Perdijk PM.indd   144 04-09-18   19:57
SL and GOS modulate barrier function, microbiota composition and SCFA production
145
7
Caco-2 intestinal epithelial cells suggested that cell cycle pathways were modulated 
by SL and GOS; this could be corroborated in bioassays where phenotypes showing 
less proliferation and more differentiation were obtained. In vitro epithelial wound 
healing assays showed that SL and GOS oligosaccharides also promoted re-
epithelialization of a scratch area introduced in a confluent epithelium monolayer, 
an important aspect of wound healing. Additionally, our data showed that SL and 
GOS distinctly modulate microbiota composition, by promoting the outgrowth 
of Bacteroides and bifidobacteria, respectively, which resulted in distinct changes in 
SCFA profiles, including increased propionate and lactate levels, respectively, and 
increased levels of butyrate for both SL and GOS.
The epithelial lining along the GI tract is the physical barrier that separates the 
intestinal lumen from the underlying tissue and protects against harmful antigens. Of 
note, gut closure (i.e. the state in which no macromolecules leak through the barrier) 
occurs in humans, in contrast to mice, already a few days after birth127. Later in infancy, 
infection may temporarily disrupt barrier function, so continuous barrier function 
support is important to appropriately protect underlying tissues from invasion 
and to prevent inflammation. Nutritional intervention to support barrier function 
is especially relevant in premature infants whose gut function is characterized by 
immature mucosal and immune function and high level epithelial leakage, increasing 
the risk of uncontrolled inflammatory responses and the detrimental consequences 
of such response. Microbiota dysbiosis in combination with barrier dysfunction, 
and unbalanced immune responses can aggravate these detrimental consequences222. 
HMO have been shown to improve intestinal homeostasis in vitro135,345,346 and 
provide systemic anti-inflammatory effects in animal models294. It is thus essential to 
translate these in vitro and animal studies to human nutritional intervention studies.
We assessed the effect of GOS and SL on epithelial barrier functioning using in 
vitro assays investigating proliferation, differentiation and re-epithelialization. Our 
transcriptome analysis showed that GOS and SL both modulated the expression of 
genes involved in regulating stages of the cell cycle (e.g. cyclins and cyclin-dependent 
kinases; see Supplementary text). To investigate how this transcriptome profile 
showing modulation of pathways regulating cell cycle control translated into an 
epithelial phenotype in Caco-2 cells, we cultured the Caco-2 cells for four days in the 
presence of HMO. Cell counts after 4 days showed that at higher concentrations (>10 
mg/ml) SL and GOS suppressed proliferation and induced differentiation, as shown 
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by increased activity of ALP, a well-established differentiation marker for enterocytes. 
ALP was shown to modulate microbiota composition and inactivate different 
serotypes of LPS347. The effects of SL that we observed are in line with previous 
findings by other groups that also reported suppressed proliferation and induced 
differentiation135,346. Thus, SL and GOS halt proliferation and induce production 
of ALP, which is a marker for intestinal homeostasis and epithelial differentiation. 
Importantly we show in this study that this effect was not restricted to SL, but was 
also observed when Caco-2 cells had been incubated for 4 days with GOS.
Since SL and GOS modulated very basic cellular mechanisms involved in epithelial 
differentiation, we questioned whether they are also capable of promoting re-
epithelialization of epithelial cells, a process that involves tight regulation of 
proliferation and differentiation of epithelial cells. In the re-epithelialization phase 
of the “wound healing” process, cells migrate into the wound area, which involves 
reorganization of cellular cytoskeleton and cellular differentiation after the wound 
is closed348,349. HMO were previously shown to indirectly contribute to the wound 
healing process in the colon by modulating microbiota composition349 and boosting 
SCFA production350. Here, we observed that GOS and SL in concentrations 
present in cow’s milk and breast milk can directly induce closure of the scratch 
area representing the wound in an in vitro model of wound healing. A well-known 
signaling cascade that induces re-epithelization is activation of the epidermal growth-
factor receptor (EGFR) by ligands such as TGFα351,352. Interestingly, acidic HMO 
fraction and to a lesser extent, neutral HMO induced EGFR signaling in HT-29 
cells345, and we observed a similar boosting effect of the acidic SL and neutral GOS in 
our re-epithelialization model. Thus, we show here that oligosaccharides such as GOS 
and SL may promote epithelial barrier function and thus contribute to intestinal 
homeostasis. Future studies could investigate these effects on barrier function in early 
life using animal (e.g. allergy or colitis) models.
Since the early 1980’s, research unraveled that breastfed infants show higher numbers 
of bifidobacteria and a lower pH compared to bottle-fed infants supplemented 
without prebiotics267,353. This lower pH of the stool in breastfed infants is caused by 
higher lactate and acetate levels318,354. Infant formulae supplemented with a mixture 
of GOS/FOS promote a more bifidogenic microbiota composition324–328 and a SCFA 
profile more similar to breast-fed infants329,354. In line with these findings, our batch 
cultures showed that GOS induced the outgrowth of bifidobacteria and an increased 
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production of lactate. Although to a lesser extent, SL also boosted the abundance of 
bifidobacteria, which is in line with earlier reports showing that different strains of 
bifidobacteria are capable of metabolizing both neutral and acidic HMO102,103,355.
We showed that GOS induced the production of acetate and lactate in fecal batch 
cultures of adults and, to a lesser extent, in infants. Animal models have shown that 
acetate can protect against E.coli infections in the gut356 and systemic diseases such as 
asthma45. The concentration of lactate declined rapidly after 9 hours of the culture, 
indicating utilization by other bacteria which may include secondary butyrate 
producers (e.g. Eubacterium halii and F. prausnitzii)357. Butyrate is known to induce 
anti-inflammatory response via binding G-protein coupled receptor (GPR) 109A 
and downregulation of NF-kB activity358.
Multiple pathogenic bacteria and several commensal bacteria from different phyla 
encode genes that may participate in biochemical pathways that utilize sialic acid359. 
Commensal bacteria that express pathways to utilize SL are Bacteroides members such 
as B. fragilis, B ovatus and B. vulgatus. Our data shows that Bacteroides increase in 
abundance upon culturing in the presence of SL. SL also increased the abundance 
of Ruminococcus obeum that was shown to switch to propionate production if fed 
with fucose or rhamnose360. Propionate has been shown to exert systemic anti-
inflammatory responses in allergic animal models for instance, suppression of 
allergic inflammation44. Recent evidence shows that purified sialylated bovine milk 
oligosaccharides are mainly metabolized by B. fragilis158, which is in line with in 
vitro cultures361. The authors showed that sialylated oligosaccharides may be essential 
for optimal growth in early life. B. fragilis was also shown to contribute to immune 
homeostasis by producing polysaccharide A, a molecule that was shown to induce 
differentiation of CD4+ T cells into regulatory T cells in the gut362.
Importantly, our results show that SL and not GOS promotes the outgrowth of F. 
prausnitizii in adult batch cultures. GOS supplementation to elderly363 or healthy 
adults did also not show a marked increase in fecal F. prausnitizii abundance364. The 
infant pooled samples did not show the presence of F. prausnitzii at the start of the 
batch culture that might explain its absence after the incubation period with the 
inoculum (data not shown). Interestingly, at least some F. prausnitzii strains produce 
proteins that degrade sialic acid359. F. prausnitizii induces anti-inflammatory responses 
which is shown to protect against colitis in animal models365 and its prevalence has 
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been reversely associated with the prevalence of ulcerative colitis in adults366. However, 
increased F. prausnitizii numbers were observed in pediatric Crohn’s disease367.
Conclusions
In conclusion, SL and GOS directly interact with the epithelial lining where they 
can support differentiation and wound repair. In addition, these compounds may 
distinctly modulate intestinal microbiota composition and activity and change the 
corresponding SCFA profiles in the gut lumen. The consequences of the effects in 
terms of the host health in infants and adults remain to be determined.
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Supplementary files
Table S1. Number of pathways predicted to be induced or repressed by GOS or SL.
 GOS SL
total 63 28
NaN 39 24
 positive Z-score 8 1
 negative Z-score 13 3
Z-score = 0 3 0
SL vs medium GOS vs medium
(log2 based) Fold Change gene name  (log2 based) Fold Change gene name
-7.91 IFIT1 6.45 REG4
2.32 FOXM1 3.12 EGR1
2.70 CDK1 2.94 TNFRSF11B
5.43 TNFRSF9 2.71 CDK1
6.36 EDNRB 2.39 FOXM1
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Figure S1. Comparison gene-expression induced by SL as quantified by transcriptome and qPCR.
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Figure S2. Counting of viable Caco-2 cells by flow cytometry. (A) Counting beads were added to the 
trypsinized cell suspension of Caco-2 cells to count the number of viable cells. Caco-2 cells were gated based on 
size (FSC-A) and granularity (SSC-A). Single cells were selected based on plotting FSC-A versus FSC-H. These 
single cells were then gated on live cells. The number of viable cells/ml was calculated by: viable cell count/ 
(volume of beads * beads count) * bead concentration. (B) the number of Caco-2 cells grown in DMEM + 10% 
FCS was counted at different days of culture. (C) viable Caco-2 cell counts if cultured in the presence of SL or 
GOS.
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Figure S3. SL and GOS do not modulate the numbers of lactobacilli, Clostria or E. coli. Batch cultures of 
(A-C) adults (D-F) and infants pooled fecal samples were inoculated with SL or GOS. Fecal samples were 
collected at the start and after a culture time of 3, 6, 9 and 24 hours and determined for the numbers of bacteria 
by qPCR.
Supplementary text
In this transcriptome study, we found, using Ingenuity Pathway Analysis (IPA), 
that cell cycle control stands out among the significantly modulated pathways. 
Intriguingly, our transcriptome analysis shows that GOS and SL modulate cell cycle 
control in a similar fashion in Caco-2 cells. Here, we provide a more extensive analysis 
of cell cycle genes that were significantly differentially regulated. 
Cell cycle control is regulated by two key classes of molecules, cyclin-dependent 
kinases (CDKs) and their binding partners, the cyclins. In mammals there are a 
wide variety of CDK that form complexes with the corresponding stage-specific 
cyclins during different phases of the cell cycle. In the first phase of the cell cycle, the 
G1 phase of cell division, the cell increases in size and ensures it is ready for DNA 
synthesis. Cdk4 are activated by cyclin D proteins, resulting in the transcription of 
E2F transcription factors and cell cycle progression. E2F responsive genes are CCNA 
and CCNE, coding for cyclin A and E, respectively. Cyclin E activates Cdk2, resulting 
in E2F transcription, which results in entry into the S-phase. Our transcriptome data 
shows that GOS and SL upregulate genes involved in G1/S phase progression; these 
genes can also be regulated by estrogen. This is in agreement with the predicted (IPA 
analysis) induction of the estrogen-mediated S-phase entry pathway by GOS. Our 
IPA output shows that this pathway is only induced by GOS and not by SL, which 
can be explained by the strict statistical cut-off value (i.e. FDR 3-8) that we used for 
the analysis of the transcriptome of SL stimulated Caco-2 cells. Nevertheless, SL also 
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induced these genes involved in G1/S progression (Figure 2C). 
At the beginning of the S-phase, cyclin A that phosphorylates proteins involved in 
DNA replication, is synthesized. Finally, cyclin B binds CDK1 to enter prophase and 
drive mitosis (Peters 2002). Our results showed that CDK1, CCNB1 and CCNB2 
are upregulated by SL and GOS. Yet additional proteins regulate cell cycle. PLK 
activates CDC25 and together with CDK1 initiate the entry of G2 to mitosis phase. 
PLK and CDC25A and CDC25C are upregulated by SL and GOS. Cyclin B:CDK1 
complexes are involved in the final stage of the cell cycle, inducing cell proliferation. 
PLK and MKLP1 are also needed for the formation of mitotic spindles (Sumara et 
al. 2004) and midzone formation (Zhu et al. 2005). In line with the upregulation 
of genes coding for the Cyclin B:CDK complex, these mitosis progression genes 
were upregulated as well by SL and GOS treatment. Proteins of the Cip/Kip family 
(e.g. p21Cip1 and p27Kip1) inhibit the activity of cyclin A, B and E activity thus 
blocking multiple stages of cell division. Interestingly, we found that p21Cip1, coded 
by CDK1NA had been 3 fold downregulated in SL and GOS treated Caco-2 cells. 
A table listing the differential expression of cell cycle control genes is provided below 
(Table S2). In summary, our IPA results showed that at least some concentrations of 
SL and GOS induce the transcription of genes that control multiple stages of cell 
division. 
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Table S2: Genes involved in cell cycle control as  fold change compared to medium control. Genes were 
selected based on the SL dataset with a FDR cut-off value of 10-8.
fold change 
SL GOS
AURKA 4.1 3.3
BLM 2.0 3.7
CCNA2 3.3 4.8
CCNB1 4.5 3.6
CCNB2 3.2 3.2
CCNE2 4.5 5.5
CDC25A 4.8 4.4
CDC25C 5.9 4.4
CDK1 6.5 6.5
CDKN1A 0.4 0.3
CHEK1 2.6 3.5
CKS2 7.6 4.4
CREB3L3 0.4 0.3
E2F1 5.6 3.8
E2F7 3.4 5.9
E2F8 3.9 5.2
FANCD2 0.5 4.2
FBXO5 4.0 3.7
HIPK2 2.9 3.1
KIF11 3.7 4.4
KIF23 7.3 5.5
MDM2 3.3 3.7
PCNA 3.0 3.8
PLK1 5.4 4.3
PLK4 6.1 4.9
PPM1D 6.6 2.7
PRC1 7.4 4.0
PTTG1 4.4 3.1
RPS6KA1 3.2 2.5
SFN 10.1 3.2
SMC2 3.7 3.8
SMC4 4.1 3.5
TOPB1 2.8 2.6
TP73 3.3 3.2
FOS 2.2 3.2
FOSL1 6.1 4.9
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Abstract
Epidemiological studies show that the consumption of cow’s milk in early life is 
associated with reduced prevalence of asthma, hay fever and allergic sensitization. Since 
causality cannot be proven in controlled studies due to safety risk of raw cow’s milk 
consumption in infants, mechanistic studies are limited to in vitro work and animal 
models. Mouse models show that allergies and asthma can be prevented by a high 
fiber diet, boosting the production of microbial-derived short chain fatty acid (SCFA) 
that have local and systemic anti-inflammatory effects. Cow’s milk is rich in immune 
related proteins and contains sialylated oligosaccharides such as 3’-sialyllactose (3’SL) 
and 6’-sialyllactose (6’SL). Here we investigated whether cow’s milk, 3’SL or 6’SL 
can protect against asthma via effects on the microbiota. To this aim we used an 
ovalbumin (OVA)-induced asthma model using female BALB/c mice. Mice were 
switched from normal chow to a low-fiber diet at the start of the study and had ad 
libitum excess to drinking water supplemented with 100 µg/ml 3’SL, 100 µg/ml 6’SL 
or lactose-depleted raw cow’s milk. After sensitization with OVA, airway inflammation 
was measured by airway hypersensitivity measurements after metacholine challenges, 
and white blood cell numbers in bronchioalveolar lavage fluid were quantified. Fecal 
and cecal samples were collected and analyzed for microbiota composition and SCFA 
levels, respectively. No significant differences were found between mice receiving 
raw cow’s milk or sialyllactose in methacholine-induced airway hyper-responsiveness 
or white blood cell counts in bronchioalveloar lavage fluid. A gradual decrease in 
Bacteroidetes and increase in Firmicutes was observed during the complete course of 
the study. Most of the variation in microbiota composition was explained by the day 
of collection, rather than the dietary supplementation with raw milk or sialyllactose. 
Nevertheless, mice that received 3’SL or raw cow’s milk showed a higher abundance 
of the genus Akkermansia or Corynebacterium, respectively at the day of sacrifice. No 
differences in SCFA levels in the caecum were found. We conclude that the microbial 
changes are most likely driven by the transition of normal chow to low-fiber diet. It 
is therefore possible that the immunomodulatory effects of the dietary intervention 
are masked by the effect of the low-fiber diet. Future studies should therefore include 
a longer run-in period (of at least four weeks) before studying the effect of a dietary 
intervention.
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Introduction
Children growing up on a farm have a lower risk of developing asthma, hay fever and 
allergic sensitization83. Interestingly, epidemiological studies show inverse correlations 
between the consumption of cow’s milk in early life and allergy and asthma 
prevalence66,84,86,88,368,369. A few epidemiological studies show that the thermosensitive 
fraction of cow’s milk is responsible for the protective effect66,88, while others do not 
specify the heating status of the milk or only look at unprocessed cow’s milk84–86,368–
370. However, causality cannot be proven since controlled studies with unprocessed 
cow’s milk in infants are ethically not possible due to safety reasons. Hence, the 
effects of cow’s milk on the mucosal immune system has mostly been investigated 
in vitro. Nevertheless, a recent study in mice showed that raw cow’s milk and not 
heated cow’s milk prevents against house dust mite (HDM) induced asthma67. 
Several mechanisms (e.g. improved epithelial barrier functioning and induction of 
regulatory immune cells) have been proposed by which cow’s milk contributes to 
immune homeostasis in the respiratory tract371.
It is appreciated that there is a critical window in early life in which the microbiota 
composition and diversity, driven by environmental factors such as diet, is essential for 
appropriate immune functioning later in life49,163. The microbiota is essential for the 
host for energy harvest and fermentation323. In the last decade a wealth of information 
is emerging showing that the microbiota and microbial-derived metabolites have a 
central role in human physiology and health321–323. Fermentation in the colon of non-
digestible carbohydrates by the microbiota results in the production of metabolites 
that become available to the host372. When these non-digestible carbohydrates confer 
physiological effects to the host they may be defined as functional fibers372.
One group of metabolites produced in large amounts upon fiber fermentation in 
the colon are short-chain fatty acids (SCFA). SCFA as well as other metabolites (e.g. 
medium-chain fatty acids) bind specific G-protein coupled receptors that induce 
directly (e.g. on colon epithelium and immune cells) or indirectly (e.g. epigenetics) 
anti-inflammatory responses in the host321. Interestingly, two recent mouse studies show 
mechanistic evidence for the consumption of fibers, which resulted in the production 
of SCFA that protected against asthma44,45. Trompette et al. (2014) showed a higher 
abundance of Bifidobacteria and a higher production of SCFA in mice fed with 
pectin44. The SCFA propionate showed to alleviate HDM-induced allergic symptoms 
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in a GPR41-dependent manner. Interestingly, the authors showed that propionate 
induced hematopoiesis of dendritic cell precursors. These dendritic cells were found 
in the lungs and showed an impaired ability to induce Th2 responses44. The second 
study showed that acetate can inhibit allergic airway diseases by enhancing regulatory 
T cell numbers and function, which was induced by epigenetic changes promoting 
transcription of the FOXP3 promoter45.
In contrast to breast milk, cow’s milk contains only a limited amount of non-
digestible oligosaccharides that are dominated by sialylated oligosaccharides of which 
the trisaccharides 3’-sialyllactose (3’SL) and 6’-sialyllactose (6’SL)78. 3’SL and 6’SL 
are utilized by several bifidobacteria strains in vitro, resulting in the production of 
SCFA103.
Thus, cow’s milk might protect against allergies and asthma, although the relative 
contribution of milk proteins and sialyllactose is not known. One protective 
mechanism against upper airway inflammation would be the prebiotic effect of SL 
resulting in an enhanced production of SCFA. To this aim, we investigated the effect 
of raw cow’s milk, 3’SL and 6’SL in an OVA-induced asthma model of BALB/c mice 
fed a low-fiber diet.
Materials and Methods
Mice 
Ten week old in-house bred BALB/c female mice (n=8 per group) were housed at the 
animal facility of ALK-Abelló, Hørsholm, Denmark. Mice were fed normal chow, 
and were switched to a low-fiber chow at the start of the study (C1013, Altromin). 
Drinking water was available ad libitum. Animal experiments were conducted in 
accordance to the Danish animal ethical committee (2016-15-0201-01059).
Raw milk preparation
Raw milk from a local farm was stored at <6°C until used. The protein, fat and 
lactose content of the milk was measured in duplicate by the Milkoscan (Foss 
Electric, Hillerod). Milk samples were sent to internal lab (LQS FrieslandCampina, 
Leeuwarden) for detailed compositional and microbiological analysis. Diafiltration 
together with concentration was performed using an ultrafiltration system with a 
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hydrophilic Poly Ether Sulfone membrane (model TUF3838 N1) with a molecular 
weight cut-off of 10 kDa in a spiral-wound UF format (Toray Membrane Europe 
AG). During UF concentration, the retentate was recycled and the permeate was 
continuously removed from the system until a mean concentration factor (CF) of 2, as 
determined by the volume of permeate collected, reached at constant transmembrane 
pressure (167 kPa) and temperature(15ºC). At a concentration factor 2, diafiltration 
water was added to the balance tank and the same volume of permeate was collected. 
This procedure was repeated two more times. After the final water addition, permeate 
was removed till the final CF of 3 and desired lactose to protein ratio was achieved. 
The final retentate was fed in multiple disinfected metal trays and kept in a freeze 
dryer (Virtis Genesis 25XL) to produce raw milk powder. The produced lactose 
depleted powder samples from each tray were collected into sterilized bags and 
vacuum sealed. The powder was frozen at -20°C. To improve the solubility, the raw 
cow’s milk powder was freshly dissolved at 50% of the protein concentration found 
in the milk.
OVA-induced asthma model
A schematic overview of the experimental set-up is shown in Figure 1. Mice were 
group housed from the start of the study. Mice had ad libitum access to 100 µg/ml 
3’SL (Carbosynth, OS04397), 100 µg/ml 6’SL (Carbosynth, OS04398) or 50% of 
the protein content found in the raw cow’s milk (FrieslandCampina) in the drinking 
water. Raw cow’s milk was depleted for lactose, freeze-dried and the powder was 
kept at -20ºC until further use. Drinking bottles were refreshed each day to limit 
bacterial growth. The cow’s milk was tested negative for mouse pathogens. Mice were 
weighed at day 0, 14, 20 and 30 and individual fecal samples were collected at day 
0, 14 and 30. A parallel experiment with 5 mice per group was conducted for airway 
hyperresponsiveness measurements. Mice were sensitized intra peritoneal (i.p.) with 
250 µg OVA and 300 µg 1.3% Alhydrogel (batch INMA-RM0001870975-ZLI4-01) 
at day 14 and 20 of the study. Intranasal challenges with 25 µg OVA were performed 
at three consecutive days, one day prior to sacrificing the mice (Figure 1).
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Whole study
Ad libitum low fiber-
diet with water +/-
treatments
Day 01 4
I.P. sensitization
250 µg OVA + 
300 µg Alum
20 27  28  29  30
I.N. c hallenge
25 µg OVA
Sacrifice
faeces faeces feces
Figure 1. Schematic study set-up. From day 0 onwards, mice were fed a low-fiber diet and cow’s milk, 3’SL 
or 6’SL were supplemented ad libitum via the drinking water. After an adjustment time of 14 days, mice were 
sensitized at day 14 and day 20. Mice were challenged intra-nasally on three consecutive days prior to sacrifice.
Airway-responsiveness
Anaesthetized mice were intubated with tracheal cannula and exposed to ascending 
concentrations of methacholine (Mch) (0, 0.1, 0,3, 1.0, 3.0 and 10 MCh/kg) (Sigma-
Aldrich, A2251). Bronchoconstriction was measured in real-time with the Flexivent 
apparatus (Scireq, Montreal, Canada).
White blood cell counts in bronchoalveolar lavage fluid
Bronchoalveolar lavage (BAL) was performed by washing the lungs of the mice with 
750 µl Hank’s balanced salt solution. The collected fluid was kept on ice and spun 
down at 1900 rpm for 8 minutes at 4°C. Supernatants were frozen and kept at -20°C. 
The pellet was resuspended in 100 µl PBS containing 0.5% FCS and white blood cell 
counts were performed with Sysmex 1800i apparatus.
ELISA: cytokine measurements BALF and OVA specific IgE levels
IL-5 and IL-13 were quantified in BALF using a mouse IL-5 (R&D Systems 
DY405-05) or IL-13 Duoset ELISA (R&D Systems DY413-05) according to the 
manufacture’s recommendations, respectively. OVA specific IgE was measured 
in serum. Serum was diluted 30X times in PBS and measured by a mouse OVA-
IgE ELISA kit (M036005N, MDBiosciences) according to the manufacture’s 
recommendations.
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Microbiota analysis
Bacterial DNA was extracted by using a Maxwell® 16 Total RNA system (Promega) 
with Stool Transport and Recovery Buffer (STAR; Roche Diagnostics Corporation, 
Indianapolis, IN, USA). Approximately 0.1 g of fecal sample was homogenized with 
0.25 g of sterilized 0.1 mm zirconia beads and three glass beads (2.5 mm) in 350 µL 
STAR buffer for 3 min at 5.5 m/s. The samples were incubated for 15 min at 95oC and 
pelleted by 5 min centrifugation at 4oC and 14000 g. The supernatant was stored and 
the pellets were processed again with 200 µL STAR buffer. The obtained supernatants 
were pooled and 250 µL was loaded for purification with Maxwell® 16 Tissue LEV 
Total RNA Purification Kit (AS1220) following manufacturer’s instructions. DNA 
was cleaned using magnetic racks and eluted with 50 µL of DNAse and RNAse 
free water (Qiagen, Hilden, Germany). DNA concentrations were measured with 
NanoDrop ND-1000 (NanoDrop® Technologies, Wilmington, DE, USA) and 
adjusted to 20 ng/µL with DNAse and RNAse free water for downstream steps. 
The V5-V6 region of 16S ribosomal RNA (rRNA) gene was amplified in duplicate 
PCR reactions using 20 ng of template DNA. Each sample was amplified with a 
unique barcoded primer 784F-n and 1064R-n (10 µM each/reaction; Supporting 
information), 1x HF buffer (Finnzymes, Vantaa, Finland), 1 µL dNTP Mix (10mM 
each, Roche Diagnostics GmbH, Mannheim, Germany), 1 U Phusion® Hot Start II 
High Fidelity DNA Polymerase (Finnzymes, Vantaa, Finland) and 36.5 µL of DNAse 
and RNAse free water in a total volume of 50 µL per reaction. The amplification 
program included 30 sec initial denaturation step at 98oC, following by 25 cycles 
of denaturation at 98oC for 10 sec, annealing at 42oC for 10 sec and elongation 
at 72oC for 10 sec, and a final extension at 72oC for 7 min. The PCR product was 
tested qualitatively for correct amplification with gel electrophoresis 1% size (~290 
bp). PCR products were purified with CleanPCR kit (CleanNA, Alphen aan den 
Rijn, Netherlands), and DNA concentrations were measured with Qubit® dsDNA 
BR Assay Kit (Life Technologies, Leusden, Netherlands). For the construction of 
the libraries, 100 ng from each barcoded and purified sample was used. Each library 
contained 70 unique barcode tags, thus 70 different samples were included. The 
final amplicon pool was concentrated with CleanPCR kit to 25 µL volume and 1 
µL was used for DNA quantification using Qubit® dsDNA BR Assay Kit. Mock 
communities, with known microbial composition were included as sequencing 
control within each library. Finally, the libraries were sent for adapter ligation and 
HiSeq sequencing (GATC-Biotech, Konstanz, Germany). Raw data was processed 
using NG-Tax pipeline373. Analyses of alpha and beta diversity along with PCoA 
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generation were conducted using QIIME. Diversity index group comparisons were 
done in GraphPad. Finally, multivariate redundancy analysis was performed with 
Canoco5 using the microbial composition data in phylum and genus level.
Statistics
Normality was tested with a Kolomogorov-Smirnov test. Abundances on genus level were 
log transformed to fit a normal distribution. A Kruskal-Wallis test was used to compare 
groups within each time point and to assess differences between time points. A repeated 
measures linear mixed model with LSD post-hoc test was used to compare microbial 
changes between different time points with each other. Treatment groups were compared 
within each time point with a Tukey post-hoc test or non-parametric Dunn’s multiple 
comparisons test. Graphpad Prism 5.0 and IBM SPSS Statistics 23 were used.
Results
Mouse characteristics in OVA-induced asthma model
During the study no signs of discomfort or changes in stool consistency were observed 
in any of the experimental groups. Mice were weighed at the start of the study, before 
sensitization and before sacrifice. The mice gained weight in the first 20 days of the 
study, which stabilized in the last week of the study as seen by the significant increase 
in weight (Figure S1A). Mice in the non-challenged group were significantly lighter 
at the start and the end of the study compared to mice in the 3’SL and challenged 
group (Figure S1B-C). Mice receiving raw cow’s milk drank approximately twice the 
amount of those in the control groups (data not shown) and ate slightly less during 
the first 20 days of the study (Table S1). Nevertheless, no signs of discomfort (e.g. 
diarrhea) or weight loss were observed in any of the groups.
Airway hyper responsiveness and bronchoalveolar lavage
Mice were sensitized with OVA intraperitoneally twice during the study and intra-
nasally challenged with OVA (challenged mice) or PBS (non-challenged mice) on 
three consecutive days before sacrifice (Figure 1). All treatment groups were compared 
to the challenged control mice to test whether the consumption of raw cow’s milk or 
SL alleviated airway inflammation. Airway hyperresponsiveness upon metacholine 
challenge was measured as an indicator for bronchoconstriction. The respiratory 
system resistance (Rrs) increased in all groups receiving OVA challenge compared to 
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the non-challenged mice. No differences were observed between the treatment groups 
and challenged control mice (Figure 2A). Next, we performed a bronchoalveolar 
lavage (BAL) and measured differential white blood cell counts (WBC) and cytokines 
in the bronchoalveolar lavage fluid (BALF). The WBC in the challenged mouse 
group was 2.7*105 with a 95% CI of [2.0-3.4*105]. In the 3’SL group the mean was 
lower showing a mean WBC of 1.9*105 with a 95% CI of [1.4-2.4*105]. However, 
only the non-challenged mice and not the treatment groups showed lower WBC 
compared to challenged control mice (Figure 2B). In line with these non-significant 
changes between groups, eosinophilia was observed in all treatment groups except 
from non-challenged mice (Figure 2C). The frequency of monocytes and neutrophils 
in the BAL in challenged mice compared to non-challenged mice was therefore lower 
(Figures 2C,S2A-C). Unexpectedly non-challenged mice showed significantly higher 
IL-13 levels in BALF (Figure 2D), which was not observed for IL-5 (Figure S2E). No 
significant differences were found systemically in OVA-specific IgE levels, indicating 
that these serum levels are elevated by the sensitization (Figure S2F).
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Figure 2. Asthmatic and immunological read outs in the lungs. (A) Bronchoconstriction measured with 
flexivent (Rrs). Raw milk (n=3), 3’SL (n=4), 6’SL (n=4), OVA/OVA (n=5) and OVA/PBS (n=4). (B) Total 
white blood cell counts as found in the BALF were shown per treatment group. (C) The mean counts of 
different white blood cell types is shown. (D) IL-13 was measured by ELISA in the BALF. Bar graphs are 
represented as mean +/- SEM (n=8/group).
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Microbiota
At the start of the study, mice were switched from a normal chow diet to a low-fiber 
diet with or without supplementation in the drinking water. First we analyzed whether 
the variables time and treatment could explain changes in microbiota composition. 
We therefore performed principal component analysis (PCA) and redundancy 
analysis (RDA) on genus level. The phylogenetic diversity decreased between first 
sensitization (day 14) and sacrifice (day 30) of the study, and not between the start 
of the study and first sensitization (Figure 3A). Next, we performed PCA of beta-
diversity, using the weighted and unweighted distances. Strikingly, the samples 
clustered together based on the time point of collection in the unweighted distance 
matrix and not in the weighted distance matrix, showing that the separation is driven 
by change in microbial taxa over time (Figures S3A-B). In line with these findings, 
RDA plots showed separation that revealed 11.06% of the total variation that was 
mainly driven by the microbial change over time (Figure 3B). As shown by PCA, 
time point 0 showed to account for the highest variation by RDA. This suggests that 
the changes in microbiota composition of mice are mostly driven by deprivation of 
fiber (Figure 3B). We therefore further assessed the changes in microbiota over time. 
On phylum level we showed that the mean abundance of Bacteroidetes decreased and 
Firmicutes and Actinobacteria increased (Figure 3C). The decrease in Bacteriodetes 
was mainly driven by a decrease in the genus Bacteriodales and increase in the genus 
Faecalibaculum (Figure 3D) of the family Bacteroidales and Erysipelotrichacaea, 
respectively (Figures S3C-D). Next we performed pairwise analysis on bacterial 
groups that showed significant changes over time. On phylum level, the decrease in 
Bacteroidetes and increase in Firmicutes (Figure 3E) was significant between all-time 
points. On genus level this was represented by a significant decrease of Bacteriodales 
(Figure 3F), while Faecalibaculum was not significantly increased (pairwise analysis 
not shown). However, the genus Blautia, also a member of the Firmicutes, was 
significantly increased over time, showing the most drastic increase after 14 days 
(Figure 3F). The frequency of Lactobaccilus was significantly increased in the first 
14 days and reduced to initial levels between day 14 and the end of the study, 
respectively (Figure 3F). Despite these dramatic changes over time, RDA showed 
that the treatment groups accounted for minor (2.0-2.8% of the total variation), but 
significant (P<0.05) variation in the total data set as well. Thus this shows that the 
dietary supplementation of raw cow’s milk or SL did induce significant microbial 
changes, although the biggest variation in microbiota composition driven by the 
change over time.
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Figure 3. Microbial changes over time. (A) the phylogenetic diversity is shown over time. () Redundancy 
analysis B on genus level using as explanatory variables the time points and the treatment. Explanatory variables 
account for the 11.06% of the total variation. The mean abundances of (C) phyla and (D) genus per time point 
were shown by stacked bar graphs. Pairwise comparison on significantly changing (E) phyla and (F) genus over 
time were performed.
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Next, we compared whether the microbiota was significantly different between 
treatment groups. At the day of the first sensitization (day 14 of the study) no 
significant differences were found between treatment groups. At the day of 
sacrifice however, the abundance of Verrucomicrobia (P=0.007) and Actinobacteria 
(P=0.06) tended to be different between the groups, showing a higher prevalence 
of both phyla in the 3’SL group (Figure 4A). On genus level the treatment groups 
clustered together deviating from the control groups who received water without 
supplements (i.e. 3’SL, 6’SL or raw cow’s milk) (Figure 4B). No differences between 
the treatment groups was measured in phylogenetic diversity (Figure S4). The mice 
that received 3’SL showed a different microbiota profile on genus level compared to 
the other groups (Figure 4C). For instance, they showed a lower mean abundance of 
Faecalibaculum and higher mean abundance of Coriobacteriacaea compared to the 
other groups (Figure 4C). However, these changes were not significantly different 
(pairwise analysis not shown). The significant change in Verrucomicrobia was 
completely driven by the genus Akkermansia that was significantly different between 
the treatment groups. Moreover, significant higher abundances of Akkermansia 
(Figure 4D) and Corynobacteria (Figure 4E) were found, in the 3’SL and raw milk 
groups, respectively. Both genera of bacteria are present in their respective treatment 
group in 6/8 mice compared to 0/8 or 1/8 in the other groups. To investigate whether 
these microbial changes correlated with an increase in local SCFA levels, we measured 
SCFA in the caecum. No significant differences were found between the treatment 
groups in caecum levels of acetate, propionate and lactate (Figure S5).
Discussion
Controlled studies with unprocessed cow’s milk in infants are not ethically possible 
due to safety risks. Therefore, causal links of cow’s milk consumption and protection 
against asthma and allergies in infants are limited to epidemiology, in vitro studies and 
animal models. The mechanism by which raw cow’s milk affects lung health remains 
largely unknown. We postulated that, among others, modulation of the gut-lung axis 
via fermentation of milk proteins or sialylated oligosaccharides promotes immune 
homeostasis in the respiratory tract371. Although no animal model can represent the 
complex clinical episodes in asthma patients and even various factors within the model 
(e.g. dosage, mouse strain, duration of challenge) can alter the response drastically, 
they may provide us with information about potential mechanisms374. An important 
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limitation of the OVA-induced asthma model that was used here is that mice are 
sensitized via the intra-peritoneal route, making it impossible for cow’s milk proteins 
to directly interact with the allergen. For instance, one of the postulated mechanisms 
involves complex formation of bovine IgG with allergens in the oropharynx that could 
alter immune responses. Indeed, bIgG was shown to bind allergens112 and human 
FcγRII in vitro111. Interestingly, a recent study showed, that gavages with raw cow’s 
milk and not with heated milk protected against house dust mite-induced asthma 
in mice67. The authors showed that raw milk reduced the production of IL-5 and 
IL-13 by lung homogenates upon HDM restimulation. The authors supplemented 
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0.5 ml of cow’s milk via oral gavage three times per week to the mice. Since the mice 
in this HDM model are sensitized intra-nasally, it is not likely that these protective 
effects are mediated by a direct interplay of milk proteins (e.g. bIgG) and HDM. 
However, they did not assess the microbiota composition or production of SCFA67. 
Our model aimed to investigate indirect effects of raw cow’s milk or SL consumption 
on respiratory health via the microbiota.
In this study we show in an OVA-induced mouse model that the microbiota changed 
dramatically during the complete length of the study, which is most likely driven 
by the dietary change at the start of the study from normal chow to low-fiber diet. 
Therefore, it is possible that this transition masked the effect of our treatments given 
via the drinking water on microbiota composition and SCFA production. Hence, we 
cannot draw firm conclusions on the effects of the ingredients tested due to the study 
set-up. Future studies investigating the effect of a dietary intervention on respiratory 
health should include a run-in period of at least a month for the microbiota to 
adjust to the low-fiber diet. Nevertheless, a strong increase in Akkermansia and 
Corynebacteria in mice receiving 3’SL and raw cow’s milk, respectively was noted at 
the day of sacrifice, which is considered as a beneficial microbe375.
The microbiota changed drastically during the first two weeks of the study due to 
the switch from normal chow to a low-fiber diet at the start of the study. In line with 
literature, the microbiota consisted at the start of this study mainly of Firmicutes and 
Bacteroidetes, which shifted towards dominance of the Firmicutes over Bacteroidetes 
after feeding the low-fiber diet for two weeks44. However, we show a continued 
decrease of Bacteroidetes during the entire duration of the study. This is indicative of 
adaptation to the low-fiber diet during the complete length of the study, but might 
theoretically also be driven by the OVA-induced asthma model. However, a very 
similar microbial shift was seen between day 0 and day 14 (i.e. just before first i.p. 
sensitization), suggesting that the low-fiber diet is the main driving factor of these 
changes. Hence, follow-up studies should include a run-in period of at least four 
weeks before investigating the effects of a dietary intervention in mice fed a low-fiber 
diet. Interestingly, a similar switch towards dominance of Firmicutes was seen in germ 
free mice inoculated with human microbiota from a low-fat polysaccharide-rich diet 
to a high-fat, high-sugar “Western” diet, which is also low in fiber376. These mice 
showed higher adiposity, which could be transferred to recipient gnotobiotic mice via 
the microbiota. In the present study we observed an increase in weight in the first 3 
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weeks of the study. However, this weight gain is exactly in line with the normal weight 
gain of 10 weeks old BALB/c mice377 and thus is likely not related to the low-fiber 
diet.
We further noted that mice fed with 3’SL have a lower abundance of Firmicutes and 
a higher abundance of Verrucomicrobia. The Verrucomicrobia found in this study are 
all from the genus Akkermansia. The genus Akkermansia consists of several species of 
which only one has been cultivated and which is suggested to contribute to various 
anti-inflammatory mechanisms375. The specific microbial changes between mice fed 
3’SL or 6’SL has been shown before in C57/BL6 mice, showing a significant increase 
of Verrucomicrobia and Akkermansia after receiving 3’SL-fortified chow compared to 
control chow378. Indeed, supplementation of non-fermentable carbohydrates to animal 
models have been shown to induce the abundance of fecal Akkermansia379,380. An 
increase in fecal Akkermansia after prebiotic supplementation in rats was shown to be 
indicative of higher mucin levels in the colon and postulated to improve gut health380. 
Others show improved growth in animal models fed with sialylated oligosaccharides158 
and the authors showed that the primary consumer of sialylated oligosaccharides in 
animal models is B. fragilis. This commensal bacterium was shown to induce the 
conversion of CD4+ T cells into FoxP3+ T cells by producing polysaccharide A (PSA) 
that promoted mucosal tolerance362. In contrast, in vitro batch cultures showed that 
3’SL and 6’SL are most efficiently metabolized by Bifidobacterium longum, resulting in 
the production of SCFA103. However, in this study no differences between treatment 
groups were found for the genus Bacteroides and Bifidobacteria were not detected. 
Nevertheless, a higher prevalence of Akkermansia in the colon and feces after prebiotic 
supplementation in rats was shown to correspond with higher colonic mucin levels 
and SCFA levels380. Despite the higher prevalence of Akkermansia in mice receiving 
3’SL, we did not find elevated SCFA levels in the caecum. We also observed significant 
microbial changes in mice fed with raw milk. However, this increase in Corynobacteria 
might be derived of the milk itself, which is present in cow’s milk381,382 and breast 
milk383. Even though these bacteria may be derived from the milk, it is of interest to 
note that breastfed children who were better protected against respiratory infections 
and wheezing in early infancy showed a higher abundance of Corynebacterium in 
the nasopharynx38.
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Conclusions
In this study we show a major shift in microbiota composition during the complete 
length of the study, which is most likely driven by the low-fiber diet. Therefore, the 
effects of dietary intervention might be masked by the microbial changes induced by 
the low-fiber diet. Nevertheless, mice that received 3’SL showed a significant increase 
in Akkermansia, that has been shown to contribute to immune homeostasis. Future 
studies should include a run-in period for at least four weeks if shifting mice from 
normal chow to a low-fiber diet before testing any dietary intervention.
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Figure S1. Feed intake and weight gain declines during the course of the study. (A) All mice were weighted 
at the start of the study, before the first and second sensitization and before sacrifice. Mouse weight at (B) the 
start of the study (t=0) and (C) at the end of the study. (D) Feed intake per cage.
Table S1. Feed consumption per mouse/day (grams).
Day 0-14 14-20 20-30
Raw milk 2.3 2.0 1.9
3’SL 2.4 2.2 1.9
6’SL 2.6 2.4 1.9
challenged 2.6 2.5 1.9
non-challenged 2.4 2.2 1.9
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Figure S2. Immunological parameters in OVA-induced asthma model. The percentage of (A) eosinophils, 
(B) monocytes, (C) neutrophils, (D) lymphocytes were determined BAL. (E) IL-5 was measured in the BALF. 
(F) OVA-specific IgE levels were measured in the serum.
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Figure S3. Microbial changes over time. Beta-diversity is shown by plotting (A) unweighted and (B) 
weighted unifraq scatter plots. Mean changes on microbial (C) class and (D) family are shown.
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group at the day of sacrifice was represented by the Shannon-index.
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Figure S5. SCFA levels in caecum samples. (A) Acetate, (B) propionate, (C) butyrate and (D) lactate were 
quantified in the cecum and normalized for the weight of the cecal content.
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In a growing world population in which chronic inflammatory diseases are on the rise 
and allergies and asthma affect 30-40% of the population384, there is a pressing need 
to understand underlying mechanisms to develop successful preventive strategies for 
these diseases. Recent advances in translational, clinical and mechanistic research 
provide evidence for the modulation of immune responses by dietary ingredients and 
natural products.
It is widely accepted that breast milk confers health benefits to the infant (e.g. increased 
cognitive ability, reduced gastrointestinal (GI) and respiratory infections, and reduced 
diabetes prevalence). Although there is some discrepancy in the current literature5 
that may be caused by individual differences in breast milk composition, most studies 
show that breast milk protects against the development of allergies and asthma. Raw 
cow’s milk consumption in early life has been associated with a significant decrease 
in the prevalence of allergies and asthma. Raw cow’s milk contains components (e.g. 
tumor growth factor (TGF) β, lactoferrin (LF), immunoglobulins (Igs), and vitamin 
D3 (VitD3)) that are also present in breast milk. These bovine components are 
highly homologous to their human counterpart and might be functionally active on 
human immune cells. Hence, raw cow’s milk may be an important source to deliver 
functional components that can potentially be applied in infant nutrition, and that 
may aid in inducing and maintaining immune homeostasis. The aims of this thesis 
were therefore:
1. To address the effect of components that are present in raw cow’s milk 
on human immune function
2. To investigate the effect of sialyllactose on barrier functioning and 
microbiota composition
3. To describe implications of these findings for respiratory health
In this discussion, I will discuss the implications of our findings and provide 
considerations for future research to continue with this line of research.
Which factors in raw cow’s milk protect against allergies 
and asthma?
In chapter 2 we described potential mechanisms by which raw cow’s milk components aid 
in mucosal immune homeostasis and immune functioning in the upper respiratory tract 
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and intestine371. We did not aim to describe the full array of potential immunomodulatory 
components in bovine milk since excellent reviews are already available describing the 
immunomodulatory effects of milk proteins and peptides73,385, exosomes307,386, fatty acids387, 
microbes388, and sialylated oligosaccharides78. The basis for the proposed mechanisms of 
cow’s milk mediating immune homeostasis in the respiratory tract as described in chapter 
2, are based on epidemiological studies. We here further elaborate on these studies to 
discuss the background of this thesis. Several epidemiological studies showed inverse 
associations between farm milk consumption in early life and the prevalence of allergies 
and asthma85,86,88,368,369 or respiratory tract infections66. Most of these studies specify that 
the consumed cow’s milk was essentially unprocessed66,85,86,88,368,369, while one study defined 
it as “farm milk”85. Only two studies compared the consumption of different heated and 
processed milks in early life on respiratory health66,88. Loss et al. (2011) collected cow’s 
milk that was consumed on the farm itself and specified the heating status of the milk 
by reporting the residual enzyme activity and whey and fat concentrations in the milk. 
This study allowed for the first time to associate individual milk fractions with the risk of 
developing asthma or allergies. Importantly, the authors showed that the whey fraction 
and not the total protein concentration, the viable bacterial count or total fat content 
was associated with the risk of developing asthma or allergies88. These epidemiological 
findings thus exclude the possibility that heat-stable bacterial-derived components such 
as Toll-like receptor (TLR) ligands (e.g. lipopolysaccharide (LPS)) or total bacterial 
counts are protective factors in the cow’s milk. Of note, although pathogenic bacteria 
(e.g. Listeria monocytogenes) are reduced after heating of the milk, it is also plausible 
that probiotic bacteria are killed by the heat treatment388. It is therefore possible that, 
although the reduction in total bacterial counts did not correlate with allergy and asthma 
prevalence, the decline of specific probiotic bacterial species does correlate with allergy 
and asthma prevalence. A second study was based on weekly diaries in which parents 
specified the quantity and the type of milk (i.e. ultra-heat treated (UHT), pasteurized 
or boiled) that was consumed by their neonate. This study confirmed that raw cow’s 
milk consumption in early life improved respiratory health later in life as observed by 
a reduced odds ratio’s for rhinitis, respiratory tract infections, otitis and fever66. Thus, 
based on these epidemiological findings, heat instable components and particular whey 
proteins are of interest for mechanistic studies. The top five most abundant whey proteins 
are β-lactoglobulin, α-lactalbumin, bovine serum albumin, Igs and LF389. Hence, due 
to their high abundance and known immunomodulatory effects Igs and LF, as well as 
TGFβ (present in lower amounts), are of special interest as functional proteins for infant 
formulas.
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Bovine milk ingredients and homeostasis in the upper 
airways
The upper airways of infants are constantly exposed to allergens and viral antigens. 
Since viral infections and allergen exposure are risk factors for asthma development, we 
speculated in chapter 2 that bovine milk components can contribute to maintaining 
local immune homeostasis in mucosal tissues. The upper and lower airways are clearly 
linked, as was shown by a high percentage of asthma patients (i.e. 88%) suffering from 
allergic rhinitis117. In our review, we proposed that bovine Igs can neutralize allergens 
or viruses. We also speculated that bovine IgG (bIgG):allergen complexes may induce 
regulatory immune responses, as was shown for human IgG15,16 and murine IgG14. 
Although bIgG is reported to bind house-dust mite (HDM) extract112, we measured 
a very low specificity of bIgG to the two main allergens of HDM. The low specificity 
of bIgG to recombinant Der-p1 and Der-p2 (data not shown), indicates that bIgG 
recognizes a different HDM allergen. Ingested antigens can come into contact with 
the palatine and lingual tonsils in the upper airways. Interestingly, a novel mechanism 
involving a tightly regulated interplay between innate group III lymphoid cells (ILC3) 
and B cells was discovered in the palatine tonsils36. The authors showed that ILC3 
produced B cell activating factor (BAFF) that activated interleukin (IL) 15 production 
by B cells. IL-15 in turn upregulated CD40 ligand (CD40L) expression on tonsillar 
ILC3 that stimulated survival, IL-10 production and programmed death (PD) L1 
expression by B cells36. Since allergic patients showed a reduced ILC3 frequency in 
palatine tonsils, the authors proposed that these cells are essential for maintaining 
immune homeostasis. These ILC3 also promoted barrier functioning in the gut20. 
Their role in upper airway epithelium is however unknown. It is an interesting thought 
that dietary ingredients or immune complexes may impact the induction of regulatory 
B cells in the tonsils. A recent study by Byars et al indicated that surgical removal of 
tonsils and adenoids early in life are associated with long-term risk of upper airway 
infections and allergic diseases390. Nevertheless, the role of the tonsils in oral tolerance 
induction in early life remains poorly understood and requires more research.
Sialylated oligosaccharides, LF and TGFβ in the GI tract
In chapter 3 and chapter 6 we investigated the effects of bovine LF and TGFβ on 
monocyte differentiation. Since most proteins are degraded in the small intestine, 
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we will initially discuss the bioavailability of these proteins in infants. LF is poorly 
digested by infants and is found back in their urine and stool197, and in blood and 
lymphatics of mice and piglets after oral supplementation201,391. In the intestine of 
cows, a higher binding affinity of LF was found at the epithelium overlaying Peyer’s 
Patches, indicating uptake of LF via microfold cells392. LF was shown to bind to 
human LF receptor (intelectin-1) on human epithelial cells in vitro and induced the 
production of TGFβ77.
Early studies in TGFβ1 knock-out mice showed that exogenous milk-derived TGFβ 
becomes systemically available and is essential for normal development393. Since 
TGFβ derived from human and cow’s milk is structurally identical73, cow’s milk 
might be an important source of TGFβ. TGFβ binds to its receptor that is expressed 
on intestinal epithelial cells. The TGFβ receptor (TGFβR) family consists of two 
structurally different transmembrane serine/threonine kinases TGFβR (type I and II). 
Upon binding of TGFβ to these receptors, it binds to accessory proteins and initiates 
intracellular SMAD (in)dependent signaling that subsequently induces regulation 
of several genes394. Human epithelial cells express TGFβRI, which was also found 
on duodenal biopsies of human infants (aged from 7-120 days) with food protein-
induced enterocolitis395. Thus, milk-derived LF and TGFβ are actively taken up into 
the mucosa of the intestine and may even become systemically available in infants.
Unlike humans, cows produce very low amounts of milk oligosaccharides. The 
oligosaccharides that are present in cow’s milk are sialylated oligosaccharides of which 
the structurally simple trisaccharides 3'-sialyllactose (3’SL) and 6'-sialyllactose (6’SL) 
are predominantly present78. A small fraction of these oligosaccharides is taken up 
in the circulation and the majority is fermented in the colon to short-chain fatty 
acids (SCFA) where they may modulate immune cells and microbiota composition, 
respectively40.
Dendritic cells and oral tolerance
To date, immunotherapy to treat allergies consists of oral tolerance induction by 
administering different dosages of allergens. Although the exact mechanism is poorly 
understood, allergen immunotherapy results in the expansion of allergen-specific 
regulatory T cells (Tregs) that are essential for the suppression of allergen-specific IgE 
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production and allergic inflammation396. In addition, the IgG4/IgE ratio is increased 
upon immunotherapy. This may further reduce IgE-receptor mediated T cell activation 
and mast cell degranulation, since IgG4 blocks binding of IgE to FcεR397. In early 
life, it is thought that oral tolerance induction to breast milk components is essential 
to maintain immune homeostasis and prevent allergen sensitization. This could be 
mediated by the induction of a regulatory milieu by breast milk components that 
allows the suppressive responses towards allergens34. Such a form of aspecific tolerance 
induction was effective to suppress allergic inflammation, as shown in mouse models 
using in vitro generated IL-10-treated dendritic cells (DC)398,399. Recent evidence 
implicates that a local microenvironment consisting of dietary and microbial factors 
are essential to instruct DC to maintain immune homeostasis in the GI tract. Hence, 
the induction of tolerogenic DC may be a promising strategy to prevent inflammation. 
In chapters 3, 5, and 6 we therefore investigated the effect of bovine milk components 
on human DC functioning.
To study this immunoregulatory effect of bovine milk components on DC, we used 
monocyte-derived DC (moDC). moDC are often used as a model for DC functioning, 
since the numbers of CD34+ pre-classical (pre-DC) or mature DC in adult human 
blood are limited. Conventional DC (cDC; i.e. all DC, except plasmacytoid DC 
or pDC) arise from monocytes or pre-DC. cDC express high levels of CD11c and 
major histocompatibility complex (MHC) class II molecules. Monocytes and pre-
DC originate from a common macrophage-DC progenitor that differentiates into 
a monocyte progenitor or a common DC progenitor that gives rise to pDC and 
pre-DC23,400. These pre-DC differentiate into two distinct circulating DC types (i.e. 
CD141+ and CD1c+) or tissue-specific DC types23. Differentiation of DC is highly 
dependent on environmental signals (e.g. cytokines like FMS tyrosine kinase 3 ligand 
or Flt3L) that drive expression of selective transcription factors. cDC thus originate 
from monocytes or pre-DC that may respond differently upon environmental 
exposure. In chapter 3, 5 and 6 moDC were used as a model study the effect of 
bovine milk components on human DC differentiation and function. It is therefore 
essential to first discuss the relevance of these cells in the GI tract.
Tolerogenic CD103+ DC in the gut – Induction of Tregs
Most of our knowledge of DC biology in the GI tract is derived from experiments 
performed in mice. In the gut, a local microenvironment comprised of dietary 
components and microbial- or epithelial-derived molecules induce differentiation 
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of pre-DC into DC expressing CD10325. These CD103+ DC express retinal 
dehydrogenase (RALDH) that is capable of converting dietary vitamin A into 
retinoic acid (RA). This production of RA and local TGFβ aids in the capacity of 
CD103+ DC to induce polarization of naive T cells into Forkhead box P3+ (FoxP3+) 
Tregs180. Although CD103+ and CD103- DC can both migrate to the mesenteric 
lymph node (MLN) to prime naïve T cells28, only CD103+ DC have the unique 
capacity to induce polarization into tolerogenic T cells that express the gut-homing 
receptors α4β7 and C-C chemokine receptor (CCR) 9 (Figure 1)25,26. In mice, these 
CD103+ DC derived from pre-DC and were essential for oral tolerance induction401. 
However, human moDC that were cultured in the presence of RA expressed CD103 
and were capable of inducing Tregs27,160. In humans, it is therefore possible that also 
monocytes contribute to the pool of CD103+ DC that prime naive T cells to become 
tolerogenic T cells. Additionally, although recent studies performed in mice indicate 
that monocytes are less important in inducing oral tolerance, in the next section we 
discuss the importance of monocytes in maintaining oral tolerance.
Monocytes and moDC maintain oral tolerance
Monocytes have a short half-life of 22 days in the periphery and were originally merely 
seen as precursors for macrophages and DC402. However, recent evidence shows that 
monocytes do not always differentiate after extravasation and are capable of sampling 
antigens in the tissue and recirculate to draining lymph nodes403. Additionally, 
monocytes give rise to CX3C chemokine receptor 1+ (CX3CR1+) macrophages 
that are essential to suppress inflammation in the gut404. These CX3CR1+ cells are 
distinct from CD103+ DC as shown by their capacity to sample antigens directly 
from the gut lumen and their poor T cell stimulatory capacity405. Compromising 
80% of all MHC class II-expressing cells in the colon, CX3CR1+ macrophages are 
the dominant antigen presenting cell that release high levels of IL-10 in response 
to microbiota30,293. A similar distribution of these monocyte-derived cells was 
suggested to reside in the human and mouse ileum30. Interestingly, these CX3CR1+ 
macrophages were shown to induce expansion of Tregs in the lamina propria by 
presenting antigens in this local tolerogenic microenvironment that aided in oral 
tolerance induction406. CD103-CX3CR1+ mouse DC are similar to a population of 
CD103-Sirpα+ DC in the human small intestine, which were transcriptionally related 
to blood monocytes407. Although these cells expressed lower levels of CCR7 compared 
to CD103+Sirpα+ DC, these monocyte-like DC might be able to migrate to the 
MLN as well407. Collectively, these studies show that the local microenvironment 
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in the GI tract, driven by microbial and dietary products, allows a constant state of 
primed homeostasis or sterile inflammation, which induces monocyte migration into 
tissues. Under homeostatic conditions, these monocytes may thereby contribute to 
the maintenance of regulatory responses by inducing Treg expansion in the lamina 
propria30,31 (Figure 1).
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Figure 1. Distinct roles for monocytes and DC in oral tolerance. In homeostasis, the intestine is in a constant 
state of low-grade inflammation (“primed homeostasis”) that is driven by exposure to microbial compounds. This 
results in a constant influx of monocytes that differentiate by unknown factors into distinct subsets of monocyte-
derived cells. The subpopulation of monocyte-derived CX3CR1+ macrophages are shown to be essential in 
maintaining homeostasis by secreting IL-10 and RA. It is to date unknown whether monocytes give rise to 
CD103+ DC. These DC migrate to the MLN to prime naive T cells to polarize into Tregs expressing gut homing 
markers (e.g. α4β7 and CCR9). *Sirpα+CD103- in human intestine are transcriptionally related to CX3CR1+ 
phagocytes in the lamina propria of mice.
Bovine milk components and human DC differentiation
In chapter 3, 5 and 6 we investigated the effect of milk components on the 
differentiation of monocytes into moDC and their responsiveness upon exposure to 
different TLR ligands. We aimed to investigate whether bovine milk ingredients are 
capable of inducing the differentiation of monocytes into tolerogenic DC.
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Human monocytes can differentiate in the presence of RA into CD103+ DC, which 
were shown to induce Tregs27,160. None of the bovine components tested induced 
differentiation into CD103+ DC (data not shown). The moDC differentiated in the 
presence of bovine milk components expressed CD11c, human leukocyte antigen 
(HLA) DR and similar expression levels of CCR7, showing that the monocytes 
differentiated into moDC. Nevertheless, the functionality of these moDC largely 
depends on environmental factors, as these “moDC” may also express more classical 
monocyte or macrophage markers. Hence, classification of monocyte-derived cells 
into DC or macrophages in remains controversial. Hence, these monocyte-derived 
cells are to date often termed as monocyte-derived phagocytes. In this thesis, we 
referred to our monocytes cultured in the presence of IL-4 and granulocyte-
macrophage colony stimulating factor (GM-CSF) as DC. However, even in this in 
vitro system it is challenging to define a true DC. For instance, VitD3-induced DC 
(VitD3DC) show low expression of DC-specific intracellular adhesion molecule 
(ICAM)-grabbing non-integrin (SIGN), retain CD14 expression and show lower 
HLA-DR expression (chapter 6), indicating that these VitD3DC are more ‘monocyte-
like cells’ than moDC generated in the presence of only IL-4 and GM-CSF.
Bovine milk components halt CD1a expression: a marker of DC 
differentiation
Monocytes differentiated in the presence of IL-4 and GM-CSF lose expression of their 
pan monocyte marker CD14 and gain expression of CD1a during differentiation. 
CD1a was initially described as a marker for Langerhans cells and is now known to be 
also expressed on DC in different tissues, including the human colon408. However, the 
functionality and expression of CD1a on DC subsets in vivo remains largely unknown. 
Nevertheless, we will discuss here that CD1a expression marks DC differentiation and 
determines the responsiveness of DC to TLR stimulation, which may consequently 
alter T cell polarization. Interestingly, in chapter 3, 5 and 6 we showed that LPS, 
TGFβ, VitD3, and LF inhibited CD1a expression that results in a DC phenotype 
that is hyporesponsive towards LPS or polyinosinic-polycytidylic acid (Poly:IC) + 
resiquimod (R848) stimulation. Moreover, in chapter 3 and chapter 6 we showed 
that LF and TGFβ respectively inhibit CD1a expression, while we showed in chapter 
5 and 6 that DC differentiated in the presence of LPS or VitD3 remain CD14+ and 
do no gain CD1a expression.
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Milk-induced modulation of DC differentiation via distinct pathways
Several mechanisms may underlie the altered DC differentiation pattern induced 
by selected bovine milk components. In chapter 5 and 6 we observed that, besides 
exposure to VitD3, LPS contamination also halts DC differentiation as shown by 
their CD14+CD1a- phenotype on LPS-DC and VitD3-DC. In literature it was 
shown that a common factor upon exposure of monocytes to TLR ligands and 
VitD3 is the production of suppressor of cytokine signaling (SOCS) 1288,304. SOCS1 
production was boosted by VitD3 via the suppression of microRNA (miRNA) 155304. 
Suppression of miRNA-155 in turn hampered IL-12p70 production by DC409. 
Indeed, SOCS1 inhibits the generation of a pro-inflammatory response and halts 
DC differentiation by loss of sensitivity to GM-CSF285,288. In chapter 6 we showed, in 
line with others, that VitD3 induces specifically high levels of IL-6 that induce PD-
L1 expression295. Although, we observed a non-specific production of IL-6 by moDC 
that were differentiated in the presence of LPS, IL-6, signal transducer and activator 
of transcription (STAT) 3 dependent expression of PD-L1 has also been described 
for these TLR exposed DC287. However, IL-6 production is abrogated early during 
DC differentiation (as shown in chapter 5), which may be regulated by SOCS3 that 
induces a negative feedback loop dampening autocrine IL-6 production285. It has 
been shown that the selective production of IL-6 may induce DC differentiation 
into tolerogenic DC286. Indeed, an early study showed that IL-6 activates STAT3 
and halts DC differentiation, promoting the number of resting immature DC that 
are hyporesponsive upon TLR stimulation (i.e. tolerogenic) in lymph nodes and 
spleen410. However, more recent studies show that blocking STAT3 by SOCS1 is an 
important therapeutic target for halting DC differentiation and inducing tolerogenic 
DC411–413. Thus, a complex interplay between cytokine production, STAT3 activation 
and SOCS proteins regulates DC differentiation. The underlying mechanism by 
which VitD3 and LPS may block DC differentiation and induce tolerogenic DC 
involves IL-6 production by monocytes. This results in STAT3 activation, PD-L1 
expression and SOCS3 production. Subsequently, SOCS3-incuded dampening of 
IL-6 production may repress STAT3 expression and allow SOCS1 to suppress GM-
CSF signaling. Suppression of GM-CSF signaling by TLR ligands and VitD3 thereby 
halts differentiation as shown by increased CD14 and low CD1a expression.
In contrast to DC cultured in the presence of VitD3 or LPS that do not completely 
lose CD14 expression, we demonstrated in chapter 3 and 6 that DC cultured in the 
presence of bovine LF or TGFβ do lose CD14 expression. Although all these bovine 
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milk components have in common that they halt CD1a expression on immature DC, 
their differential expression of other surface markers (e.g. CD14) indicates that their 
effect is mediated via distinct pathways. We showed that 10 µg/ml LF did not induce 
the production of tumor necrosis factor α (TNF), IL-10 or IL-6 and yet halted CD1a 
expression, indicating that IL-6 production was not the driving factor. Although 
we cannot exclude that other cytokines (e.g. IL-8) are responsible for halting CD1a 
expression, it seems that there is a different mechanism responsible. We postulate that 
LF may directly modulate gene transcription since LF can be taken up and internalized 
into the nucleus of monocytes147. Transfection experiments of the LF gene in a human 
embryonic cell line showed that LF inhibits GM-CSF expression216. Future research 
should investigate the role of SOCS1 in the LF-induced differentiation of monocytes 
into tolerogenic DC. Similarly, TGFβ modulates DC differentiation that were initially 
described to be morphologically and functionally similar to Langerhans cells306. In 
line with literature297, we showed in chapter 6 that TGFβDC express a distinct array 
of phenotypic markers (e.g. CD80, PD-L1) compared to VitD3DC, indicating that 
differentiation is modulated via distinct pathways. However, the exact mechanism 
by which TGFβ halts DC differentiation is unknown. Importantly, monocytes 
cultured solely in the presence of IL-4 differentiated into a DC type expressing low 
CD1a levels215. Similarly, moDC cultured in the presence of components present in 
bovine milk such as VitD3, TGFβ and LF express lower CD1a levels compared to 
conventional moDC, indicating that these bovine milk components inhibit GM-CSF 
signaling. Interestingly, novel evidence implies that the microbiota also modulates 
GM-CSF signaling, which was essential for the induction of oral tolerance414 and 
protection against respiratory infections415. ILC2 are now known to play an essential 
role in lung immunity416. Microbial stimuli were shown to enhance the production 
of GM-CSF via macrophage-derived IL-1β that triggers GM-CSF production by 
ILC2, which enhanced mononuclear phagocyte effector functioning and increased 
Tregs numbers414. This is in line with earlier findings showing that monocyte-
derived cells are essential for oral tolerance induction406 (Figure 1). Thus, based on 
our in vitro data, we postulated that not only microbial products but also dietary 
ingredients modulate GM-CSF signaling (Figure 2). Future research should elucidate 
the relationship between dietary and microbial-induced GM-CSF production and its 
effect on monocyte differentiation.
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Figure 2. Bovine milk components halt DC differentiation by blocking GM-CSF signaling. In this thesis, 
we showed that VitD3, TGFβ, LF, and LPS halt differentiation of monocytes into moDC. We suggest that these 
components block GM-CSF signaling that results in hyporesponsiveness of the moDC towards TLR ligands, 
which could be important in immune homeostasis.
CD1a as a marker for tolerogenic DC
Thus, LF, TGFβ, VitD3 and LPS all hamper CD1a expression, which might be caused 
by reduced activity of GM-CSF. After six days of differentiation, we stimulated these 
distinct DC types with TLR ligands and assessed their responsiveness. Interestingly, 
we showed that these DC were hyporesponsive to LPS or Poly:IC and R848, as 
was most profoundly observed by abrogated production of IL-12p70. This is in line 
with earlier studies that showed an abrogated production of IL-12p70 by CD1a- 
cells212,213,417. Additionally, other reports showed that CD1a- DC were capable of 
decreasing IFNγ production212,213,417 and increasing IL-10213  by T cells compared to 
T cells that were polarized by CD1a+ DC. This suggests that CD1a- DC are prone 
to induce T cells with regulatory functions. CD1a- DC are also found in vivo in 
the circulation and secondary lymphoid organs. These DC produce IL-10 and are 
CD14+HLA-DR+CD11c+, which shows that they relate to monocytes and also have 
regulatory functions in vivo144.
Other markers of tolerogenic DC
DC that were differentiated in the presence of bovine milk components (i.e. VitD3, 
TGFβ, LF and LPS) showed to be hyporesponsive towards TLR ligands. These DC 
showed a reduced expression of all costimulatory molecules measured (e.g. CD80, 
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CD86), but also inhibitory molecules (e.g. PD-L1 and inducible T cell costimulator 
ligand) and production of all cytokines measured (e.g. not only IL-12p70 but also 
IL-10, TNF, IL-6) compared to moDC cultured in the absence of bovine milk 
ingredients. Hence, the question is whether these DC are truly tolerogenic. Previous 
work showed that DC that have a lower expression of costimulatory molecules (i.e. 
showing a semi-mature phenotype) are associated with tolerance induction in vivo and 
in vitro418,419. Indeed, semi-mature DC and soluble factors such as TGFβ and RA are 
required for the polarization of naïve T cells into Tregs162,420. In line with our findings, 
Unger et al. (2009) showed that VitD3 induced PD-L1 expression on immature DC. 
However, after maturation VitD3-DC show lower expression of PD-L1 compared to 
moDC. Nevertheless, this PD-L1 expression on VitD3-DC was essential to induce 
Tregs. The authors proposed that the ratio of PD-L1/CD86 expression determined 
the potential of the DC to induce tolerogenic responses295. However, human 
moDC cultured in the presence of RA expressed CD103 and fully matured upon 
stimulation27. Yet, these RA-DC were capable of inducing differentiation of naïve T 
cells into IL-10 producing T cells and FoxP3+ T cells when cultured in the presence 
of TGFβ. Indeed, DC expressing high levels of costimulatory molecules were also 
shown to be capable of expanding CD4+CD25+ T cells421. Thus other signals such 
as indoleamine 2,3-dioxygenase expression, the capacity to activate cytotoxic T 
lymphocyte antigen (CTLA) 4 on T cells422 and the production of anti-inflammatory 
soluble mediators such as RA, TGFβ and IL-10 also determine the tolerogenic nature 
of the DC145,162,398. Hence, it is essential for future studies to follow-up on our work 
investigating the effect of our DC phenotype on the polarization and chemokine 
receptor expression of T cells.
Nutritional immunology or endotoxin tolerance?
In nutritional immunology, many researchers work with naturally derived food or 
feed products. One of the major challenges is to isolate the components of interest 
without endotoxins. These endotoxins can mask the true immunogenicity of the 
food compound or give false positive results. The gram-negative bacterial cell-wall 
constituent LPS is one of the major contaminants that can be responsible for false 
positive results due to its high immunogenicity on myeloid cells. Hence, in chapter 4 
we optimized a method using Triton X-114 to remove LPS from food proteins. Triton 
X-114 is an amphiphilic (i.e. contains hydrophilic and lipophilic traits) molecule that 
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can be used to remove LPS from aqueous solutions by a simple bilayer separation. 
Since we showed that the introduction of Triton X-114 inhibits cell viability, 
gives false positive results in LPS detection (limulus amebocyte lysate) assays and 
immunogenicity210, it is essential to remove the Triton X-114 traces after removing 
LPS from the sample. We showed that Triton-binding beads are the most efficient 
method and that the protein structure of bovine β-lactoglobulin and soy proteins 
remains identical after applying this method210. In chapter 3, we applied this method 
to remove LPS from a LF concentrate. Although we observed a fivefold reduction in 
LPS in the sample, complete removal of LPS was unsuccessful. We hypothesized that 
the Triton X-114 method was not able to remove all LPS due to the high binding 
affinity of LPS to LF208,423 and that the method only removed non-bound LPS in 
aqueous solutions. The LF concentration was unaltered after applying the method, 
showing that the LF is not caught in the lipophilic fraction, possibly because its 
interaction with LPS is based on charge and not on hydrophobicity424. In contrast, 
molecules carrying highly hydrophobic domains will be caught into the hydrophobic 
layer. Indeed, Triton X-114 has been successfully used to extract membrane proteins 
(that have highly hydrophobic domains) from total cell lysates261. As such, we showed 
that the Triton X-114 method removed major HDM allergen Der-p2 from HDM 
extract (Figure 3). The Triton X-114 method is therefore unsuitable to remove LPS 
from proteins with highly hydrophobic domains. On the other hand, it is an efficient 
method to remove specific hydrophobic molecules such as Der p 2. Der p 2 is a 
lipid-binding protein highly homologous to myeloid differentiation 2 (MD2) that 
binds hydrophobic molecules such as LPS425,426. Our optimized method is thus not 
applicable to remove all LPS from proteins with hydrophobic domains (e.g. membrane 
proteins) or proteins that bind LPS (e.g. LF). Therefore, in chapter 3, we applied 
proteinase K treatment to degrade LF instead of aiming to further remove LPS from 
LF. Of note, proteinase K treatment did not affect the capacity of LPS to activate 
NF-kB signaling via TLR4. Hereby we showed that the LF-induced effects on DC 
functioning were completely abrogated after proteinase K-mediated degradation of 
LF, showing that the protein structure is essential for its immunomodulatory effect.
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Figure 3. Triton X-114 method applied to HDM extract removes Der p 2. HDM extract (ALK-Abello) was 
treated with Triton X-114 to remove LPS. This HDM extract was loaded on SDS-PAGE gel before and after 
application of the Triton X-114 method. The arrow points toward the missing band of Der p 2 (15.6kDa).
LPS in sialyllactose
In chapter 5 we showed that LPS contamination in commercially available 3’SL 
results in differentiation of monocytes into tolerogenic DC. The concept of endotoxin 
tolerance upon exposure to LPS is a well-known and accepted phenomenon. In 
particular myeloid cells are highly sensitive to LPS262. In line with an earlier study 
performed in mice156, we showed that LPS contaminated 3’SL and not 6’SL induced 
signaling via TLR4 that induced the differentiation into tolerogenic DC157. In chapter 
5 we showed that 0.5 EU/ml of LPS induced the differentiation into tolerogenic 
DC. In chapter 6 we showed that even small traces of 0.17 EU/ml as measured in 
6’SL, did not induce phenotypical changes on DC, and induced the production 
IL-6 and IL-8 during DC differentiation. The in chapter 4 optimized Triton X-114 
method showed to be a valuable method to remove these LPS traces in oligosaccharide 
preparations. Removal of LPS showed that 3’SL, 6’SL, galactooligosaccharide (GOS) 
and 2-fucosylalactose (2’FL) do not modulate DC differentiation or functionality.
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Prebiotics, human milk oligosaccharides and TLR4 signaling
Infant nutrition is nowadays often supplemented with synthetic or plant-derived 
prebiotic oligosaccharides. Due to the wide variety of health effects attributed to 
the presence of human milk oligosaccharides (HMO)40, it is of interest to discover 
functional HMO that can be isolated from cow’s milk. HMO and prebiotic 
oligosaccharides are suggested to directly modulate immunity since a small fraction is 
absorbed in the intestine into the bloodstream where they are postulated to directly 
affect the immune system.
One of the receptors that has been described in literature to mediate both anti- and 
pro-inflammatory immune responses is TLR4. Several studies show that the prebiotics 
inulin and fructooligosaccharides (FOS)270,271, 3’SL156, a 9:1 mixture of short-chain 
GOS/long-chain FOS272 and GOS271 induce immune responses via interacting 
with TLR4. In Chinese medicine a variety of other natural polysaccharides are 
used that - depending on their structural composition – are shown to induce TLR4 
signaling283. However, in chapter 5 we showed that LPS contamination could result 
in false conclusions drawn with regard to the immunomodulatory capacity of 3'SL. 
Hence, an important question that was raised is whether it is possible that simple or 
structurally more complex oligosaccharides can actually induce TLR4 signaling.
Although TLR4 signaling is triggered by exposure to a wide variety of molecules, 
the exact interaction of TLR4 and its ligand remains largely unknown. However, the 
interaction of TLR4 with LPS has been extensively researched. LPS initially interacts 
with several proteins including the LPS binding protein (LBP) that shuttles insoluble 
lipids such as LPS or phospholipids427 to CD14, which in turn facilitates binding 
to the MD2:TLR4 complex228. This complex formation results in recruitment of its 
downstream adaptor proteins (including MyD88 and TRIF) that induce downstream 
signaling resulting in nuclear factor (NF) kB activation228. The interaction of LPS with 
MD2:TLR4 has been studied in great detail. LPS contains a highly immunogenic 
part, which is the amphipathic lipid A tail. The lipid A part of Escherichia coli-derived 
LPS consists of two phosphorylated glucosamines that are connected to six lipid 
chains428. MD2 has two anti-parallel β-sheets that form a large hydrophobic binding 
pocket for hydrophobic molecules such as LPS. These long lipid chains of LPS are 
essential for the interaction with the hydrophobic binding pocket of LPS428.
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Although conventional chemical models are capable of predicting specificity of 
antibodies to antigens and peptides that fit into the MHC groove, it remains difficult 
to predict ligand:TLR interactions due to difficulties defining the crystal structural 
of the ligand-binding domain of TLRs429,430. A wide range of self (damage associated 
molecular patterns; DAMPS) and exogenous molecules (pathogen associated 
molecular patterns; PAMPS) have been shown to activate TLR4431. Although there 
is evidence showing evolutionary pressure on the ligand-recognition domain of 
TLRs430, TLR4 signaling is very conserved between species. It was therefore suggested 
that there must be a very basic mechanism that allows recognition of this wide range 
of ligands. Seong and Matzinger (2004) proposed that the common factor of the 
ligands that bind TLR4 is the hydrophobic portions that docks into the MD2:TLR4 
pocket. They propose that hydrophobicity is the common evolutionary driver for 
TLR4 signaling. On the one hand the hydrophobic nature of phospholipids is 
essential to dissociate between the interior milieu of cells and the outside world and 
is thus crucial for life. On the other hand, hydrophobic domains tend to cluster 
together, forming aggregates that are harmful for the cell. Hence, humans have 
evolved to express a wide array of chaperone proteins (e.g. heat-shock proteins (HSP)) 
that shield hydrophobic groups of e.g. LPS432. Intracellular release of HSP thereby 
signals to the cell that cell-damage is being controlled, which results in induction 
of anti-inflammatory responses433. Sudden release of hydrophobic molecules is 
therefore a sign of cellular damage that the immune system should react upon429. 
Pathogens such as viruses use fusion proteins with highly hydrophobic domains to 
enter host cells and PAMPs (e.g. LPS, peptidoglycans, lipoteichoic acid and even the 
supermolecular organization of RNA) have large hydrophobic structures429. Thus, 
TLR4 signaling is triggered by molecules with hydrophobic domains that can dock 
into the MD2:TLR4 pocket. Therefore, there is structurally no grounded reason to 
assume that hydrophilic components such as HMO and prebiotic oligosaccharides 
should interact with TLR4 on immune cells.
Sialyllactose and GOS affect microbiota composition and 
SCFA production
The establishment of a stable microbiome runs in parallel to immune maturation 
in early life. This microbial community remains stable later in life and alteration are 
shown to increase the risk of several diseases434. Microbial colonization in early life is 
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driven by a few crucial events such as vaginal delivery and breast milk. The microbial 
composition is shaped upon vaginal delivery that enriches bacteria of the genera 
Bifidobacterium and Bacteroides39. In the first weeks, the microbiota gradually changes 
from a community with facultative anaerobic bacteria to a community comprised of 
obligate anaerobic bacteria (e.g. Bacteroides fragilis and bifidobacteria)435. Thereafter 
in the first months of life, breast milk is essential to further shape the microbiota 
composition. We already know now for almost fifty years that the high amounts 
of HMO in breast milk drive the dominance of bifidobacteria40. Since HMO are 
postulated to exert a wide range of beneficial effects, our hypothesis was that finding 
HMO that aid in establishing a microbial community most similar to breast milk 
may be essential for improving the health of the infant. Moreover, breastfeeding 
results in the outgrowth of bifidobacteria, lactobacilli and B. fragilis that are thought 
be important in achieving tolerance in early life and are associated with lower 
allergy prevalence37,434. Perturbation during the important colonization phase in 
early life may result in different bacterial compositions (i.e. enterotypes) that are 
associated with allergic disease. As such, a microbial colonization pattern consisting 
of Akkermansia, Ruminococcus gnavus, and Lachnospiracaea are associated with lower 
atopic dermatitis incidence436. In line with this finding, another recent study showed 
that the abundance of Akkermansia in the gut is negatively associated with asthma 
risk437.
Recently, SL gained a lot of interest because of its postulated health effects and due to 
the fact that it can be easily isolated from bovine milk78. Infant formulas are nowadays 
often supplied with prebiotic oligosaccharides such as GOS and FOS, which 
are synthetically-derived polymers of lactose and plant-derived oligosaccharides, 
respectively. This prebiotic mixture of GOS/FOS in a 9:1 ratio is often used and was 
shown to induce the outgrowth of Bifidobacteria compared to infant nutrition not 
supplemented with these prebiotics324–328. Nevertheless, compared to breastfed infants, 
formula-fed infants show a more diverse microbial profile than breastfed infants and a 
decrease in the genera Bifidobacterium (e.g. B. longum) and Lactobacillus while the genus 
Bacteroides (e.g. B. adolescenentis) and Clostridium species are more abundant39,438. In 
chapter 7 we investigated the effect of SL and GOS on microbiota composition using 
fecal batch cultures. Interestingly, we showed that GOS predominantly induced the 
outgrowth of Bifidobacteria, while SL induced the outgrowth of Bacteroides, including 
Bacteroides fragilis but also other bacteria such as Feacalibacterium prausnitzii. 
Bacteroides is a genus of bacteria that contains many species capable of fermenting 
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plant-derived polysaccharides439. The fact that Bacteroides are main fermenters of 
plant-derived fibers is in line with reports showing that infants of four months of age 
that are not exclusively breastfed show a higher abundance of Bacteroides in the feces 
compared to exclusively breastfed infants39. A recent study showed that LPS derived 
from Bacteroides induced immune silencing in early life rather than immune priming 
(e.g. as induced by E. coli-derived LPS). The authors show that this immune silencing 
may induce the development of early onset auto-immune diseases275. Additionally, 
sialic acid becomes available upon fermentation of SL that can be potentially utilized 
by pathogenic bacteria359. On the other hand, we showed that SL induced the 
outgrowth of species such as Fecalibacterium prausnitizii and B. fragilis that have anti-
inflammatory effects362,365,366. Additionally, SL was also essential for growth in stunted 
infants mediated via microbiota-derived metabolites158. Thus, future research should 
further investigate the effect of SL on microbiota (e.g. risk of outgrowth of pathogenic 
and probiotic bacteria), subsequent metabolite production and immune functioning 
in animal models before moving to clinical trials. We confirm the bifidogenic effect 
of GOS. This supports the current line of though and previous research showing 
prebiotic effects of GOS supplementation to infant nutrition, since bifidobacteria are 
the signature bacteria of breast-fed infants.
Interestingly, upon fermentation of carbohydrates Bacteroidetes produce metabolites 
of which SCFA are shown to be essential for the hosts physiology321–323. Recent 
evidence shows that SCFA can alleviate allergic symptoms via distinct mechanisms. 
For instance, SCFA promote the induction of oral tolerance via inducing RALDH 
expression in epithelial cells159,440. Recently, it was shown that SCFA also directly 
dampen DC activation and T helper (Th) 2 cell skewing46. Additionally, propionate 
was shown to induce hematopoiesis of tolerogenic DC that prevented allergic 
inflammation in the lung44. A high fiber diet, acetate or propionate supplementation 
to mice was also capable of AAD via epigenetic modifications45. The authors showed 
that acetate induced epigenetic changes that regulated the accessibility to the FOXP3 
promoter, resulting in systemic anti-inflammatory that prevented allergic airway 
inflammation. Additionally, although the mechanism is still unknown, SCFA are 
also shown to directly dampen Th2-mediated airway inflammation through DC and 
T cells46.
In this line of thought, enhanced SCFA production in the colon in early life may 
be essential for allergy prevention. It has been recognized for decades that a higher 
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prevalence of bifidobacteria results in a lower pH. Interestingly, a recent review 
highlighted that the pH of infant stool increased in the last century441. This increase 
in pH and thus decrease in bifidobacteria prevalence may be caused by disturbances 
in microbiota colonization in early life (e.g. delivery by caesarean section, formula 
feeding and antibiotic use)441. Indeed, formula fed infants without prebiotic 
supplementation are shown to have higher pH compared to breastfed infants442. 
Moreover, breastfed infants show higher lactate- and lower propionate and butyrate 
levels compared to formula fed infants. Infants receiving infant formula that contains 
a 9:1 GOS:FOS ratio show a SCFA profile that resembles that of breastfed infants329. 
Similarly, GOS supplementation to infant formula resulted in lower butyrate levels 
and lower stool pH compared to non-supplemented infant formula327. Of note, in 
contrast to normal breastfed infants, exclusive breastfeeding resulted in an increase 
in total SCFA levels in very-low birth weight infants444. Thus, HMOs in breast milk 
maintain a specific microbial profile comprised of Bifidobacterium and Lactobacilli. 
These bacteria produce high levels of lactate and low levels of other SCFA, which 
results in a low fecal pH. Prebiotic supplementation to infants have been shown 
to boost the abundance of bifidobacteria and mimic the SCFA profile of breastfed 
infants. Although bifidobacteria are shown to protect against GI infections, SCFA 
(i.e. acetate, propionate and butyrate) are shown to have anti-inflammatory effects 
and dampen Th2 cell immunity in animal models44–46. Therefore, there is a pressing 
need to investigate the role of metabolites such as SCFA on immune cell maturation 
during early life. This knowledge is required to interpret the relevance of SCFA 
production by prebiotics (e.g. the SL-induced propionate production as described 
in chapter 7).
Microbial-derived SCFA alleviates allergic airway inflammation
In chapter 8, we aimed to investigate the effect of raw cow’s milk and its predominant 
oligosaccharides 3’SL and 6’SL in concentrations present in cow’s milk in a murine 
ovalbumin (OVA)-induced asthma model. Of note, this OVA-induced asthma 
model with acute intranasal challenges cannot fully mimic the chronic inflammatory 
symptoms of asthma in humans445. Nevertheless, it allowed us to study the in vivo 
effect of diet, microbiota composition and SCFA production on lung health in 
particular. Based on previous studies44,45,446, we chose to feed the mice a low fiber diet, 
since we hypothesized that this would augment microbial-derived SCFA production 
induced upon fermentation of SL. However, there were several technical issues in this 
pilot study revealed by the microbiota analysis. We aimed to run a two-week run-in 
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period with raw cow’s milk or SL before introducing the first sensitization. This two-
week run-in period was in line with an earlier study by Trompette et al, who studied 
the effect of fibers on HDM-induced allergy in mice44. This preventive strategy was 
shown to be effective if mice were fed a high fiber diet or were supplemented with 
200 mM acetate or propionate while receiving normal chow for three weeks. This 
has been shown to protect against HDM-induced allergy45. However, the low-fiber 
diet was introduced in the two-week run-in period in which the supplements were 
given to the mice. The microbiota analysis revealed that the microbial changes might 
be purely driven by the dietary transition and that this change lasted throughout the 
total study period of 30 days, which makes it difficult to draw conclusions of the effect 
of raw cow’s milk and SL in this model. Hence, in follow-up studies mice should 
be fed a low-fiber diet for at least four weeks before testing specific dietary effects 
on airway-induced inflammation. This follow-up study ideally should use a more 
physiological relevant allergy model such as a HDM-induced model. Additionally, 
supplementing the dietary ingredients via oral gavages would reduce inter-individual 
variation between intake volume. Nevertheless, it is interesting to note that 3’SL 
in our pilot study induced the outgrowth of the probiotic genus Akkermansia that 
has been negatively associated with development of atopic dermatitis and asthma. 
Unfortunately, the intestinal microbiota chip results provided in chapter 7 in the 
human batch cultures treated with SL do not allow to detect this genus of bacteria. 
Chapter 7 and 8 indicate that it would be very interesting to test different dosages of 
SL in HDM-induced allergy model (e.g. GPR41 and GPR43 knock-out mice).
Epithelial barrier functioning
The term “epithelial barrier functioning” is often used to describe an epithelial barrier 
that does not allow leakage of macromolecules447. However, the definition is poorly 
defined and can encompass several underlying mechanisms such as differentiation 
and proliferation of epithelial cells, expression of tight junction proteins and even 
anti-inflammatory responses induced by the epithelium. Early life is often referred 
to as a period in life in which barrier integrity is suboptimal, which could result in 
inflammation and exposure of allergens. However, this vulnerable period in humans 
lasts only for a few weeks in homeostasis127 and a mild dysfunctional barrier has 
been shown to promote the formation of Tregs that protect the GI tract against 
colitis448. Thus, the first week of life may actually give a window of opportunity to 
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induce regulatory responses to environmental antigens and breast milk components. 
However, breastfed neonates show a lower permeability, as measured by the lactulose/
mannitol ratio in urine, compared to infants fed infant formula, indicating that 
certain breast milk components aid in gut maturation96. From an evolutionary point 
of view, breast milk is the golden standard. Hence, promoting gut closure would thus 
be beneficial. Later in life, stress factors such as infections may temporarily disrupt 
barrier function. It is therefore possible that continuous barrier function supported 
by nutrition may be important to suppress the inflammatory response.
Intestinal epithelial cells are at the frontline to discriminate harmful bacteria from 
commensals. The highly polarized organization of epithelial cell allows discrimination 
between signals coming from the commensal microbes and pathogenic bacteria 
infiltrating the intestine20,449. The microbiota express TLR ligands450 and SCFA451 
that signal via TLRs, thereby inducing epithelial cell differentiation. We showed in 
chapter 7 that SL and GOS modulate cell cycle control and induce differentiation 
of Caco-2 cells, which is in line with earlier reports showing enhanced alkaline 
phosphatase (ALP) production by intestinal cell lines135,345,346. Overexpression of 
ALP in Caco-2 cells was shown to induce tight junction expression452. ALP is a 
well-established differentiation marker for enterocytes, and was shown to modulate 
microbiota composition and inactivate different serotypes of LPS347. Together, 
increased ALP levels are known to increase barrier function. HMO or prebiotic-
oligosaccharides may thus improve barrier functioning directly and indirectly via 
modulation of microbiota composition that in turn produce SCFA and directly via 
microbe associated molecular patterns (MAMPs) that enhance barrier functioning 
(Figure 4). Additionally, we showed in chapter 7, using a different human in 
vitro assay, that SL and GOS also induced re-epithelization of epithelial cells. Re-
epithelization is a phase in the “wound healing” process in which epithelial cells 
migrate into the wound area, reorganize their cytoskeleton and differentiate after 
the wound is closed348,349. Previous research showed that HMO may also indirectly 
modulate this process via the microbiota349 and SCFA production350. Future studies 
should identify the relevance of these findings using epithelial barrier studies on 
human organoids or colitis animal models.
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Figure 4. SL and GOS directly and indirectly modulate epithelial barrier functioning. In in vitro batch 
cultures, we showed that SL and GOS induce the outgrowth of Bacteroides and bifidobacteria that produce 
propionate and lactate, respectively. Oligosaccharides may thereby indirectly promote barrier functioning 
indirectly via the microbiota via the production of 1) SCFA, 2) MAMPs (e.g. TLR ligands), and directly via 
production of 3) ALP.
Concluding remarks
There is a pressing need to better understand the mechanisms underlying the 
worldwide rise in chronic inflammatory diseases. Since allergic sensitization and 
predisposition to childhood asthma already occur early in life, preventive strategies 
should aim at this period. Various environmental factors have been shown to trigger 
the regulatory compartment of our immune system. Exposure to these factors may 
be essential to maintain immune homeostasis and induce tolerance towards harmless 
antigens such as allergens. Breast milk has been suggested to consist of a unique 
mixture of tolerogenic components that could prevent allergen sensitization. As such, 
it is interesting that epidemiological studies show an inverse correlation between raw 
cow’s milk consumption in early life and allergy and asthma prevalence. Since some 
components are identical between breast milk and cow’s milk and others are highly 
homologous, raw cow’s milk may be a useful source for functional ingredients for 
infant nutrition.
The overall aim of this thesis was therefore to investigate the effect of raw cow’s 
milk and its components on human mucosal immune homeostasis. We found a 
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novel role for LF in inducing the differentiation of monocytes into tolerogenic DC. 
Chapter 3 shows that LF alters the differentiation of monocytes into tolerogenic 
DC. This shows that LF is not just an anti-microbial or anti-viral protein but that 
it has immunoregulatory effects. Follow-up studies should therefore investigate 
whether fortification of infant formula with LF could, in addition to prevention of 
GI infections and inflammation, potentially also result in a reduction of allergy or 
asthma prevalence. From a mechanistic point of view, it would be very interesting 
to further investigate the mechanism by which LF halts DC differentiation. In 
chapter 4 we optimized an existing method to remove LPS, which we applied in 
chapter 3, 5, and 6. However, we also warrant that this method does not work 
for removing LPS from proteins with highly hydrophobic domains (e.g. membrane 
proteins) or proteins that strongly interact with LPS such as LF (chapter 3). Thus, in 
line with other commercially available methods to extract LPS, the suitable method 
is based on the structure of the protein of interest. Additionally, in chapter 5 we 
challenged the current thought that HMO or prebiotic oligosaccharides can activate 
TLR4 signaling by showing that in contrast to mice, 3’SL does not induce human 
TLR4 signaling. In this discussion we further elaborated why, based on biochemical 
features of these milk oligosaccharides, it is not likely that any HMO would activate 
TLR4 signaling. Further attempts to predict TLR:ligand interactions in silico are 
needed to efficiently develop therapeutics and screen for immunomodulatory food 
components. Additionally, we showed in chapter 6 that the trisaccharides 2’FL, 
3’SL, and 6’SL and the prebiotic GOS do not modulate human DC differentiation 
or maturation. Instead, we showed in chapter 7 that high concentrations of SL and 
GOS are capable of inducing epithelial cell differentiation and distinctly modulate 
microbiota composition and SCFA production. In line with literature, GOS induced 
the outgrowth of bifidobacteria and boosted lactate production, while SL induced 
the outgrowth of Bacteroides and produced propionate in fecal batch cultures from 
adults. Nevertheless, these changes were not this black and white in infant fecal 
batch cultures. Of note, our knowledge on the role of SCFA in early life is too 
limited to interpret these results. Hence, future studies should investigate the role 
of host metabolome in early life to understand the implications of these findings. In 
chapter 8, we aimed to measure the effect of raw cow’s milk or SL supplementation 
on microbiota composition and systemic anti-inflammatory effects by SCFA in a 
murine model. However, our data showed that effect of the raw cow’s milk and SL 
are probably masked due to fact that the microbiota of the mice was not stabilized to 
the low-fiber diet. Nevertheless, 3’SL induced the outgrowth of Akkermansia, which 
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has been shown to contribute to immune homeostasis and is reduced in children with 
atopic dermatitis436 and asthma437. Hence, it is essential to repeat the current pilot 
study, preferably in a different allergic model such as a HDM-induced model with 
mice fully adapted to the low-fiber diet (i.e. fed for at least four weeks) and SL or raw 
milk fed via oral gavage.
In this thesis we show that prebiotic oligosaccharides (i.e. GOS) and HMO such as 
sialylated oligosaccharides induce differentiation of intestinal epithelium and modulate 
microbiota composition and their production of SCFA upon fermentation. Further 
deciphering these microbiota-dependent mechanisms are essential to understand the 
impact of milk and prebiotic oligosaccharides on the physiology of the infant. We 
could not demonstrate direct immunomodulatory effects of these oligosaccharides on 
monocytes and DC. In contrast, bovine milk-derived proteins such as LF and TGFβ 
do contribute to immune homeostasis by inducing differentiation of monocytes into 
tolerogenic DC. Finally, we also highlighted the necessity of endotoxin removal in 
nutritional immunology, and discuss the strength and weaknesses of our optimized 
LPS-removal method. This thesis thereby gives novel insights into regulation of mucosal 
immune responses by cow’s milk components. Future studies should investigate the 
effects of these components in in vivo allergy and respiratory infection models, which 
ultimately could result in novel approaches to improve respiratory health.
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Abstract
Our environment poses a constant threat to our health. In order to survive all 
organisms must be able to discriminate between good (food ingredients and microbes 
that help digest our food) and bad (pathogenic microbes, viruses and toxins). In 
vertebrates, discrimination between beneficial and harmful antigens mainly occurs 
at the mucosal surfaces of the respiratory, digestive, urinary and genital tract. Here, 
an extensive network of cells and organs form the basis of what we have come to 
know as the mucosal immune system. The mucosal immune system is composed of a 
single epithelial cell layer protected by a mucus layer. Different immune cells monitor 
the baso-lateral side of the epithelial cells and dispersed secondary lymphoid organs, 
such as Peyer’s patches and isolated lymphoid follicles are equipped with immune 
cells able to mount appropriate and specific responses. This review will focus on 
the current knowledge on host, dietary and bacterial-derived factors that shape the 
mucosal immune system before and after birth. We will discuss current knowledge 
on fetal immunity (both responsiveness and lymphoid organ development) as well 
as the impact of diet and microbial colonization on neonatal immunity and disease 
susceptibility (summarized in tables 1 and 2). Lastly, Inflammatory Bowel Disease 
will be discussed as an example of how the composition of the microbiota might 
predispose to disease later in life. A fundamental understanding of the mechanisms 
involved in mucosal immune development and tolerance will aid nutritional 
intervention strategies to improve health in neonatal and adult life.
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A
Fetal life
Sterile or not?
Previously it was thought that the fetal environment in the uterus was sterile and 
the fetal immune system was immature and inactive. However, in recent years more 
and more evidence has emerged that the fetus is actually exposed to environmental 
antigens prior to birth and that the contact between the immune system of mother 
and child is far more intimate than previously thought.
For example, bacteria belonging to the genus of Enterococcus, Streptococcus, 
Staphylococcus, and Propionibacterium could be cultured from umbilical cord blood of 
healthy neonates born by caesarian section (table 1)453. Additionally, while cultivation 
of the placental samples did not reveal the presence of viable bacteria, Bifidobacterium 
and Lactobacillus DNA could be detected in 33 and 31 of 34 placenta samples 
respectively454. In a recent study, 320 placental samples were analyzed by comparative 
16S ribosomal DNA–based and whole-genome shotgun metagenomics. Here, the 
authors report that the placenta harbors a unique microbiome consisting of several 
non-pathogenic bacteria. This placental microbiome mostly resembled the mother’s 
oral microbiome455 The placenta, therefore, might harbor several antigens to which 
the fetus needs to develop tolerance456. Furthermore, lactic acid bacteria and enteric 
bacteria have been found in the meconium - the first fecal discharge of neonates - 
that was thought to be sterile457. These data suggest that bacteria or at least bacterial 
DNA can come in contact with fetal tissues and this does not automatically lead to 
premature birth or spontaneous abortion. Thus, during fetal life overt inflammatory 
responses towards environmental or maternal (commensal) bacteria must be 
prevented, to forestall premature birth or death of the fetus.
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Underdeveloped or repressed immunity?
Stoppelenburg and colleagues have shown that umbilical cord blood T cells fail to 
differentiate toward the pro-inflammatory Th17 lineage in the presence of autologous 
antigen-presenting cells459. In a separate study, they also showed that neonatal T cells 
have an intrinsic mechanism that prevents Th17 differentiation through the regulation 
of RORγt expression, possible via DNA methylation and histone acetylation458. This 
again indicates that overt inflammatory responses are actively repressed in the fetus 
and neonate. At the same time, this might pose a risk to mother and child. Indeed, 
it has been shown that pregnant women have a 20-fold increased risk of developing 
listeriosis; infection with Listeria bacteria that causes infections of the central nervous 
system of the unborn, such as meningitis510. This is probably due to repressed Th1 cell 
proliferation and IFNγ production during pregnancy510.
To further prevent pro-inflammatory responses, the fetus is surrounded by amniotic 
fluid. This amniotic fluid contains antimicrobial peptides such as defensins 
and lactoferrin. Furthermore, it contains endotoxin-neutralizing histones and 
lipopolysaccharide (LPS)-binding protein that might prevent Toll-like receptor (TLR) 
signaling and possibly fatal immune responses for the unborn child465,466. Recently, it 
was shown in mice that epidermal growth factor (EGF) in the amniotic fluid inhibits 
fetal TLR signaling through binding to the EGF-receptor on fetal intestinal epithelial 
cells468. So instead of being underdeveloped and unresponsive, the fetus can respond 
to antigens, however, these responses are actively prevented.
Development of mucosal lymphoid tissue during fetal life
Meanwhile in the gut of the fetus, interspersed Peyer’s patches develop around 11 
weeks of gestation and functional B and T cells can be found from 12 and 16 weeks 
respectively (Figure 1)469,511–515. Both the Gut Associated Lymphoid Tissue (GALT) 
and the intestinal epithelium mature during the gestational period. Specialized 
epithelial cells called Paneth cells develop in the colon and small intestine at 13.5 
weeks of gestation. After 17 weeks, Paneth cells are confined to the small intestine516. 
Paneth cells reside at the bottom of the crypts, secrete anti-microbial peptides and 
are important in protecting the intestinal stem cells and maintaining intestinal 
homeostasis19,517,518. In the human fetal intestine Goblet cells appear around 9-10 
weeks of gestation519. Goblet cells produce mucins, that serves as a first line of defense 
against luminal antigens. In addition to mucins (large glycoproteins), mucus consists 
of water, ions and immune mediators such as immunoglobulin A (IgA) and anti-
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microbial peptides, which help clear pathogens520,521. Early during development 
lymphoid precursor cells are present and spread to Peyer’s patches and mesenteric 
lymph nodes522. Memory T cells were found to be relatively abundant in fetal spleen 
and in cord blood samples from premature births. These cells comprised about 25% 
and 10% of the T cells, respectively, expressed CD25 and were anergic523. Later, it 
was shown that (at least part) of these cells are regulatory T cells (Tregs) that are 
already present in the second trimester of the pregnancy. At that time, 15-20% 
of CD4+ T cells in the fetus’ secondary lymphoid tissues are comprised of Tregs. 
Murine studies suggest that these Tregs are largely induced by maternal cells that 
cross the placenta and reside in fetal lymph nodes469. In this way, regulation of fetal 
anti-maternal immunity is established. The authors also suggest that this form of in 
utero induced antigen-specific tolerance, might also be active in regulating immune 
responses after birth469. Next to the GALT, the nasopharynx-associated lymphoid 
tissue (NALT), and bronchus-associated lymphoid tissue (BALT) are also part of the 
mucosal-associated lymphoid tissue (MALT). The NALT (named Waldeyer’s ring 
in humans), consists of the nasopharyngeal tonsil, tubal tonsils, palatine tonsils and 
lingual tonsils524. Its appearance is similar to Peyer’s patches; follicles underneath 
follicle-associated epithelium (FAE) containing interspersed microfold (M) cells 
that can sample antigens525. Tonsils are secondary lymphoid organs. The tonsillar 
subepithelial space is formed by several lymphoid follicles containing B and T cell 
areas. Tonsils are not encapsulated like the spleen, but are lined by tonsillar epithelium 
that invaginates forming crypts 524. From the 14th week of gestation B and T cells 
populate the area under the tonsillar epithelium and primary follicles develop from 
16 weeks of gestation (earlier than any other secondary lymphoid tissue). The tonsils 
will keep growing until 7 years of age after which they slowly involute526. While 
NALT is present at birth, BALT develops from 3-4 days of age525,527,528. It isn’t until 3 
to 4 weeks of age until B and T cell areas are formed in the BALT525,528.
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Figure 1. Important factors in early life affecting mucosal immune development. During the fetal life stage 
there is a direct interaction between maternally derived environmental factors (e.g. diet and microbes) and the 
fetus. Additionally, the amniotic fluid contains antimicrobial peptides (AMPs) and epidermal growth factors 
(EGF) and endotoxin-neutralizing proteins that protect against pathogenic bacteria and possible fatal immune 
responses, respectively. Birth, and the way of delivery, is a critical point in immune development that determines 
which types of microbes will colonize the GI-tract. In the neonatal life stage, breast milk (or alternatively infant 
formula) provides the infant with proteins, short-chain fatty acids (SCFAs) and vitamins that are critical for 
immune cell differentiation and development. Environmental factors such as diet and microbes early in life set 
an immunological stage that impact the hosts susceptibility towards disease.
Immune modulation via dietary or bacterial factors during fetal life?
Recently, a specific subset of T cells with an invariant receptor (mucosa-associated 
invariant T cells (MAIT)) was also found to be present in the second trimester of 
human fetal tissues463. MAIT cells are innate-like T cells that recognize antigens in 
complex with the MHCIb-like protein MR1464. MAIT cells recognize microbial-
derived riboflavin metabolites and can subsequently produce IFNγ, TNF and IL-
17460–462. Interestingly, these cells are present at high frequency in fetal lung, liver 
and small intestine, and display a mature phenotype (i.e. they express IL-18Rα(+) 
and CD8αα)463. Compared to adult MAIT cells fetal small intestinal MAIT cells 
have an increased proliferative capacity and can respond to bacterial stimulation with 
production of IFNγ and IL-22463. The factors that drive this fetal MAIT maturation 
are currently unknown, but also might suggest that the human fetal environment is 
not devoid of external or environmental stimuli.
The fact that environmental factors can reach the fetal immune system via the 
placenta, suggests that fetal immunity might be altered or enhanced by dietary or 
microbial intervention in pregnant women. However, scientific evidence on the effect 
of dietary intervention in pregnant women on fetal immunity is limited. Rautava 
and colleagues (2012) report that women that received either Bifidobacterium lactis 
or Bifidobacterium lactis together with Lactobacillus rhamnosus GG (LGG) 14 weeks 
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prior to elective caesarean section showed altered TLR expression in the exfoliated 
cells present in the meconium of the newborn as compared to the placebo group473. 
However, others have shown that dietary supplementation with probiotics during late 
pregnancy might alter maternal immune parameters, but does not alter fetal immune 
responses529,530. Additionally, while supplementation with galacto-oligosaccharides 
(GOS) and long-chain fructo-oligosaccharides (lcFOS) alters maternal fecal 
microbiota (increase of bifidobacteria), it did not affect fetal immunity as measured by 
cord blood cell stimulation assays531. However, experiments performed with pregnant 
mice suggest that live bacteria can transfer from the mother to the fetus. Labeled 
Enterococcus faecium that were orally given to pregnant mice, could be cultured 
from the amniotic fluid as well as from the mammary glands of the mothers453. 
Interestingly, in mice treated with a diet devoid of vegetable material decreased 
numbers of intraepithelial lymphocytes are seen as well as a reduction in type three 
innate lymphoid cells (RORγt+ ILC) in the intestines470–472. Additionally, in a recent 
paper van de Pavert and colleagues (2014) have shown in mice that maternal diet 
derived vitamin A induces lymph nodes in the unborn pups. Pups derived from mice 
fed vitamin A-deficient diets had markedly reduced lymph node size and decreased 
efficiency of immune responses. In this paper, van der Pavert showed that retinoic 
acid (RA; the metabolite of vitamin A) is necessary for differentiation of lymphotoxin 
inducer cells (LTi) that play a crucial role in lymph node formation532.
In conclusion, while increasing evidence suggests a direct interaction between the 
maternally derived environmental factors (such as diet and microbes) and the fetus, 
more research is warranted to investigate the mechanisms by which these factors 
might (beneficially) alter fetal and subsequent neonatal immunity.
Neonatal life
Caesarean section versus vaginal birth - Effect on the microbial 
composition
 During birth the amniotic membranes will rupture and the unborn child will passage 
through the birth canal. This birth canal is not sterile and during labor the child 
will get exposed to vaginal bacteria, maternal skin and feces followed by exposure to 
environmental antigens533. This exposure has a profound impact on the host. Here, 
we summarize what is known in this interesting research field (see also Table 2).
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Studies comparing children born vaginally or by caesarean section have shown 
differences in microbial community and immune responses. For example, a 
Venezuelan cohort showed that most vaginally delivered infants acquired a 
bacterial composition dominated by Lactobacillus, Prevotella, or Sneathia; species 
that are found in their mothers vaginal microbiota534. In contrast, infants born by 
caesarean section displayed a bacterial community dominated by Staphylococcus, 
Corynebacterium, and Propionibacterium, typical skin bacteria534. A Finnish study 
compared the microbiota and antibody production at 1 month after birth and 
showed that children delivered by caesarean section harbored fewer bifidobacteria 
and were shown to mount a stronger humoral immune response. During the first 
year of life, infants born vaginally displayed lower total IgA-, IgG- and IgM-secreting 
B cells in peripheral blood535. The mode of delivery also has been reported to affect 
serum cytokine levels. Malamitsi-Puchner et al. (2005) reported that soluble IL-2 
receptor, IL-1β and TNF were significantly higher in cases of vaginal delivery than 
in cases of elective caesarean section in neonates at day 1 (IL-1β , IL-2Receptor 
and TNF) and day 4 (IL-2R, TNF) of life536. These two studies might suggest that 
children born vaginally have lower humoral and higher cellular immunity in early 
life, compared to children born by caesarean section. However, more data will be 
necessary to support this hypothesis. Several studies report increased abundance of 
bifidobacteria  and Bacteroides in vaginal-delivered children compared to children 
born by caesarean section535,537. Additionally, analysis of bacterial colonization from 
birth to 12 months of age in a cohort of Swedish, Italian and British infants using 
culturing techniques showed that children delivered by caesarean section displayed 
more Klebsiella, Enterobacter, and Clostridia, including the pathobiont Clostridium 
difficile compared to vaginally delivered babies538–540. Interestingly, studies performed 
in Western countries revealed that children born by caesarean section take 6 months 
to a year to acquire the same levels of Bacteroides, bifidobacteria  and Escherichia coli 
colonization as vaginally born children display directly after birth538,540,541. In contrast, 
children born by caesarean section in the developing world catch up much quicker 
indicating that the environment is an important factor in colonization patterns after 
birth542.
Caesarean section versus vaginal birth - Effect on allergic diseases
Thus, from these studies it seems that vaginally born children harbor bacterial 
species that have been considered beneficial (bifidobacteria), while children born by 
caesarean section are more prone to harbor species that are associated with, but do 
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not necessarily lead to, disease (Escherichia coli and Clostridia). Indeed, colonization 
with Clostridium difficile has been associated with a higher risk of a diagnosis of atopic 
dermatitis543,544. Several meta-analyses have shown that babies born by caesarean 
section are at higher risk to develop allergy, including food allergies. Interestingly, in a 
Norwegian birth cohort it was shown that children of allergic mothers that were born 
by caesarean section had a seven fold increased risk of developing food allergy to egg, 
fish or nuts545. This effect was not seen in children whose mothers were not allergic, 
indicating that a predisposition exists that together with birth by caesarean section 
can lead to food allergy. Likewise, in a German cohort, babies with a family history 
of allergy and born by caesarean section also showed an increased risk of allergic 
sensitization to food allergens compared with babies at risk born vaginally546. Finally, 
a large meta-analysis in which 26 studies on the effect of delivery by caesarean section 
on one or more allergies were described showed that caesarean section was associated 
food allergy, atopy, allergic rhinitis, asthma, and hospitalization for asthma. However, 
they found no association with inhalant atopy and eczema/atopic dermatitis547. Since 
children born by caesarean section have an altered bacterial community, it is generally 
thought that this altered microbiota can lead to differences in mucosal immune 
tolerance which can predispose to the development of allergies548. Indeed in Dutch 
cohort, colonization by Clostridium difficile (associated with caesarean section) at 
an age of 1 month was associated with wheeze and eczema in the first 6 years of 
life and with asthma from age 6549. Although the associations exist, reports on the 
mechanisms how these changes early in life lead to disease are understandingly scarce. 
However, from animal studies we do know that exposure to certain bacterial species 
has an important impact on host immunity. In the next section, we will discuss 
the current knowledge of microbial modulation of host immunity generated using 
animal models.
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Table 2. Effect of microbial colonization on host immunity
Factor Microbial composition Immunological mechanism/
clinical effect on host
Model Ref.
B
ir
th
Vaginal birth  more Bifidobacteria and 
Bacteroides
stronger humoral response 
(higher levels of IgA, IgG and 
IgM secreting B cells)
human 535,537
higher serum levels of sIL-2r 
and TNF
human 536
Caesarean section  more Klebsiella, 
Enterobacter and 
Clostridia
higher risk of allergies (excl. 
inhalant atopy and eczema)
human 538–540,543,544,547
Bottle feeding more intestinal 
Bacteriodes and 
Clostridia
might predispose to 
development of autoimmunity, 
and childhood infections, 
atopy and asthma
human 533,550
oral microbiome 
without Lactobacillus
human 551,552
Breast feeding more intestinal 
Bifidobacteria
associated with protection 
from autoimmune disease, and 
childhood infections, atopy 
and asthma
human 533,550,553
oral microbiome with 
Lactobacillus
human 551,552
Segmented filamentous 
bacteria (SFB)
IgA plasma cells are restored to 
normal levels
mice 554,555
Bacteria from 
conventional raised mice
increased FoxP3 expression in 
colitis model
mice 556
Autologous bacteria tolerance induction that 
protects against IBD
mice 557
Altered Schaedler flora 
(ASF)
Treg induction mice 558–560
Bacteriodes fragilis Treg induction in a 
polysaccharide A-TLR2 
dependent manner
mice 362
Faecalibacterium 
prausnitzii
enhances anti-inflammatory 
responses
mice 365,561
Cluster IV, XIVa and 
XVIII of Clostridia
induce Treg frequency and 
inducible T-cell co-stimulator
mice 562
Segmented filamentous 
bacteria (SFB)
more Th17 cells in small 
intestinal lamina propria, less 
in colon
mice 563,564
How do colonizing microbes influence host immunity?
The last decades it has become clear that the composition of the microbial 
communities that colonize our bodies have a profound influence on our health. Most 
if this knowledge derives from studies using gnotobiotic experimental animals. These 
studies show that colonization by different microbial species early in life has clear 
effects on the development of the intestinal mucosal immune system. Interestingly, 
host responses to microbial colonization are highly conserved between species. A 
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study investigating zebrafish responses towards colonization revealed 59 responses 
that are conserved between mouse and zebrafish. These responses included pathways 
involved in epithelial proliferation, promotion of nutrient metabolism, and innate 
immune responses565. Several immune cells and mediators are influenced by the 
microbiota, for example, germfree mice that are devoid of bacteria have almost no IgA-
secreting plasma cells. Only upon colonization with specific subtypes of bacteria IgA 
plasma cells are restored to levels seen in conventionally raised mice554,555. IgA is the 
predominant antibody secreted by plasma cells in the mucosal tissues566. Low-affinity, 
poly-specific IgA is believed to prevent adhesion of commensal bacteria to epithelial 
cells, while high-affinity, mono-specific IgA neutralizes toxins and pathogens558–560.
Studies have also shown that germ-free animals have altered Treg frequency. In a 
transfer model of colitis, it was shown that co-transfer of CD4+CD62L- cells into 
SCID mice prevented colitis induced by CD4+CD62L+ cells only when those cells 
were derived from conventionally-raised mice. The CD4+CD62L- cells from germfree 
animals were not able to suppress the colitis. This associated with a low expression 
of regulatory T cell marker FoxP3 in this population form germfree mice556. Already 
in 1995, Duchmann et al. reported that hyporesponsiveness exists towards the hosts’ 
autologous bacteria557. Lamina propria mononuclear cells (LPMCs) and peripheral 
blood mononuclear cells (PBMCs) did respond towards heterologous intestinal 
microbes. In patients with inflammatory bowel disease this tolerance towards 
autologous bacteria was lost557. Together these studies clearly indicated that Tregs are 
directly or indirectly induced by the intestinal microbiota.
Using the altered Schaedler flora (ASF), a mixture of eight bacterial species including 
Lactobacilli, Bacteroides, Eubactrium, Mucispirillum, Fusiform and Clostridial 
species, MacPherson and colleagues demonstrated that ASF colonization of germfree 
mice increased the inducible Treg frequency in the colonic lamina propria by 
twofold558–560. Likewise, it was shown that Bacteroides fragilis was able to induce 
Tregs upon colonization. Interestingly, when germfree mice were given B. fragilis 
devoid of polysaccharide A (B. fragilis ΔPSA), Tregs were not induced362. Further 
experiments showed that PSA induction of FoxP3 in CD4+ T cells required TLR2 
activation362. Likewise, Faecalibacterium prausnitzii has also been demonstrated to 
enhance anti-inflammatory responses365,561. This indicates that bacteria and their cell 
wall components are important mediators of immune cell differentiation. Recently, 
Atarashi and colleagues (2013) inoculated mice with a healthy human fecal sample, 
18039 Olaf Perdijk PM.indd   214 04-09-18   19:57
Mucosal immune development in early life: setting the stage
215
A
and selected for mice enriched in Treg-inducing species562. From these selected mice, 
they isolated 17 strains of bacteria that were able to enhance Treg frequency and 
induce interleukin-10 and inducible T-cell co-stimulator (ICOS) upon inoculation 
into germ-free mice. Identification of these 17 strains revealed that these bacteria 
were members of the clusters IV, XIVa and XVIII of Clostridia, which lack prominent 
toxins and virulence factors562.
More evidence for the bacterial specific effects on immune development was reported 
by Ivanov and co-workers who have shown that the ability to increase the number 
of Th17 cells in the small intestinal lamina propria associated with the presence of 
Segmented Filamentous Bacteria (SFB) in mice563,564. Th17 cells are T cells that 
produce IL-17A, Il-17F and IL-22 and have been shown to play a role in inflammatory 
responses and host defense against bacterial and fungal pathogens567–569. Conversely, 
in the colon lamina propria it was shown that germfree mice harbor more Th17 
cells than conventionally raised mice. Upon microbial colonization epithelial cells 
produce IL-25, which in turn inhibits (either directly or indirectly) the expression 
of IL-23 by antigen presenting cells570. IL-23 is a cytokine that is described to be 
necessary for Th17 pool maintenance571. Reduction of IL-23 therefore results in 
decreased numbers of Th17 cells in the colon. Likewise, Corbett and colleagues 
(2014) reported that bacteria with an active vitamin B2 (riboflavin) pathway generate 
epitopes that (in conjunction with host metabolites) can be recognized by the MAIT 
cells via MR1460. This finding again illustrates that colonization by (specific subsets 
of ) bacteria can give rise to different mucosal immune environments.
Recently, much attention has been directed towards a newly discovered cell subset: 
innate lymphoid cells (ILCs). Three types of ILCs have been identified: T-bet+ ILCs 
(including NK cells, ILC1), GATA3+ ILCs (ILC2) and RORγt+ ILCs (ILC3)572. 
These ILCs are in close contact with the microbes since they reside in between the 
epithelial cells573–577. While Gata3+ and T-bet+ ILC development does not seem 
to depend on microbial colonization, this is not completely clear for the RORγt+ 
ILCs. Some studies show normal development, while other show reduced frequency 
of RORγt ILCs in germfree mice572,574,578–581. RORγt ILCs express TLR2 and can 
therefore directly be activated by bacterial ligands582.
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In conclusion, colonization is an important process during which the immune 
system develops to a certain set-point in each individual. Therefore, colonization by 
Bifidobacteria or Bacteroides species (vaginally-delivered children), might result in a 
different immune cell-repertoire (for example T cell subsets) and distribution than 
colonization by Escherichia coli (Caesarean section), thereby leading to a different 
immunological set-point that may or may not predispose (in combination with host 
genetic susceptibility) towards certain diseases.
Dietary exposure and host immunity in early life
Bottle feeding versus breastfeeding
Next to bacteria, the newborn encounters several new environmental antigens of which 
most will be derived from the diet. Therefore, children that will be breastfed will be 
exposed to different dietary antigens than those that will be bottle-fed. Human breast 
milk contains immunoglobulins, cytokines, growth factors, lysozyme, lactoferrin and 
a complex mix of milk oligosaccharides73,81,583. Breast milk and colostrum contain 
large amounts of IgA, but also immune cells and cytokines, and soluble TLR2 that 
might help restrict innate immune activation by microbes584,585
The structure of breast milk oligosaccharides has been shown to be very diverse and 
depend on several factors including diet, lifestyle, and ethnicity589. Oligosaccharides 
can improve diversity and rate of metabolism of the microbiota476–478. Also 
breastfeeding has an impact on the composition of the microbiota. Breastfeeding 
is associated with high numbers of Bifidobacteria in the gastrointestinal tract of 
the newborns, whereas bottle feeding resulted in more intestinal Bacteroides and 
Clostridia550,553,590. Recently, it was shown that Lactobacilli could be cultured from 
saliva in 27.8% of exclusively and partially breast-fed infants, but not from formula-
fed infants551,552, indicating that the oral microbiome is also influenced by infant 
feeding456. Furthermore, it has been shown that human milk glycans can protect 
infants from enteric pathogens479,480. Insulin like growth factor is important for wound 
healing and tissue repair and epidermal growth factor plays a role in cell proliferation 
and differentiation, induces mucus production by intestinal Goblet cells and can 
suppresses pro-inflammatory cytokines481,482. Interestingly, human milk also contains 
bacteria. Culture-dependent mechanisms have shown the presence of Staphylococcus, 
Streptococcus and Bifidobacterium species483,484. Subsequently, sequence analysis has 
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identified the presence of DNA from 9 different bacterial genera383. Interestingly, 
recently it was reported that house dust mite allergen, DerP1, is present in human 
breast milk. Subsequent testing of breast milk containing DerP1 in a mouse model 
revealed that instead of protecting these mice from allergic responses, they were 
sensitized591. This suggests that not only are neonates exposed to dietary antigens 
early in life via breast milk, they are also exposed to respiratory allergens via breast 
milk, and this does not always lead to tolerance to the antigens but may well result 
in sensitization.
Maternal IgA is reflective of the environment of mother and child and therefore 
can protect the newborn against possible pathogens that he or she might encounter 
right after birth. Maturation of the IgA-producing plasma cells slowly develops after 
birth. While, IgA H chain transcripts are found in cord blood as early as 27 weeks of 
gestation, at 60 weeks of age, somatic mutation frequency of IgA H chain transcripts 
only reaches 25% of the adult values, with little evidence of Ag-driven selection486. 
Therefore, maternal IgA from the milk will equip the newborn with antigen-specific 
humoral immunity at the time the child itself does not have a fully developed 
repertoire. Interestingly, recently it was shown in mice that breast milk-derived IgA 
modulates the composition of the microbial community in the gastrointestinal tract 
485. Next to preventing bacterial infections, maternal IgA can also reduce the oxidative 
burst and represses TNF and IL-6 production by human monocytes487,488.
Protection from disease?
There is a long debate in the literature about the possible beneficial effect of (prolonged 
and/or exclusive) breastfeeding for children at risk for type 1 diabetes. Already in 
1984, Borch-Johnson reported an inverse correlation between breastfeeding and 
incidence rates of childhood type 1 diabetes592. Several other studies confirmed this 
correlation593,594, while others did not595,596. Animal studies using the spontaneous 
diabetic rat model (the BB-DP rat) showed that prolonged exclusive breastfeeding 
decreased diabetes incidence by 40-50% and associated with increased frequency 
of Treg cells and less pro-inflammatory cytokine secretion in the mesenteric lymph 
nodes597. Furthermore, antibiotic treatment reduces the incidence in both the BB-
DP rat and the NOD mouse model for spontaneous diabetes598,599. Interestingly, in 
the BB-DP rat the composition of the microbiota before onset of disease differed 
between BB-DP rats that did and rats that did not develop diabetes, suggesting 
that microbial dysbiosis occurs prior to disease onset598. Likewise, several studies 
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report an association between breast milk and protection against infection such as 
diarrhea, atopic diseases and asthma during childhood600–603. Interestingly, a meta-
analysis of twelve human studies showed that the protective effect in most studies 
correlated with the (high) concentrations of TGF-β1 or TGF-β2 in the milk71. A 
recent meta-analysis of studies published between 1983 and 2012 on breastfeeding 
and asthma in children reported a strong protective association at ages 0-2 years 
between breastfeeding and asthma, which diminished over time604. The availability of 
nutrients, and especially of milk oligosaccharides, in the intestinal tract of newborns 
also has a profound influence on the microbial species that are able to survive there. 
Indeed it has been shown that breastfeeding and bottle-feeding result in different 
microbial colonization patterns, which results in different host immune responses605.
To improve the composition of infant formulas for mothers that cannot provide 
breastfeeding to their child, investigators try to develop formulas that resemble 
the composition of human breast milk. Recent developments include the use of 
prebiotics to provide non-digestible oligosaccharides and probiotics. Like breast milk, 
bovine milk also contains several proteins that have an immunomodulatory function 
such as large quantities of immunoglobulins, lactoferrin, caseins and cytokines like 
TGFβ, but only very low levels of oligosaccharides65. Many of these proteins are, 
surprisingly, active across the species barrier. The active form of bovine TGFβ2 (the 
predominant cytokine in milk) is even 100% identical to human TGF-β2, and 
bovine IL-10 is fully comparable to human IL-10 in its anti-inflammatory effects of 
human monocytes and DC50,73. Bovine IgG can bind to human Fc gamma receptors 
on monocytes and neutrophils111,606,607, and bovine IgG recognizes a wide range of 
pathogens that can also infect humans such as RSV111,607. Bovine colostrum, that 
is extremely rich in bovine IgG has been shown to significantly reduce recurrent 
diarrhea in AIDS patients, showing that bovine IgG can have an anti-pathogenic 
effect in humans489. Milk also contains anti-microbial proteins, most prominently 
lactoferrin, lactoperoxidase and lysozyme. Lactoferrin was shown to protect low birth 
weight infants against necrotizing enterocolitis195. In line with this, it has already 
been known for a long time that growing up in a farm environment lowers the risk 
of developing allergies608. Next to exposure to farm animals, drinking farm milk 
has also been implicated as a factor that might reduce allergy risk65,609,610. A recent 
study showed that consumption of raw milk inversely associated with development 
of rhinitis, respiratory tract infections, otitis, and fever in infants66. However, since 
bovine milk is heated and homogenized, a substantial proportion of these protective 
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proteins will be denatured in milk products110. New insights into how dietary 
components influence host immunity, continuously promotes development of health 
stimulating or disease preventing (infant) nutrition.
Fermentation products: how bacterial products influence host immunity
The microbes that are present in the intestinal tract of mammals are important for 
digestion of foods that would otherwise not be available to the host. The products 
of bacterial fermentation, such as butyrate, are readily taken up by colonocytes for 
energy, but also have important immunological effects. Most of the bacteria that 
reside in the mammalian gastrointestinal tract are saccharolytic, meaning that they 
mainly feed on carbohydrates611. Human milk oligosaccharides are complex glycan 
molecules that are present in very high concentrations in breast milk. Several 
studies have shown that milk oligosaccharides influence the composition of the 
intestinal microbiota279,612,613. Human milk oligosaccharides promote the growth of 
Bifidobacteria612,613, and prevent pathogenic bacterial adherence to epithelial cells 
by acting as a soluble ligand for glycan receptors412,614–616. Next to effects on the 
microbiota milk oligosaccharides and non-digestible carbohydrates have also been 
show to directly influence host immunity and epithelial cell biology (reviewed in 553).
Short chain fatty acids (SCFAs) are the end products generated by the colonic 
microbiota617. The type of SCFA formed is dependent on the substrate provided. 
Acetate and butyrate are mainly the result of starch fermentation, while acetate is 
the end product from the fermentation of pectin and xylan618. The succinate and 
acrylate pathways have been shown to lead to propionate production619–622, and some 
bacteria can produce propionate from deoxy sugars such as fucose and rhamnose 
or lactate623. SCFAs can interact with G protein coupled receptors (GPR43, 
GPR41 and GPR109a)500. GPR43 is mainly located on neutrophils, and at lower 
levels on PBMCs and monocytes, while GPR41 is expressed on PBMCs but not 
on neutrophils, monocytes and dendritic cells. Both receptors have also been found 
on intestinal epithelial cells, and recently it has been shown that binding of SCFAs 
to these G protein coupled receptors can promote inflammatory responses in mice. 
Binding of SCFAs to GPR43 and GPR41 induced colon epithelial cell production 
of chemokines, recruited leukocytes and activated effector T cells501. Niacin receptor 
GPR109A has recently been shown to also be a receptor for butyrate in the colon. 
Singh and colleagues (2014) reported that Gpr109a signaling induced differentiation 
of Tregs and IL-10 producing T cells through effects on colonic macrophages and 
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dendritic cells502. Both propionate and acetate can reduce LPS-induced TNF release 
from human neutrophils507, and butyrate seems to inhibit chemotactic effects on 
human monocytes504. Furthermore, SCFAs have been shown to reduce cell adhesion 
thereby preventing immune cell infiltration624,625. Interestingly, butyrate can inhibit 
histone deacetylase (HDAC). HDACs prevent gene transcription by keeping the 
chromatin in a closed form, so transcription is prevented. Butyrate inhibits this effect 
leading to hyper-acetylation and open chromatin626. Butyrate has been reported to 
have anti-inflammatory effect through its HDAC activity on the NF-kB pathway, 
IL-5 expression and COX-2 expression410,503,506. Another interesting example of the 
effect of butyrate on host immunity comes from the study by Atarashi and colleagues 
(2013)562. They isolated 17 strains Clostridial species that were able to enhance Treg 
frequency and induce IL-10 and ICOS upon inoculation into germ-free mice562. In 
a follow up study of the same research group they showed that these Clostridiales 
(indirectly or directly) induced butyrate that subsequently induced functional colonic 
Treg cells, via epigenetic modification of the FoxP3 gene in T cells627.
In conclusion, SCFAs are able to modify host immunity directly by binding 
to receptors on host cells or indirectly through epigenetic changes of host DNA. 
These modifications result in activation or repression of host immune genes and the 
outcome will depend on the type of SCFA and host (immune) cell type studied. 
Whether SCFAs can induce epigenetic changes in the host throughout life, or 
whether a specific window (early in life) exists is currently unknown.
Vitamin A and D
Vitamin D deficiency, together with vitamin A deficiency are two of the most common 
food related medical conditions worldwide. As vitamin A and D are conveyed to the 
newborn via breast milk, vitamin A and D status of the mother is very important 
for the developing child. Vitamin D deficiency leads to poor skeletal development 
and bone and joint deterioration, while vitamin A deficiency is one of the important 
causes of blindness in children628,629. Appropriate vitamin D status has been reported 
to convey protection against several cancers, bacterial infections and autoimmune 
diseases such as rheumatoid arthritis and multiple sclerosis630. Also, low vitamin 
D levels during pregnancy associates with increased risk for type 1 diabetes in the 
offspring. However, too much vitamin D (especially D2) might lead to local tissue 
intoxication (reviewed in 630). In recent years, vitamin A and D have received a lot of 
attention from immunologists. Vitamin A can be converted to retinal and subsequently 
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into retinoic acid by dendritic cells and epithelial cells. In an elegant paper, Coombes 
and colleagues (2007) showed that in mice retinoic acid together with TGF-β are 
essential for promotion of Tregs by CD103(+) DCs180. Recently, it was also shown that 
retinoic acid can promote the development of human CD103+ dendritic cells from 
monocytes160. The CD103+ intestinal DC subset can convert retinal into retinoic acid 
because it expresses the retinal dehydrogenase enzymes (RALDH1 and RALDH2)180. 
Retinoic acid has been shown to inhibit Th17 and the conversion of Tregs to T 
follicular helper (Tfh) cells, and induce intestinal mucosal homing molecules CCR9 
and α4β7179,492,494,495,497. Also, retinoic acid is important for IgA-secreting cells, since 
mice deficient for vitamin A lack these cells in the small intestine184. There have been 
reports that miR-10a, a microRNA induced by retinoic acid in Th17 cells can induce 
expression of T-bet (associated with Th1 cells)497. This indicates that next to Tregs 
retinoic acid might also induce Th1 cells. Indeed, in an inflammatory environment 
retinoic acid could induce Th1 immunity631. Not only has vitamin A update via the 
diet an effect on the host, vitamin A uptake by pregnant mothers also influences 
the development of the neonatal immune system. As shown by van de Pavert and 
colleagues (2014) pups derived from mice fed vitamin A-deficient diets had markedly 
reduced lymph node size and decreased efficiency of immune responses532.
Vitamin D has been reported to enhance regulatory T cell induction via binding 
of the VDR-RXR (vitamin D receptor-retinoic X receptor) binding to an enhancer 
in the FoxP3 gene498. While vitamin D deficiency causes a reduction in CD8α+ 
intraepithelial T cells499. Recently, Spencer and colleagues (2014) showed that vitamin 
A deficiency leads to severely diminished type 3 innate lymphoid cells (ILC3s), 
which results in compromised immunity to acute bacterial infection. Additionally, 
vitamin A deprivation resulted in increased IL-13-producing ILC2s and resistance 
to nematode infection in mice490. Since vitamins A and D can have several direct 
and indirect effects on cells and signaling pathways, further research is necessary to 
understand their complete role in immune modulation. These findings, however, 
suggest that exposure to certain dietary factors (both in mother and child) can have 
profound influence on the development and effectiveness of the immune response. As 
with many multi-factorial diseases the interplay between host, microbes and dietary 
exposure might be different in each individual patient, making it extremely difficult 
to find causal relations rather than incidental associations. This is very well illustrated 
by what is known for Inflammatory Bowel Disease (IBD).
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When homeostasis between host and microbes is lost – the 
case of Inflammatory Bowel Disease
In recent years, genome wide association studies have revealed many single nucleotide 
polymorphisms (SNPs) in host genes that are associated with multi-factorial diseases. 
For example, in Inflammatory Bowel Disease (IBD) >160 genes are found to be 
associated with either ulcerative colitis and Crohn’s disease or both632. Each and every 
patient therefore, can have a unique combination of these SNPs. Interestingly, several 
of these associated genes has a role in bacterial-host interaction. Studies performed 
using experimental animals showed that knock-outs of these genes (such as Nod2 or 
enteric defensins) can change the intestinal microbial community518,633. Subsequently, 
changes in microbial community can influence disease susceptibility. The IL-10 
knock-out mice for example, does not develop colitis under germfree conditions. 
Interestingly, narrow and broad spectrum antibiotics can prevent disease in IL-
10-/- mice under specific pathogen free (SPF) conditions634. Furthermore, we have 
shown that that the composition of zebrafish intestinal microbiota can determine 
recruitment of different immune cells, enterocolitis susceptibility and severity635.
An illustration of influence of gene alterations on microbial dysbiosis and disease 
susceptibility comes from the studies performed by Garrett and colleagues636. Mice 
deficient for transcription factor T-bet and Rag2 (TRUC mice) showed increased 
TNF production by colonic dendritic cells leading to increased apoptosis of colonic 
epithelial cells and spontaneous colitis. This colitis was dependent on the intestinal 
microbiota since treatment of TRUC mice with a combination of antibiotics cured 
the mice from colitis. Later studies confirmed that TRUC mice have an altered 
microbiota (presence of Klebsiella pneumoniae and Proteus mirabilis)637. This colitis 
was also transmissible via the microbiota, since co-housing adult TRUC mice and 
WT mice (3:1) rendered WT mice more susceptible to develop colitis. Likewise, 
when a TRUC mother fostered pups of Rag2-/- or wild type mice, these mice-pups 
were also more susceptible and developed colitis that was histologically similar to 
colitis in TRUC mice637.
Another study that illustrates the importance of a functioning adaptive immune 
system was performed using zebrafish. In zebrafish, lymphocytes deficiency leads 
to failure to suppress bacteria of the order Vibrionales (that contains known fish 
pathogens) (our own unpublished observations). Adoptive transfer of T lymphocytes 
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could actively suppress outgrowth of these Vibrionales. Additionally, zebrafish T 
lymphocytes are able to induce epithelial Cxcl8-l1 expression, thereby augmenting 
mucosal immune responses638. In summary, these studies emphasize that genetic 
deficiencies (of genes involved in mucosal immunity) can modify the mucosal 
environment and allow for modulation of the microbiota which in turn can alter 
susceptibility towards disease. This clearly illustrates that modulation of the gut 
microbiota might be beneficial for IBD patients. Indeed, Sokol and colleagues 
(2008) identified Faecalibacterium prausnitzii as an anti-inflammatory commensal 
bacterium, which was severely reduced in Crohn disease patients365,639. These studies 
have encouraged fecal transplantation as a therapy for IBD patients, which results 
in remission in some but not all patients640–642. Clearly, future research to elucidate 
the complex interaction between host, diet and microbes in the context of chronic 
intestinal inflammation and during health is dearly needed.
Timing of exposure, does a window of opportunity exist?
Next to investigating the different pathways by which food and microbes alter 
host immunity, investigation on the concept of timing will be crucial. It has been 
suggested, that a window exists early in life when microbes alter host immunity, 
after which a set point is reached and homeostasis is established. There is indication 
that some processes might indeed take place in a specific time window, where after 
they cannot be changed again. For example, iNKT cells, a subset of invariant T 
cells that recognize glycolipids in the context of MHC-like molecule CD1d, were 
found to be more abundant in the colon (and lungs) of germfree mice643. These 
germ-free mice displayed increased morbidity in models of IBD and allergic asthma. 
The increased number of iNKT cells in the colon (and lungs) of germfree mice was 
shown to be the result of high expression of the chemokine CXCL16. Colonization 
of neonatal - but not adult - germfree mice protected the animals from this mucosal 
iNKT accumulation and related pathology643. This difference in iNKT accumulation 
associated with epigenetic modifications that enabled modification of CXCL16 
expression early in life, but not at adult age. This suggests that a host developmental 
(epigenetic) program exists that allows for environmental agents to shape immune 
responses only at certain time points of life. However, other studies suggest microbial 
and dietary modulation can also affect host immunity in later life. The success of 
fecal transplants in obese people and inflammatory bowel disease patients suggests 
18039 Olaf Perdijk PM.indd   223 04-09-18   19:57
Appendix 1
224
that lifelong modification of diet and microbes might be beneficial644. Likewise, it has 
been shown that glucosinolates derived from vegetables in the diet, such as cabbage 
and broccoli, can activate the aryl hydrocarbon receptor (AhR) and modulate 
immune responses508. AhR ligand TCDD can induce differentiation of Tregs while 
inhibiting development of Th17 cells, which correlates with increased methylation 
and demethylation of the respective promotors for FoxP3 and IL-17, indicating 
that epigenetic modification can occur upon AhR activation509. Thus, whereas host 
epigenetic changes might be induced by bacteria or nutrients it is not clear whether 
a specific window (early) in life exists or whether it can take place throughout life.
Figure 2. Development of mucosal immunity before and after birth. Contrary to what was believed, the 
fetal immune system contains mature T and B cells, that are actively repressed by regulatory T cells. Of note, 
the gut-associated lymphoid tissue (GALT) and the nasal-associated lymphoid tissue (NALT) are present before 
birth, while the bronchial-associated lymphoid tissue (BALT) develops after birth.
Future perspectives
In the last decade, through the development of large-scale metagenomic technologies, 
we have gained access to enormous datasets containing information on microbial 
and host genes in health and disease. The future challenge will be to make sense 
of these large datasets and to stratify patient groups according to their genomic or 
metabolomic profiles. In addition, modification of the mucosal immune system 
through dietary interventions (in both mothers and infants) requires more in depth 
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knowledge on how dietary nutrients or microbial patterns can alter host immunity 
(Figure 2). The fact that fetal life might not be as devoid of environmental stimulation 
as previously thought suggests that modification of the environment during pregnancy 
and early life might be able to (beneficially) alter immunity. Furthermore, epigenetic 
modification of the host by bacteria or dietary components might be time dependent. 
Future research should focus on the question whether host epigenetic modification 
can only be achieved in a specific window (early) in life or whether changes can be 
induced lifelong. Rapid technological advances in this field as evidenced by large 
metagenomic screens and epigenetic sequencing platforms will soon provide more 
answers on these questions.
In conclusion, environmental factors, such as dietary components and microbes can 
shape the mucosal immune system by influencing differentiation and development 
of immune cells and tissues. This in turn influences host susceptibility towards 
disease. By using model systems that can be easily manipulated both genetically 
and environmentally (i.e. zebrafish and mice) novel pathways can be discovered 
that control host responses towards environmental antigens. Elucidation of these 
conserved pathways will yield novel targets for nutritional interventions that will 
benefit human health.
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Summary
The increasing prevalence of allergies and asthma results in major health and socio-
economic burden. Globally 300 million people suffer from asthma, which is the 
cause of an estimated 250.000 annual deaths. Important risk factors for asthma are 
allergic sensitization and respiratory viral infections in early life. Allergic sensitization 
occurs upon the induction of an aberrant T helper (Th) 2-mediated response towards 
an – under homeostatic conditions - harmless antigen. The hygiene hypothesis 
that was already postulated in 1989, suggested that our more hygienic lifestyle 
caused a misbalance in our immune system. Now we know that exposure to several 
environmental factors may in fact trigger the regulatory compartment of our immune 
system that is essential for immune homeostasis. Furthermore, several epidemiological 
studies show a negative association between raw cow’s milk consumption in early life 
and allergy and asthma prevalence, indicating that raw cow’s milk induces immune 
regulation. Hence, studying the immunomodulatory effect of raw cow’s milk may 
improve our understanding of which components are relevant, and how we can apply 
these components to ultimately prevent allergic diseases and asthma.
In chapter 2, we reviewed the literature and suggested several mechanisms by 
which raw cow’s milk might promote immune homeostasis in the respiratory tract. 
In chapter 3, we showed that bovine lactoferrin (LF) modulates differentiation 
of human monocytes into dendritic cells (DC) that are hyporesponsive towards 
lipopolysaccharide (LPS) stimulation. This phenotype is suggestive for tolerogenic 
DC. However, LF binds LPS with high affinity. Therefore, it was of interest to 
investigate whether the immunomodulatory effect was mediated by LF or bound LPS. 
We showed for the first time that the protein structure of bovine LF was essential for 
its immunomodulatory effect, showing that the effect of LF was not solely mediated 
by endotoxin tolerance. LPS is a gram-negative cell wall constituent that often 
contaminates biological samples. LPS is highly immunogenic on myeloid cells, which 
gives false positive results in immunological assays. Hence, we optimized an existing 
Triton X-114 method to ensure complete removal of LPS (chapter 4). Importantly, 
the tested LPS-depleted food proteins maintain their correct folding after applying 
this method, which is essential for their effect on the immune system. In chapter 5, 
we showed that in contrast to results from studies in mice, 3’-sialyllactose (3’SL) does 
not signal via human Toll-like receptor (TLR) 4. By applying the optimized Triton 
X-114 method, we concluded that TLR4 signaling was driven by LPS contamination 
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that modulated differentiation of IL-4+GM-CSF-cultured monocytes into tolerogenic 
DC. In chapter 6 we showed that the milk saccharides 2’-fucosyllactose (2’FL), 
6’-sialyllactose (6’SL) and galactooligosaccharides (GOS) do not modulate human DC 
differentiation. In contrast, vitamin D3 (VitD3) and TGFβ induced differentiation 
of monocytes into tolerogenic DC. Using these immature TGFβDC and VitD3-
DC, which were characterized for their expression of receptors that recognize milk 
saccharides, we revealed that 2’FL, 6’SL and GOS do not modulate DC maturation. 
Instead, we showed in chapter 7 that SL and GOS differentially modulate microbiota 
composition and short chain fatty acid (SCFA) production. Moreover, SL and 
GOS induced the outgrowth of Bacteroides and Bifidobacterium and increased the 
production of the SCFAs propionate and lactate, respectively. Additionally, SL and 
GOS induced the expression of genes involved in cell cycle control of the stimulated 
epithelial cells. These epithelial cells produced more alkaline phosphatase (ALP) 
that is indicative for enhanced differentiation. SL and GOS also modulated barrier 
functioning by enhancing the re-epithelization rate in an in vitro scratch assay. In 
chapter 8, an ovalbumin (OVA)-induced asthma model was used and we showed 
that intervention with a low-fiber diet resulted in a gradual change in microbiota 
composition along the complete duration of the study. Moreover, the abundance of 
Firmicutes increased while the abundance of Bacteroides decreased over time. Despite 
this pronounced impact of diet on microbiota composition, supplementation of 3’SL 
to the drinking water induced the outgrowth the genus Akkermansia. Akkermansia 
has been suggested to contribute to gastrointestinal homeostasis and has been 
associated with a lower allergy prevalence. In chapter 9, key findings of this research 
are summarized and discussed, and possibilities for future research are given. This 
thesis shows that bovine milk components (i.e. LF, TGFβ and vitD3 - but not SL) 
modulate DC differentiation and functioning. Additionally, we showed that SL and 
GOS both enhance differentiation of epithelial cells, and promote re-epithelization, 
while they induce the outgrowth of a distinct microbial- and SCFA profile. In an in 
vivo pilot study, we showed that 3’SL induces the outgrowth of Akkermansia. The 
impact of these microbial and metabolomic changes should be further investigated in 
allergic and asthma models. Additionally, there is a pressing need to reveal underlying 
mechanisms to fully understand the effect of bovine milk-derived components in 
early life on microbiota composition, metabolomics and its consequence for host 
physiology.
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De toename in allergieën en astma zorgt voor een verslechtering van de 
volksgezondheid en heeft negatieve gevolgen op sociaaleconomisch vlak. Wereldwijd 
lijden ongeveer 300 miljoen mensen aan astma en is de oorzaak van 250.000 doden 
per jaar. Belangrijke riscofactoren voor de ontwikkeling van astma zijn allergische 
sensibilisatie en luchtweginfecties op jonge leeftijd. Allergische sensibilisatie vindt 
plaats als het afweersysteem een afwijkende Th2 gemedieerde afweerreactie tot stand 
brengt tegen, onder normale omstandigheden, een ongevaarlijk antigeen. De hygiëne 
hypothese werd al geformuleerd in 1989 en suggereert dat onze hygiënische levensstijl 
een disbalans veroorzaakt in het afweersysteem. Nu weten we dat de blootstelling 
aan bepaalde omgevingsfactoren essentieel is om het regulerende gedeelte van ons 
afweersysteem te activeren, hetgeen essentieel is voor immuunhomeostase. Daarbij 
laten meerdere epidemiologische studies zien dat het drinken van rauwe koemelk 
op jonge leeftijd negatief gecorreleerd is aan het voorkomen van allergieën en astma, 
wat suggereert dat rauwe koemelk het regulerende gedeelte van ons afweersysteem 
activeert. Vandaar is het mogelijk dat wij door het bestuderen van het effect van 
rauwe koemelk op het afweersysteem uit kunnen vinden welke componenten uit 
rauwe koemelk relevant zijn en hoe deze componenten uiteindelijk toegepast kunnen 
worden om allergieën en astma te voorkomen.
In hoofdstuk 2 hebben wij de literatuur opnieuw bekeken en zijn op basis hiervan 
meerdere mechanismen voorgesteld hoe rauwe koemelk bijdraagt aan homeostase 
van het afweersysteem. In hoofdstuk 3 laten wij zien dat koemelk lactoferrine (LF) 
de differentiatie van menselijke monocyten naar dendritische cellen (DC) moduleert. 
Deze DCs reageren minder op blootstelling aan lipopolysacchariden (LPS) wat 
suggestief is voor tolerogene DC. Echter, LF bindt LPS met hoge bindingsaffiniteit. 
Het was daarom belangrijk om te onderzoeken of LF, of LPS gebonden aan LF, 
verantwoordelijk was voor het effect op het afweersysteem. Wij bewezen voor de eerste 
keer dat de eiwitstructuur van LF essentieel is voor het effect op het afweersysteem 
en dat het effect van LF dus niet alleen veroorzaakt werd door endotoxine tolerantie. 
LPS is een derivaat van de celwand van Gram-negatieve bacteriën en zorgt vaak 
voor vervuiling in biologische preparaten. LPS is zeer immunogeen voor myeloïde 
cellen, wat voor fout-positieve resultaten zorgt in immunologische testen. Daarom 
hebben wij een bestaande Triton X-114 methode geoptimaliseerd om LPS volledig 
te verwijderen uit biologische preparaten (hoofdstuk 4). Belangrijker nog, de geteste 
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LPS-vrije voedingseiwitten behielden hun correcte vouwing na het toepassen van 
deze methode, wat essentieel is voor hun effect op het afweersysteem. In hoofdstuk 5 
hebben wij laten zien dat 3’-sialyllactose humane Toll-like receptor (TLR)4 signalering 
niet activeert, wat in tegenstelling is tot wat anderen hebben laten zien in muizen. 
Door het toepassen van de Triton X-114 methode bewezen wij dat TLR4 signalering 
gedreven werd door LPS vervuiling in het 3’SL preparaat. Deze vervuiling, en niet 
3’SL, induceerde de differentiatie van monocyten in tolerogene DC. In hoofdstuk 6 
onderzochten wij de melksuikers 2’-fucosyllactose (2’FL), 6'-sialyllactose (6’SL) en 
galactooligosaccharides (GOS) en hun effect op DCs. 2’FL, 6’SL en GOS waren niet 
in staat om humane DC differentiatie te moduleren. In tegenstelling, vitamine D3 
(VitD3) en TGFβ induceerden wel de differentiatie van monocyten naar tolerogene 
DC. Door gebruik te maken van deze vitD3DC en TGFβDC, die gekarakteriseerd 
werden voor hun expressie van receptoren die mogelijk de melksuikers herkennen, 
lieten wij zien dat 2’FL, 6’SL en GOS ook niet in staat waren om DC maturatie 
te beïnvloeden. Daarentegen lieten wij in hoofdstuk 7 zien dat SL en GOS wel 
een differentieel effect hebben op de microbiële samenstelling en productie van 
kortketenige vetzuren. Daarnaast bevorderden SL en GOS de groei van respectievelijk 
Bacteroides en Bifidobacterium en de bacteriële productie van propionaat en lactaat. 
Ook induceerden SL en GOS de expressie van genen betrokken bij de regulatie van de 
celcyclus. SL en GOS hadden ook invloed op de barrierefunctie door het versnellen van 
de re-epithelisatieprocess in een in vitro krasassay. De epitheelcellen produceerde meer 
alkaline fosfatase, wat duidt op verhoogde differentiatie. In hoofdstuk 8 gebruikten 
wij een ovalbumine (OVA)-geïnduceerd astma model en lieten zien dat de interventie 
met een laag vezeldieet een geleidelijke verandering in microbiotasamenstelling 
veroorzaakte; de Firmicutes namen toe en Bacteroides namen af gedurende de duur 
van de studie. Ondanks dit grote effect van het dieet op de microbiële samenstelling, 
resulteerde de toevoeging van 3’SL in het drinkwater in een groei van het genus 
Akkermansia. Akkermansia kan bijdragen aan homeostase in het maagdarmkanaal 
en zijn aanwezigheid is negatief gecorreleerd met het voorkomen van allergieën. In 
hoofdstuk 9 worden de hoofbevindingen bediscussieerd en speculeren wij over de 
mogelijkheden voor vervolgonderzoek.
Dit proefschrift liet zien dat koemelkcomponenten (d.w.z. LF, TGFβ and VitD3 – 
maar niet SL) DC differentiatie en functie moduleerden. Daarbij bevorderden SL 
en GOS beiden de differentiatie en re-epitheliasatie van epitheelcellen, terwijl de 
toevoeging van SL en GOS aan bacteriele culturen een andere uitgroei van bacterien 
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en productie van kortketenige vetzuren induceerde. In een in vivo pilot studie, 
bevorderde 3’SL de groei van Akkermansia. De invloed van deze veranderingen 
in microbiële samenstelling en metabolieten moeten verder onderzocht worden 
in allergie en astma modellen. Daarbij is het noodzakelijk om de onderliggende 
mechanismen te ontrafelen om zo het effect van koemelkcomponenten in het vroege 
leven op microbiële samenstelling, verandering in metabolieten en de consequentie 
voor de fysiologie van de gastheer beter te begrijpen.
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Propositions
1. Human milk oligosaccharides do not signal via Toll-like receptor 4 (this thesis).
2.  Bovine milk components show immunomodulatory activity by halting monocyte-
derived dendritic cell differentiation (this thesis).
3. Multi-disciplinary research is essential to understand human biology.
4. Science benefits the most if you take an adventurous approach.
5. Mistakes are of key importance for learning, so make them while doing a PhD.
6. Accepting what we do not know is key for novel ideas.
7. Writing at home increases productivity.
8. Gaming improves the ability to concentrate.
Propositions belong to the thesis, entitled
Immune modulation by cow’s milk components:
Implications for respiratory health
Olaf Perdijk
Wageningen, October 12th, 2018
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